data_2lus_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lus _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.8 m120 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.63 ' H ' ' HB3' ' A' ' 68' ' ' SER . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' CA ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.609 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.759 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.668 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' OE1' ' C ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 31' ' ' PHE . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.475 ' N ' ' HB1' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB3' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.615 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.522 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.783 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.645 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 106' ' ' ILE . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 114' ' ' ILE . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 119' ' ' GLY . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.662 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.662 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.645 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' OE1' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.533 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.377 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 7' ' ' ILE . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.636 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.587 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.563 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 65' ' ' ILE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.641 ' N ' ' OG ' ' A' ' 68' ' ' SER . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.679 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.455 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.657 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.764 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.452 ' N ' ' HB1' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.642 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.567 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.657 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.627 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.603 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.525 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.525 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.838 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.632 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.444 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.547 ' O ' HG21 ' A' ' 122' ' ' ILE . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.451 ' HZ3' HG23 ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.451 HG23 ' HZ3' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.665 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.665 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.632 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.679 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 9.5 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 1.4 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.8 m-80 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.553 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.886 0.374 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 4' ' ' ILE . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.612 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.675 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.569 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.483 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.71 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.569 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.811 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.734 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB3' ' CB ' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.571 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.71 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.604 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.46 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.593 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.743 ' HG ' ' N ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.743 ' N ' ' HG ' ' A' ' 98' ' ' SER . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.597 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.597 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.777 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.494 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.532 HD11 ' CZ3' ' A' ' 141' ' ' TRP . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.621 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.621 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.494 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.4 m-80 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.532 ' CZ3' HD11 ' A' ' 114' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.891 0.377 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 1.1 m-80 -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' A' ' 25' ' ' ASP . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG21 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.665 ' O ' ' C ' ' A' ' 35' ' ' ALA . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.686 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.815 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.627 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.547 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.474 HD13 ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.636 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.519 ' C ' ' CD ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.815 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.686 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.645 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.0 m120 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.526 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.815 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.41 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.693 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.693 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.7 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.59 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.527 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.661 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.64 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.494 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 29' ' ' ILE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 29' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 65' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.654 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.787 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.492 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.654 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.617 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.603 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.603 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.795 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.655 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG11 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 141' ' ' TRP . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.422 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.669 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.655 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.443 HD22 ' NE ' ' A' ' 136' ' ' ARG . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.477 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.443 ' NE ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.493 ' CD1' ' C ' ' A' ' 138' ' ' PHE . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.645 ' ND2' ' OE2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 114' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.621 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HZ1' ' HB3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' N ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 34' ' ' SER . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.671 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.606 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.639 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.807 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.681 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.582 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.564 ' H ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.429 ' CG2' HD11 ' A' ' 90' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.807 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.502 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.686 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.798 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD11 ' CG2' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.605 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.613 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.613 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.773 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.554 HD11 ' CH2' ' A' ' 141' ' ' TRP . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 119' ' ' GLY . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.507 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.721 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.721 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.675 ' O ' ' N ' ' A' ' 134' ' ' GLY . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.463 HD23 ' HE ' ' A' ' 136' ' ' ARG . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 136' ' ' ARG . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.2 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 140' ' ' ASN . 0.8 OUTLIER -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CZ2' ' CG2' ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.897 0.38 . . . . 0.0 110.54 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.567 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 8' ' ' LYS . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.545 ' CD1' ' CG ' ' A' ' 25' ' ' ASP . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.641 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.583 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.786 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.658 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.465 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.872 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.786 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.641 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.749 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB3' ' SD ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.434 ' H ' ' HG1' ' A' ' 101' ' ' THR . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.603 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.603 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.785 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 HD12 ' CZ3' ' A' ' 141' ' ' TRP . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.445 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.723 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.667 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.56 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 4' ' ' ILE . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.719 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' VAL . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.637 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.691 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.747 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.637 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.535 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.781 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HA ' ' CD ' ' A' ' 26' ' ' LYS . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.468 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.627 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 68' ' ' SER . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.56 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.681 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.6 m80 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.636 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.544 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.544 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.808 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.689 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.466 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.663 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.663 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.689 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.6 t-20 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.515 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.523 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.867 0.365 . . . . 0.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.686 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' VAL . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 9' ' ' LEU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.494 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HH ' ' CB ' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.679 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.624 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.786 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.654 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 138' ' ' PHE . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.426 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.601 ' CE1' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.793 ' H ' ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.635 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.635 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.617 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.617 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.806 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 ' CZ2' ' A' ' 141' ' ' TRP . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.631 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.631 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.2 OUTLIER -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.702 ' HE ' ' NE2' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.751 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.702 ' NE2' ' HE ' ' A' ' 127' ' ' ARG . 81.6 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.751 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.637 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.525 ' HE1' ' HA2' ' A' ' 126' ' ' GLY . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.64 ' C ' HE21 ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.707 HE21 ' N ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 HD13 ' A' ' 7' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.655 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.711 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.568 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.596 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.607 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 26' ' ' LYS . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.454 HD11 ' CZ ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.688 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.587 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.486 ' CG ' ' HG3' ' A' ' 63' ' ' GLU . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.669 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.434 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.633 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.633 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.522 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.841 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.55 HD12 ' CH2' ' A' ' 141' ' ' TRP . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.42 ' HG1' ' CB ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.488 HD12 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.67 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.492 ' OE1' ' CG ' ' A' ' 140' ' ' ASN . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.568 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 2.6 mt-30 -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.527 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 9.1 m-80 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.552 ' CZ2' HG22 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.455 ' NH1' ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.623 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.475 HD12 ' HG ' ' A' ' 94' ' ' SER . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.682 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.637 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.623 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.733 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.752 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.846 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.663 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.624 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.483 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.589 ' O ' ' OG ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.618 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.634 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.623 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.425 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.644 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.644 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.61 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.61 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.814 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.72 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 HG11 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.505 HD11 ' CZ3' ' A' ' 141' ' ' TRP . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.703 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.704 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.752 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 51.7 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.463 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.834 0.349 . . . . 0.0 110.582 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 7' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.674 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.581 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CE1' ' CG2' ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.61 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.663 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.744 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.621 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.635 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.663 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.477 ' CG ' ' HG3' ' A' ' 63' ' ' GLU . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.435 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.638 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.596 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.596 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.776 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 106' ' ' ILE . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.462 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.406 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.677 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.468 HD21 ' HE ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 136' ' ' ARG . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.489 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.57 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.895 0.379 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' ILE . 47.4 mm-40 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.691 ' O ' ' N ' ' A' ' 25' ' ' ASP . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.671 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.666 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.796 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' OE1' ' CD2' ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.759 ' CG1' ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.912 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.485 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.6 ' CG ' ' OE2' ' A' ' 82' ' ' GLU . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.43 ' HE1' ' HZ1' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.589 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.643 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.9 m120 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.643 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.537 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.537 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.847 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.601 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.438 HG22 ' CD1' ' A' ' 106' ' ' ILE . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.512 HD13 ' CH2' ' A' ' 141' ' ' TRP . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 119' ' ' GLY . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.686 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.686 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.601 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.719 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.585 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.681 ' O ' ' N ' ' A' ' 134' ' ' GLY . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.461 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.537 ' NE1' HG22 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 94' ' ' SER . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.413 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HZ1' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 25' ' ' ASP . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.77 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.68 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.794 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.629 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.578 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.775 ' CG1' ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.906 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.68 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.632 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 10.5 m120 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.632 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 101' ' ' THR . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.531 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.531 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.82 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.651 ' O ' ' O ' ' A' ' 124' ' ' MET . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.441 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 114' ' ' ILE . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.431 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.655 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.655 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.651 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.3 OUTLIER -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.51 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 137' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 23.6 m-80 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.552 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HD11 ' A' ' 122' ' ' ILE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.882 0.372 . . . . 0.0 110.545 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 4' ' ' ILE . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.728 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.676 ' NZ ' ' CB ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' N ' HG21 ' A' ' 29' ' ' ILE . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.699 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.783 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.543 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.624 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' OG1' ' A' ' 45' ' ' THR . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.612 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.612 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.546 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.795 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.486 ' O ' ' NH2' ' A' ' 127' ' ' ARG . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.653 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.483 HG12 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.553 ' O ' HG22 ' A' ' 122' ' ' ILE . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 120' ' ' THR . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.713 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.713 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.733 ' ND2' ' CD ' ' A' ' 127' ' ' ARG . 0.6 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.733 ' CD ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.565 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 137' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CZ2' ' CG2' ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.63 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.661 ' CG2' ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.661 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.5 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.685 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.794 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.652 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.468 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.501 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.82 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.669 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.472 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.654 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.652 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.4 m80 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.456 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.645 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.536 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.536 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.803 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.648 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 122' ' ' ILE . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.433 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.728 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.728 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.652 ' O ' ' N ' ' A' ' 126' ' ' GLY . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.3 t-20 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.794 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 4.5 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.556 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.87 0.367 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.608 ' N ' HD21 ' A' ' 20' ' ' ASN . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 7' ' ' ILE . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 6' ' ' GLY . 0.6 OUTLIER -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.606 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.635 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.667 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.657 ' H ' ' HG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.583 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.645 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.802 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.558 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.645 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.802 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.645 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.606 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.609 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.609 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.523 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.523 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.447 ' H ' HG21 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.804 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.716 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD1' ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.727 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.727 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.716 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.698 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.704 HE21 ' H ' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.49 ' O ' ' OXT' ' A' ' 143' ' ' ARG . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' ILE . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.652 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.78 ' H ' ' HZ3' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.565 ' H ' ' CB ' ' A' ' 68' ' ' SER . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.507 ' H ' ' HG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.851 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.67 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' OD1' ' CB ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.547 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.645 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.434 HG21 HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.637 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.637 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.538 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.538 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.833 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 ' CG1' ' HE1' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.78 ' HZ3' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.481 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.663 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.663 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' LEU . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.666 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.645 ' CG ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.561 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.945 0.403 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.799 ' H ' HD21 ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 7' ' ' ILE . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.649 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.549 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.799 HD21 ' H ' ' A' ' 6' ' ' GLY . 0.5 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 29' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.75 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.65 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.805 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.655 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.561 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.569 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.681 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.65 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.574 ' CH2' ' OD1' ' A' ' 86' ' ' ASP . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.791 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.515 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.786 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 106' ' ' ILE . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 HD12 ' CZ3' ' A' ' 141' ' ' TRP . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 119' ' ' GLY . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 117' ' ' LYS . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.425 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.641 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.641 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.548 ' C ' HD21 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.469 HD22 ' NE ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 136' ' ' ARG . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.549 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.925 0.393 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 20' ' ' ASN . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' CD ' ' A' ' 91' ' ' PRO . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' ARG . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.0 t-20 -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.641 ' OG ' ' O ' ' A' ' 33' ' ' PHE . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.604 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.719 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.596 ' SD ' ' CG2' ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.813 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.641 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.426 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' OD1' ' C ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.464 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.618 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.5 m80 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.641 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.626 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.779 HD21 ' HZ2' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.779 ' HZ2' HD21 ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.533 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.533 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.832 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HZ1' ' HA ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.446 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.695 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.695 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.709 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.543 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.596 ' CG2' ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 143' ' ' ARG . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 3.0 pt-20 -142.31 115.11 8.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 95.5 m-85 -157.37 173.86 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.542 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -66.26 -44.81 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.502 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.681 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.8 m120 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.662 ' C ' ' H ' ' A' ' 36' ' ' HIS . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.722 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -65.95 36.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.662 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.8 m-70 -60.12 25.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.916 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.797 ' CH2' ' SG ' ' A' ' 38' ' ' CYS . 1.9 p-90 -83.91 -40.99 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.797 ' SG ' ' CH2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -79.29 -49.1 1.47 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 61.6 Cg_endo -89.34 165.21 5.48 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.636 . . . . 0.0 112.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.658 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 41.5 Cg_endo -71.07 156.63 59.48 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.711 2.274 . . . . 0.0 112.154 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.84 40.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.463 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.454 ' NH1' ' HA ' ' A' ' 40' ' ' PRO . 2.3 mpt_? -81.32 149.8 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.815 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.66 3.27 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.759 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.668 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' OE1' ' C ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.483 HG13 ' CD2' ' A' ' 31' ' ' PHE . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.475 ' N ' ' HB1' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.716 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB3' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.451 HG21 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.615 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.522 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.783 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.645 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 106' ' ' ILE . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 114' ' ' ILE . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 119' ' ' GLY . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.662 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.662 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.645 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.4 OUTLIER -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' OE1' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.449 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.533 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' H1 ' ' H ' ' A' ' 2' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.435 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 1.7 tm-20 -47.64 120.57 3.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.57 121.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -53.7 -49.52 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.551 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.453 HG22 HD13 ' A' ' 7' ' ' ILE . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.636 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.587 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.563 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CE2' HG13 ' A' ' 65' ' ' ILE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 36' ' ' HIS . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.84 68.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.774 ' CG ' ' SG ' ' A' ' 41' ' ' CYS . 2.9 m-70 -80.05 23.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.113 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.788 ' NE1' ' SG ' ' A' ' 38' ' ' CYS . 1.6 p-90 -88.31 -41.95 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.605 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' SG ' ' NE1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.66 -53.34 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.531 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD3' ' SG ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.3 161.85 22.77 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.786 2.324 . . . . 0.0 112.275 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 62.3 Cg_endo -77.49 156.51 32.4 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.958 2.439 . . . . 0.0 112.2 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.774 ' SG ' ' CG ' ' A' ' 36' ' ' HIS . 1.1 p 156.72 45.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.487 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.28 149.58 28.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.11 -35.94 3.22 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.679 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.555 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.455 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.657 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.764 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.49 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.452 ' N ' ' HB1' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.567 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.657 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.627 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.448 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.603 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.603 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.525 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.525 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.838 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.632 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.444 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.547 ' O ' HG21 ' A' ' 122' ' ' ILE . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.451 ' HZ3' HG23 ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.451 HG23 ' HZ3' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.665 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.665 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.632 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.679 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 9.5 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 1.4 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.8 m-80 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.553 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.04 169.82 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.535 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -175.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -53.53 -51.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.644 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 4' ' ' ILE . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.612 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.604 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.492 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.675 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -31.57 -47.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' CE1' ' OG1' ' A' ' 45' ' ' THR . 1.2 t-80 65.15 -21.74 0.08 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.783 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.3 p-90 -91.64 -49.36 6.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.686 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.783 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -75.57 -49.59 3.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 110.196 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 92.8 Cg_endo -87.97 112.81 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.288 2.659 . . . . 0.0 112.15 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 50.3 Cg_exo -48.98 151.85 5.28 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.667 2.245 . . . . 0.0 112.189 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.46 45.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.436 HH11 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -81.43 149.6 28.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.08 -36.07 3.19 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.681 ' OG1' ' CE1' ' A' ' 36' ' ' HIS . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.483 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.71 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.569 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.811 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.734 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' HB3' ' CB ' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.571 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.71 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.604 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.46 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.593 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.743 ' HG ' ' N ' ' A' ' 99' ' ' ASN . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.743 ' N ' ' HG ' ' A' ' 98' ' ' SER . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.593 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.597 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.597 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.777 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.494 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.532 HD11 ' CZ3' ' A' ' 141' ' ' TRP . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.434 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.621 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.621 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' O ' ' A' ' 112' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.494 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.4 m-80 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.532 ' CZ3' HD11 ' A' ' 114' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 52.57 -125.3 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -148.48 -179.63 7.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.538 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -72.95 -44.84 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.615 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 1.1 m-80 -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.662 ' O ' ' N ' ' A' ' 25' ' ' ASP . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG21 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 36' ' ' HIS . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -6.6 -61.21 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER 68.26 -10.9 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.04 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.776 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -95.31 -51.2 4.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.611 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.776 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.44 -50.34 10.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.397 . . . . 0.0 110.153 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 86.1 Cg_endo -86.28 150.95 9.29 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.171 2.581 . . . . 0.0 112.195 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.09 135.87 19.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.797 2.331 . . . . 0.0 112.163 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . 0.1 OUTLIER 174.41 49.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -81.35 149.31 28.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 120.15 -35.76 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.545 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.686 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.815 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.627 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.547 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD13 ' CE2' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.702 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' C ' ' CD ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.815 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.686 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.645 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.0 m120 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.526 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.815 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.735 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.41 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.693 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.693 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.735 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.7 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.59 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.527 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' PHE . 35.4 mt-10 -73.52 -166.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.522 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' GLU . 16.0 m-85 33.21 -148.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.26 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.626 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.661 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.64 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.494 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG21 ' N ' ' A' ' 29' ' ' ILE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' N ' HG23 ' A' ' 29' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' CE2' HG13 ' A' ' 65' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.691 ' OG ' ' CD2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -60.69 68.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.727 ' CD2' ' SG ' ' A' ' 41' ' ' CYS . 23.4 m170 -78.4 24.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.391 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -90.5 -43.02 10.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.627 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.06 -51.0 1.34 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.292 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.8 Cg_endo -83.21 164.46 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.865 2.376 . . . . 0.0 112.044 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 Cg_endo -67.74 -87.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.724 2.283 . . . . 0.0 112.245 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.727 ' SG ' ' CD2' ' A' ' 36' ' ' HIS . 1.8 p 43.22 38.81 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 43' ' ' GLY . 4.0 ttt-85 -81.33 149.93 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.804 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . 123.51 -35.45 3.32 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.654 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.787 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.648 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.492 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.498 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.47 ' N ' ' HB3' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.654 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.617 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.617 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.603 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.603 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.795 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.655 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG11 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 141' ' ' TRP . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.422 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.669 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.655 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.443 HD22 ' NE ' ' A' ' 136' ' ' ARG . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.477 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.443 ' NE ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.493 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.645 ' ND2' ' OE2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 114' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 28.7 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.588 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.547 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -46.89 124.61 6.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -60.65 -59.65 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.621 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HB3' ' HZ1' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.625 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.625 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' N ' HG23 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' OH ' ' CD2' ' A' ' 36' ' ' HIS . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' O ' ' CB ' ' A' ' 34' ' ' SER . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 36' ' ' HIS . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -27.15 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 63.66 -24.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.904 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.679 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.3 p-90 -93.29 -47.63 6.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.614 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.83 -51.63 1.13 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.253 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.493 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 91.4 Cg_endo -87.74 143.92 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.107 2.538 . . . . 0.0 112.171 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 60.5 Cg_endo -76.28 146.25 28.07 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.78 2.32 . . . . 0.0 112.036 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 40' ' ' PRO . 0.9 OUTLIER 159.35 15.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -61.04 149.66 36.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.75 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.33 -33.35 4.02 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.606 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.639 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.589 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.807 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.582 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.564 ' H ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.509 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.429 ' CG2' HD11 ' A' ' 90' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.807 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.502 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.686 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.798 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD11 ' CG2' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.605 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.613 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.613 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.773 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.639 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.554 HD11 ' CH2' ' A' ' 141' ' ' TRP . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 119' ' ' GLY . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.467 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.507 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.721 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.721 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.639 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.584 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.675 ' O ' ' N ' ' A' ' 134' ' ' GLY . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.463 HD23 ' HE ' ' A' ' 136' ' ' ARG . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 136' ' ' ARG . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.2 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 140' ' ' ASN . 0.8 OUTLIER -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CZ2' ' CG2' ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.654 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.7 tmm? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.24 -51.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.61 -178.99 5.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -61.84 -27.46 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.54 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 ' CG1' ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 8' ' ' LYS . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.605 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.605 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' CD1' ' CG ' ' A' ' 25' ' ' ASP . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.48 77.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.699 ' O ' ' CG ' ' A' ' 36' ' ' HIS . 1.7 t60 -86.12 26.33 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -92.32 -42.31 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.475 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -87.68 -50.59 0.43 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.526 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 71.1 Cg_endo -80.15 151.79 20.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.956 2.437 . . . . 0.0 112.267 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 41' ' ' CYS . 58.0 Cg_endo -74.74 140.65 26.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.406 . . . . 0.0 112.303 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.679 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 17.0 t 173.34 48.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.413 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -81.27 149.32 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.8 -36.09 3.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.446 HD13 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.641 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.583 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.488 ' SD ' HG21 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.786 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.658 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.518 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.465 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.872 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.465 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.786 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.641 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.749 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB3' ' SD ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.504 ' CG2' ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.434 ' H ' ' HG1' ' A' ' 101' ' ' THR . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.603 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.603 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.785 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 HD12 ' CZ3' ' A' ' 141' ' ' TRP . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.445 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' CD1' ' SD ' ' A' ' 124' ' ' MET . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.723 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.723 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.667 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.667 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.56 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -67.49 34.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.608 ' H ' ' C ' ' A' ' 1' ' ' MET . 4.6 m-85 -46.25 -174.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -82.14 -52.29 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 4' ' ' ILE . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.719 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' VAL . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.637 ' CG2' ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.637 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.691 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.747 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.73 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -27.85 -48.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.73 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.9 p-80 60.71 -26.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.308 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.689 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -85.65 -45.74 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.882 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.51 -49.85 11.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.987 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 91.2 Cg_endo -86.35 164.99 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.208 2.606 . . . . 0.0 112.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.37 -101.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.762 2.308 . . . . 0.0 112.092 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 t 49.62 43.56 24.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.409 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 2.2 ptm85 -81.37 149.27 28.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.7 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.96 -34.17 4.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.637 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.535 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.781 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HA ' ' CD ' ' A' ' 26' ' ' LYS . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.468 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.423 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.627 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 68' ' ' SER . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.56 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.681 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.6 m80 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.45 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.636 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.636 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.544 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.544 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.808 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.689 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.663 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.663 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.689 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.6 t-20 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.452 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.515 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.523 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.536 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -46.31 -61.04 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.24 171.27 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -85.01 -41.52 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.686 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 17' ' ' VAL . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 9' ' ' LEU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.494 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.498 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HH ' ' CB ' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.679 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -29.17 -50.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.716 ' NE2' ' HE ' ' A' ' 42' ' ' ARG . 20.1 t-160 64.79 -22.16 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.307 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.678 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -88.62 -45.52 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -83.91 -50.8 0.63 Allowed Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.396 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.489 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 95.0 Cg_endo -87.78 154.95 7.43 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.191 2.594 . . . . 0.0 112.201 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 60.3 Cg_endo -76.43 147.33 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.853 2.369 . . . . 0.0 112.054 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.2 m 158.7 37.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.663 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.716 ' HE ' ' NE2' ' A' ' 36' ' ' HIS . 8.8 mtp180 -81.27 149.48 28.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -35.29 3.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.434 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.624 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.786 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.654 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HG2' ' CE1' ' A' ' 138' ' ' PHE . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.426 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.601 ' CE1' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.793 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.635 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.635 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.617 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.617 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.806 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 ' CZ2' ' A' ' 141' ' ' TRP . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.631 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.631 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.453 ' SD ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.2 OUTLIER -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.702 ' HE ' ' NE2' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.751 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.702 ' NE2' ' HE ' ' A' ' 127' ' ' ARG . 81.6 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.751 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.637 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.637 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.525 ' HE1' ' HA2' ' A' ' 126' ' ' GLY . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 62.68 147.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.599 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.634 ' C ' ' NE2' ' A' ' 5' ' ' GLN . 67.6 m-85 -89.05 -137.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.64 ' C ' HE21 ' A' ' 5' ' ' GLN . 0.3 OUTLIER -77.92 -46.0 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.707 HE21 ' N ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 HG23 HD13 ' A' ' 7' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.655 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.588 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.711 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 69' ' ' SER . . . -41.03 118.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.688 ' CE1' ' OG1' ' A' ' 45' ' ' THR . 0.2 OUTLIER -96.76 19.11 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.867 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.789 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 2.5 p-90 -124.59 -50.36 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.567 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.789 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.35 -57.05 7.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.943 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 38' ' ' CYS . 85.7 Cg_endo -91.94 149.83 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.01 2.474 . . . . 0.0 112.305 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.39 140.94 22.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.778 2.319 . . . . 0.0 111.988 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p 172.7 45.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.748 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' ' HE2' ' A' ' 36' ' ' HIS . 4.9 tmm_? -81.31 149.66 28.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.21 -35.4 3.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.568 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.688 ' OG1' ' CE1' ' A' ' 36' ' ' HIS . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.607 ' CD1' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.596 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 26' ' ' LYS . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.454 HD11 ' CZ ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 36' ' ' HIS . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.688 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.587 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.486 ' CG ' ' HG3' ' A' ' 63' ' ' GLU . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.669 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.633 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.633 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.522 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.841 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.55 HD12 ' CH2' ' A' ' 141' ' ' TRP . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.42 ' HG1' ' CB ' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.488 HD12 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.67 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.67 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.444 ' SD ' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.492 ' OE1' ' CG ' ' A' ' 140' ' ' ASN . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.568 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 2.6 mt-30 -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.527 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 9.1 m-80 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.552 ' CZ2' HG22 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.455 ' NH1' ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 1' ' ' MET . 5.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 102.8 9.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.57 -163.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -98.85 -50.82 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.475 HD12 ' HG ' ' A' ' 94' ' ' SER . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.682 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.637 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.637 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.43 ' CG2' HD22 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.623 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.733 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -24.87 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.797 ' CE1' ' CG ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 61.7 -28.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.185 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.659 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.4 p-90 -89.94 -47.29 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.951 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.92 -50.23 9.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.393 . . . . 0.0 110.078 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 93.8 Cg_endo -86.15 165.07 9.87 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.159 2.573 . . . . 0.0 112.103 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.66 -101.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.783 2.322 . . . . 0.0 112.034 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.8 m 42.5 28.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.25 149.38 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.623 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.06 -32.35 4.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.752 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.498 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.846 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.663 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.624 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.483 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.797 ' CG ' ' CE1' ' A' ' 36' ' ' HIS . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.589 ' O ' ' OG ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.618 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.634 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.623 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.425 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.644 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.644 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.61 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.61 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.814 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.72 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 HG11 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.505 HD11 ' CZ3' ' A' ' 141' ' ' TRP . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.703 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.72 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.704 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.752 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 51.7 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 60.1 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 81.48 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.486 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -114.84 -151.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.463 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -71.32 -43.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.582 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 HG23 HD11 ' A' ' 7' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.674 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.581 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.545 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.573 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CE1' ' CG2' ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.61 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.663 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -67.85 40.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.579 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -61.63 20.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.102 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.785 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -86.33 -42.63 13.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.573 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.785 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -78.1 -48.96 1.99 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 110.439 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 70.9 Cg_endo -87.4 164.89 8.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.089 2.526 . . . . 0.0 112.303 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.668 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.2 Cg_endo -75.87 163.19 33.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.89 2.393 . . . . 0.0 112.251 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.668 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.79 47.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.33 149.15 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.23 3.56 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.553 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.663 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.744 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.733 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.621 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.663 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.477 ' CG ' ' HG3' ' A' ' 63' ' ' GLU . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.638 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.638 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.596 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.596 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.776 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.677 ' O ' ' O ' ' A' ' 124' ' ' MET . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 106' ' ' ILE . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 HD13 ' CZ3' ' A' ' 141' ' ' TRP . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.462 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.406 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.677 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.677 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.474 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.468 HD21 ' HE ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 136' ' ' ARG . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.489 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.57 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -125.69 20.08 7.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.547 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.21 -165.03 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -82.73 -47.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.584 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' ILE . 47.4 mm-40 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' O ' ' N ' ' A' ' 25' ' ' ASP . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.765 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.671 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -26.49 128.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.791 ' CD2' ' CE2' ' A' ' 79' ' ' TYR . 22.4 m80 -89.15 -2.99 58.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.217 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.455 ' CH2' ' HB2' ' A' ' 38' ' ' CYS . 25.6 p-90 -115.86 -32.37 5.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.025 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.574 ' SG ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.02 -71.08 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.191 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.574 ' HD3' ' SG ' ' A' ' 38' ' ' CYS . 72.9 Cg_endo -75.33 165.02 31.67 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.32 2.013 . . . . 0.0 112.213 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.678 ' O ' ' N ' ' A' ' 42' ' ' ARG . 64.5 Cg_endo -78.66 -69.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.876 2.384 . . . . 0.0 111.976 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 41.5 t 28.8 32.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.3 ptp180 -81.29 136.95 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.583 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.94 -35.27 3.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.666 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.796 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' OE1' ' CD2' ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.759 ' CG1' ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.912 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.459 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.485 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.791 ' CE2' ' CD2' ' A' ' 36' ' ' HIS . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.43 ' HE1' ' HZ1' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.589 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.488 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.428 HD13 HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.643 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.9 m120 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.643 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.537 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.537 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.847 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.601 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.438 HG22 ' CD1' ' A' ' 106' ' ' ILE . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.512 HD13 ' CH2' ' A' ' 141' ' ' TRP . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 119' ' ' GLY . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' NZ ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.686 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.686 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.601 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.719 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.585 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.681 ' O ' ' N ' ' A' ' 134' ' ' GLY . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.461 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.537 ' NE1' HG22 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' C ' ' A' ' 2' ' ' GLU . 2.8 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 1' ' ' MET . 2.0 pt-20 34.93 68.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.521 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -93.78 -178.52 4.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -56.67 -47.04 83.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.592 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 94' ' ' SER . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.67 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.413 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HZ3' ' CB ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HZ1' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.667 ' O ' ' N ' ' A' ' 25' ' ' ASP . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.77 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -41.98 116.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.672 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -100.44 21.17 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.821 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.694 ' CZ2' ' OG ' ' A' ' 72' ' ' SER . 1.7 p-90 -118.11 -50.74 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.674 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.99 -54.37 0.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 55.4 Cg_endo -90.74 158.59 4.18 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 112.224 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.67 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 57.6 Cg_endo -75.09 152.12 39.97 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.871 2.381 . . . . 0.0 112.225 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.62 33.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.34 149.46 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.44 3.07 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.665 ' OG1' ' CD2' ' A' ' 36' ' ' HIS . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.484 HD11 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.68 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.794 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.629 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.578 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' CE2' ' A' ' 31' ' ' PHE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.775 ' CG1' ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.906 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.583 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' CZ ' ' O ' ' A' ' 36' ' ' HIS . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.68 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.43 HG21 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.632 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 10.5 m120 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.632 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.413 ' H ' ' HG1' ' A' ' 101' ' ' THR . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.531 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.531 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.82 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.651 ' O ' ' O ' ' A' ' 124' ' ' MET . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.441 HG12 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 114' ' ' ILE . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.431 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.655 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.655 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.651 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.3 OUTLIER -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.51 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.426 ' C ' ' O ' ' A' ' 137' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 23.6 m-80 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.552 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.405 ' N ' HD11 ' A' ' 122' ' ' ILE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' PHE . 9.3 mt-10 -71.53 3.56 3.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.7 m-85 -44.99 -179.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.575 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -93.74 -39.74 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.545 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 4' ' ' ILE . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.728 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.676 ' NZ ' ' CB ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' N ' HG21 ' A' ' 29' ' ' ILE . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.538 ' CE2' ' CG2' ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.699 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -35.97 -62.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.555 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER 70.54 -14.88 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.128 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.717 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.2 p-90 -90.5 -48.0 7.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.513 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.652 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.26 -50.65 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.207 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.72 164.23 20.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.951 2.434 . . . . 0.0 111.989 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.56 -98.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.706 2.27 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.13 37.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.631 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -81.17 149.46 29.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -33.29 4.07 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.539 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.783 ' CD1' ' N ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.543 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.717 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.539 ' OH ' ' OG1' ' A' ' 45' ' ' THR . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.612 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.612 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.546 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.795 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.486 ' O ' ' NH2' ' A' ' 127' ' ' ARG . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.653 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.483 HG12 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.553 ' O ' HG22 ' A' ' 122' ' ' ILE . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.49 ' H ' ' HG1' ' A' ' 120' ' ' THR . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.713 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.713 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.653 ' O ' ' O ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.733 ' ND2' ' CD ' ' A' ' 127' ' ' ARG . 0.6 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.733 ' CD ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.565 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 137' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.637 ' CZ2' ' CG2' ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.7 tp10 -37.55 -37.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -91.66 89.34 7.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.563 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -71.27 -43.11 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.633 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.63 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.661 ' CG2' ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.661 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.5 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.697 ' C ' ' H ' ' A' ' 36' ' ' HIS . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.721 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.26 26.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 34' ' ' SER . 1.8 m-70 -60.23 24.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.786 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.721 ' H ' ' C ' ' A' ' 35' ' ' ALA . 3.1 p-90 -79.88 -38.63 32.26 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.325 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.78 -52.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.511 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 81.4 Cg_endo -82.81 164.45 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.817 2.345 . . . . 0.0 112.21 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.657 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.3 Cg_endo -75.78 164.64 31.6 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.96 43.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 79' ' ' TYR . 12.1 mmt-85 -81.4 149.62 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.3 -36.38 3.07 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.794 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.652 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.468 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.501 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.82 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.669 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.472 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.709 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.652 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.4 m80 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.456 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.645 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.645 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.536 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.536 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.803 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.648 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 122' ' ' ILE . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.433 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.728 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.728 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.652 ' O ' ' N ' ' A' ' 126' ' ' GLY . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.3 t-20 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.794 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 4.5 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.556 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 4.1 mm-40 -28.74 140.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.558 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 1' ' ' MET . 94.5 m-85 -128.29 -89.92 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -89.69 -35.91 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.608 ' N ' HD21 ' A' ' 20' ' ' ASN . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 7' ' ' ILE . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.608 HD21 ' N ' ' A' ' 6' ' ' GLY . 0.6 OUTLIER -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.606 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.635 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.667 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.657 ' H ' ' HG ' ' A' ' 68' ' ' SER . . . -19.19 -60.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.625 ' NE2' ' O ' ' A' ' 41' ' ' CYS . 0.2 OUTLIER 77.48 -25.35 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.796 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 1.5 p-90 -87.85 -45.76 10.01 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -81.17 -51.41 0.9 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.344 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 96.9 Cg_endo -85.65 148.63 9.85 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.041 2.494 . . . . 0.0 112.254 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.54 134.09 14.98 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.337 . . . . 0.0 112.102 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 35.5 t 176.89 38.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.35 149.66 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.28 -36.22 3.12 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.583 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.431 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.525 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.802 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.604 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.558 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.495 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.645 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.802 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.645 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.445 HG21 HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.609 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.609 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.523 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.523 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.447 ' H ' HG21 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.804 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.716 ' O ' ' O ' ' A' ' 124' ' ' MET . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.447 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.473 ' CD1' ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.727 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.727 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.716 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.698 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.704 HE21 ' H ' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.525 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.0 OUTLIER -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.49 ' O ' ' OXT' ' A' ' 143' ' ' ARG . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -103.28 10.06 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.626 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.65 -103.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.598 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -125.28 -52.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 7' ' ' ILE . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.652 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.59 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' O ' ' CG ' ' A' ' 23' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.78 ' H ' ' HZ3' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 36' ' ' HIS . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.762 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -68.03 23.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.653 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.6 m80 -59.72 23.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.367 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.791 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.3 p-90 -78.69 -39.1 37.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.791 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.21 -52.94 14.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.439 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 71.8 Cg_endo -83.01 164.53 15.36 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.991 2.461 . . . . 0.0 112.273 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 41' ' ' CYS . 50.1 Cg_endo -72.74 172.62 14.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.78 2.32 . . . . 0.0 112.188 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.667 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 0.5 OUTLIER 149.3 -4.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -37.05 149.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.957 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.19 -36.6 3.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' C ' ' CD1' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.529 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.851 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.67 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.706 ' OD2' ' CG ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.547 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.645 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.434 HG21 HD13 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.637 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.637 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.538 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.538 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.833 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 ' CG1' ' HE1' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.78 ' HZ3' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.481 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.663 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.663 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' LEU . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.666 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.645 ' CG ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.561 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OE2' ' A' ' 2' ' ' GLU . 9.8 tmm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.636 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -163.2 11.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.58 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.636 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 69.55 165.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.626 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -66.54 -55.56 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.799 ' H ' HD21 ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 7' ' ' ILE . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.649 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.599 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.549 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 18' ' ' ASN . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.799 HD21 ' H ' ' A' ' 6' ' ' GLY . 0.5 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' CG2' ' A' ' 29' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.75 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -65.55 35.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.659 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.2 m-70 -58.94 14.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.081 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.788 ' CE2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -81.6 -42.29 20.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' SG ' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -77.58 -48.24 2.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.325 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 38.4 Cg_endo -88.12 167.05 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.261 2.641 . . . . 0.0 112.076 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.63 -95.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.774 2.316 . . . . 0.0 112.189 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m 51.52 29.45 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 0.0 110.481 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -81.35 150.26 28.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.869 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.11 3.08 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.65 ' CD2' ' NE2' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.503 ' SD ' HG21 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.805 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.655 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.561 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.47 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.569 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.476 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.681 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.65 ' NE2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.574 ' CH2' ' OD1' ' A' ' 86' ' ' ASP . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.791 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG23 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.515 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.786 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' O ' ' A' ' 124' ' ' MET . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 106' ' ' ILE . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 HD12 ' CZ3' ' A' ' 141' ' ' TRP . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 119' ' ' GLY . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 117' ' ' LYS . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.425 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.641 ' CG2' ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.641 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.548 ' C ' HD21 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.469 HD22 ' NE ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' ' CG ' ' A' ' 136' ' ' ARG . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.463 ' C ' ' O ' ' A' ' 137' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.549 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' H3 ' ' H ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.425 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 6.5 mt-10 -107.41 -91.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.553 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -112.35 154.21 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -53.61 -55.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.487 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' HA2' HD21 ' A' ' 20' ' ' ASN . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' CD ' ' A' ' 91' ' ' PRO . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' ARG . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.602 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 23' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.0 t-20 -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 36' ' ' HIS . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.792 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.54 19.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.666 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -58.13 20.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.521 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.795 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.7 p-90 -76.31 -38.49 55.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.795 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -67.46 -54.35 18.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.438 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.7 Cg_endo -80.2 164.69 21.84 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.953 2.435 . . . . 0.0 112.17 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.665 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 55.5 Cg_endo -74.02 164.86 33.45 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.827 2.351 . . . . 0.0 112.27 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.665 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.82 42.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -81.34 149.74 28.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.25 -36.62 3.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.719 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.59 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.596 ' SD ' ' CG2' ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.813 ' CE1' ' O ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.641 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' O ' ' OD2' ' A' ' 27' ' ' ASP . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.426 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CB ' ' CE3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.464 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.618 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.5 m80 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.641 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.471 ' CD1' ' CB ' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.626 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.779 HD21 ' HZ2' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.626 ' CG2' ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.779 ' HZ2' HD21 ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.533 ' C ' ' CG2' ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.533 ' CG2' ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.433 ' H ' HG23 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.832 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' HD22 ' A' ' 125' ' ' ASN . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.709 ' O ' ' O ' ' A' ' 124' ' ' MET . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' A' ' 106' ' ' ILE . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.522 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.449 ' HZ1' ' HA ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.446 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.695 ' CG2' ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.695 ' H ' ' CG2' ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.709 ' O ' ' O ' ' A' ' 112' ' ' LEU . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.543 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.596 ' CG2' ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.464 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.521 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 143' ' ' ARG . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 ' HG2' ' A' ' 96' ' ' PRO . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.769 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.968 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.2 m-20 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.589 HD12 ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.67 ' H ' ' HB3' ' A' ' 68' ' ' SER . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.599 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.861 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.788 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.788 HD13 ' OE2' ' A' ' 63' ' ' GLU . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.57 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.881 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.787 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.764 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 109' ' ' ILE . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.715 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.645 HG22 ' HE2' ' A' ' 124' ' ' MET . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.715 HD11 ' CD2' ' A' ' 112' ' ' LEU . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.648 ' HZ3' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.452 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.002 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.002 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.676 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 127' ' ' ARG . 58.1 t-20 -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.577 ' OE1' ' N ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.633 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.377 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 96' ' ' PRO . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.862 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 ' HG3' ' A' ' 91' ' ' PRO . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.6 ' HE ' ' C ' ' A' ' 13' ' ' ASN . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.965 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 25' ' ' ASP . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.685 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.808 ' CZ ' ' NE2' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.532 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.66 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.66 HD13 ' OE2' ' A' ' 63' ' ' GLU . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.642 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' SER . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.547 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.862 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.866 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.808 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.78 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.997 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.997 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.808 ' NE2' ' CZ ' ' A' ' 44' ' ' PHE . 30.9 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.722 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.722 ' HB2' ' CD1' ' A' ' 133' ' ' LEU . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.933 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 10.7 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.886 0.374 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 96' ' ' PRO . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 91' ' ' PRO . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' CE ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 26.4 t-20 -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 1.0 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.736 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.648 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.1 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.81 ' HD2' HD22 ' A' ' 55' ' ' LEU . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.491 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.879 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.74 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.732 ' HG2' HG21 ' A' ' 7' ' ' ILE . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.666 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 114' ' ' ILE . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 112' ' ' LEU . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.447 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.909 HD11 ' CE ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.936 HG23 ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.936 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.909 ' CE ' HD11 ' A' ' 121' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.6 t-20 -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.45 ' C ' ' OE1' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 133' ' ' LEU . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.2 m120 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.891 0.377 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.744 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.752 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 ' OE2' ' A' ' 63' ' ' GLU . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.702 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.538 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.08 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.969 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.935 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.67 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.636 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.519 ' CD ' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.969 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.844 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 16.4 m-20 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.791 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.791 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.816 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.417 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.036 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.036 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.816 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.2 t-20 -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.742 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.564 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.516 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.556 ' O ' HD13 ' A' ' 122' ' ' ILE . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 5.5 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.592 HD13 ' OG ' ' A' ' 94' ' ' SER . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.661 ' N ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.772 HD23 ' CB ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 7.2 m-20 -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.738 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 62' ' ' PHE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 29' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.71 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.89 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.416 HG21 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.595 HG22 HG13 ' A' ' 90' ' ' ILE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.513 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.842 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.772 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.595 HG13 HG22 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.661 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.771 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.934 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.005 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.005 ' H ' HG23 ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.641 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.496 ' CD ' ' OD1' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.559 HD22 ' CD ' ' A' ' 136' ' ' ARG . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.559 ' CD ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.496 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.582 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 96' ' ' PRO . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.772 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.413 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.813 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.77 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 101' ' ' THR . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.719 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.112 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.688 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.715 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.715 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 29' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.807 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.858 ' CD2' HG22 ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.727 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.964 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.747 ' O ' HG23 ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.612 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.857 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.732 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.558 ' HB2' ' H ' ' A' ' 120' ' ' THR . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.558 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.893 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.04 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.04 ' H ' HG23 ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.857 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.705 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.672 HD12 ' ND2' ' A' ' 140' ' ' ASN . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG2' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 40.5 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.672 ' ND2' HD12 ' A' ' 133' ' ' LEU . 2.8 m-20 -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.897 0.38 . . . . 0.0 110.54 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.59 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.715 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 16' ' ' GLU . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.619 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.674 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.706 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.545 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.099 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.872 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.674 ' OE1' HG23 ' A' ' 29' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.021 HG12 ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.021 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.991 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.04 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.828 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.687 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.4 t-20 -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.456 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.903 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.458 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.007 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.007 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.991 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.986 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.816 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 96' ' ' PRO . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.801 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.082 HD13 ' HB2' ' A' ' 19' ' ' ALA . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.75 HG22 ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.75 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.082 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 65' ' ' ILE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.668 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.788 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.744 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.983 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.714 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 68' ' ' SER . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.674 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.545 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.668 ' CE1' HG22 ' A' ' 45' ' ' THR . 12.7 m-70 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.455 HG23 ' CE2' ' A' ' 33' ' ' PHE . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.788 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.788 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.913 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.788 ' HA ' HG22 ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.718 ' CG2' HD11 ' A' ' 106' ' ' ILE . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.751 HD11 HD22 ' A' ' 112' ' ' LEU . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.891 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 133' ' ' LEU . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.782 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.593 ' O ' HD13 ' A' ' 122' ' ' ILE . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.867 0.365 . . . . 0.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.735 HG21 ' HG2' ' A' ' 96' ' ' PRO . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.768 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.01 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 17' ' ' VAL . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 16' ' ' GLU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.01 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG21 ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.669 ' O ' HD23 ' A' ' 112' ' ' LEU . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.083 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.925 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.803 ' OE1' HD21 ' A' ' 88' ' ' LEU . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.451 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.868 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.959 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.461 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.891 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 113' ' ' VAL . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 112' ' ' LEU . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.846 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.976 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.976 ' H ' HG23 ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.665 ' HE1' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 8.6 t-20 -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.663 ' HE ' ' CD ' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.75 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.663 ' CD ' ' HE ' ' A' ' 127' ' ' ARG . 27.0 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 133' ' ' LEU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.639 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 55' ' ' LEU . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.639 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.752 ' O ' HD13 ' A' ' 122' ' ' ILE . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 4' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.838 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.991 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 91' ' ' PRO . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.457 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.776 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.532 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.603 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.071 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 130' ' ' VAL . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 2.1 tp60 -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.688 ' SD ' ' O ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.795 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.742 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.717 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.806 ' C ' HG23 ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 114' ' ' ILE . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.777 HG13 ' HE1' ' A' ' 124' ' ' MET . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 112' ' ' LEU . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.009 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.777 ' HE1' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 1.2 t-20 -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.601 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.532 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 133' ' ' LEU . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.6 m120 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.663 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 122' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.623 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 96' ' ' PRO . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.774 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.063 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' A' ' 16' ' ' GLU . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.526 ' CG ' HG22 ' A' ' 10' ' ' VAL . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' HD21 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.797 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.673 ' CE1' ' CD ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.081 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.823 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.863 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 68' ' ' SER . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.797 ' CB ' ' H ' ' A' ' 34' ' ' SER . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.626 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.626 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.69 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.427 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.73 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.704 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.73 HD11 ' CD2' ' A' ' 112' ' ' LEU . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.449 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.009 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.979 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 127' ' ' ARG . 7.2 t-20 -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.673 ' CD ' ' CE1' ' A' ' 44' ' ' PHE . 34.3 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.802 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.554 ' CZ2' HD22 ' A' ' 112' ' ' LEU . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.834 0.349 . . . . 0.0 110.582 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 4' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.734 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.532 ' H ' HD23 ' A' ' 9' ' ' LEU . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' LEU . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 65' ' ' ILE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.663 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.967 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.781 HD22 ' HD2' ' A' ' 61' ' ' PRO . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' HD22 ' A' ' 55' ' ' LEU . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.784 HD11 HG23 ' A' ' 29' ' ' ILE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.593 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.635 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.831 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 9' ' ' LEU . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' C ' HD21 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.788 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.1 t30 -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.472 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.904 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.015 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.015 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 124' ' ' MET . 1.1 m-20 -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.551 HD22 ' CD ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.551 ' CD ' HD22 ' A' ' 133' ' ' LEU . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.588 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.895 0.379 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' ILE . 15.2 mm100 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.771 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.619 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.764 HD23 ' OE1' ' A' ' 63' ' ' GLU . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.717 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.514 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.088 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.665 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.764 ' OE1' HD23 ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.137 HG12 ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.137 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.6 ' CG ' ' OE2' ' A' ' 82' ' ' GLU . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.837 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.771 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 24.0 m-20 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.782 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.782 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.659 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.729 HG13 ' CE ' ' A' ' 124' ' ' MET . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.455 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 42.8 t-20 -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.735 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.761 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.735 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 133' ' ' LEU . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 129' ' ' GLU . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CG ' HD21 ' A' ' 55' ' ' LEU . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.761 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.734 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.025 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD23 ' OE2' ' A' ' 63' ' ' GLU . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.831 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.741 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.548 HD12 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.706 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 29' ' ' ILE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.115 HG12 ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.115 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 72' ' ' SER . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.404 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.82 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.59 ' CB ' HD23 ' A' ' 9' ' ' LEU . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.664 HG23 HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.734 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 76.7 m-20 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 98' ' ' SER . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.781 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.907 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.725 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.825 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 ' CD2' ' A' ' 112' ' ' LEU . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.893 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.825 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ARG . 61.7 t-20 -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 133' ' ' LEU . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.508 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 13.0 m120 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.575 ' O ' HD13 ' A' ' 122' ' ' ILE . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.882 0.372 . . . . 0.0 110.545 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.755 HG21 ' HG2' ' A' ' 96' ' ' PRO . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.811 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HZ3' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.809 ' HB1' HD22 ' A' ' 88' ' ' LEU . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.775 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.521 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 1.053 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.633 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG13 ' HB1' ' A' ' 97' ' ' ALA . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.624 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.787 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.635 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.812 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.458 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 114' ' ' ILE . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.981 HG13 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 112' ' ' LEU . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.025 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.981 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.587 ' OD1' ' CD ' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.587 ' CD ' ' OD1' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.535 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.676 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.704 HG21 ' HG2' ' A' ' 96' ' ' PRO . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.861 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.742 ' N ' HG22 ' A' ' 17' ' ' VAL . 13.6 m-20 -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.896 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 19' ' ' ALA . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.685 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.854 ' CD2' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.64 ' CG2' ' CE1' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.521 HD12 ' OE1' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.877 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.848 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.61 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.654 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 9.1 m-70 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.719 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.803 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.803 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.796 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.718 HG21 HD11 ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 112' ' ' LEU . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.033 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.718 ' CE ' HD21 ' A' ' 121' ' ' LEU . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' ARG . 65.2 t30 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.653 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.854 ' NE2' ' CD2' ' A' ' 44' ' ' PHE . 21.9 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.663 HD22 ' HG2' ' A' ' 136' ' ' ARG . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.687 ' O ' ' NE ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.8 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.87 0.367 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG21 ' HG2' ' A' ' 96' ' ' PRO . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.85 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 91' ' ' PRO . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 61.7 t-20 -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 65' ' ' ILE . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.716 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.611 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.69 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.419 ' CG2' ' HG3' ' A' ' 131' ' ' GLN . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.085 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.987 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.964 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.666 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.558 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 23' ' ' LEU . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.645 ' OE1' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.987 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.843 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.784 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.784 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.741 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.79 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 116' ' ' LYS . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.999 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.999 ' H ' HG23 ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.79 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.544 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.603 ' N ' HG12 ' A' ' 130' ' ' VAL . 17.9 mp0 -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.513 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.3 m120 -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 10.3 pt20 -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.8 HG21 ' HG2' ' A' ' 96' ' ' PRO . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.929 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' PRO . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.69 ' H ' ' HZ2' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.617 ' H ' ' CB ' ' A' ' 68' ' ' SER . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.066 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.5 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.609 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' OD1' ' CB ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.786 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.641 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.451 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.808 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HZ2' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.021 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.947 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.795 ' CE ' HG13 ' A' ' 113' ' ' VAL . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 51.8 t-20 -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.496 ' CG ' ' OD1' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.5 ' N ' ' HG2' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.945 0.403 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.613 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.678 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.748 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 91' ' ' PRO . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.419 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 8.0 t30 -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.812 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 65' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.581 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.781 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.655 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.559 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.868 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.537 HG21 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 68' ' ' SER . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.488 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.485 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.681 ' SD ' ' O ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.891 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 80' ' ' MET . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.781 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 106' ' ' ILE . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.769 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.723 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HE2' ' A' ' 124' ' ' MET . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.723 HD11 ' CD2' ' A' ' 112' ' ' LEU . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.981 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.981 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.782 ' HE3' HD11 ' A' ' 121' ' ' LEU . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 127' ' ' ARG . 64.9 t-20 -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' CD ' HD22 ' A' ' 133' ' ' LEU . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.623 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.925 0.393 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.638 ' C ' HD23 ' A' ' 9' ' ' LEU . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.673 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 88' ' ' LEU . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.82 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.646 ' H ' ' CB ' ' A' ' 68' ' ' SER . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.651 ' CG2' ' CE1' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.472 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.867 ' SD ' HG22 ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.625 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.651 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 8.1 m-70 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.739 ' O ' HD23 ' A' ' 88' ' ' LEU . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.82 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.797 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.797 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.726 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 1.023 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . 1.023 ' H ' HG23 ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.726 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 127' ' ' ARG . 1.9 t-20 -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.516 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.867 HG22 ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 4.0 mt-30 -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.632 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 3.0 pt-20 -142.31 115.11 8.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 95.5 m-85 -157.37 173.86 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.542 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -66.26 -44.81 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.502 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 ' HG2' ' A' ' 96' ' ' PRO . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.769 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.968 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 31.2 m-20 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.589 HD12 ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.67 ' H ' ' HB3' ' A' ' 68' ' ' SER . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.683 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -65.95 36.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.8 m-70 -60.12 25.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.916 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.793 ' CH2' ' SG ' ' A' ' 38' ' ' CYS . 1.9 p-90 -83.91 -40.99 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.793 ' SG ' ' CH2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -79.29 -49.1 1.47 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 61.6 Cg_endo -89.34 165.21 5.48 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.636 . . . . 0.0 112.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.658 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 41.5 Cg_endo -71.07 156.63 59.48 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.711 2.274 . . . . 0.0 112.154 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.84 40.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.463 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' NH1' ' HA ' ' A' ' 40' ' ' PRO . 2.3 mpt_? -81.32 149.8 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.815 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.66 3.27 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.599 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.861 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.788 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.788 HD13 ' OE2' ' A' ' 63' ' ' GLU . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.57 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.716 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.881 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.787 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.764 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 109' ' ' ILE . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.715 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.645 HG22 ' HE2' ' A' ' 124' ' ' MET . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.715 HD11 ' CD2' ' A' ' 112' ' ' LEU . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.648 ' HZ3' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.452 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.002 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.002 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.676 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' C ' ' H ' ' A' ' 127' ' ' ARG . 58.1 t-20 -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' OE1' ' N ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.633 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.64 120.57 3.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.57 121.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -53.7 -49.52 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.551 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 96' ' ' PRO . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.862 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 ' HG3' ' A' ' 91' ' ' PRO . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.6 ' HE ' ' C ' ' A' ' 13' ' ' ASN . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.965 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 25' ' ' ASP . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.685 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.84 68.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.774 ' CG ' ' SG ' ' A' ' 41' ' ' CYS . 2.9 m-70 -80.05 23.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.113 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.788 ' NE1' ' SG ' ' A' ' 38' ' ' CYS . 1.6 p-90 -88.31 -41.95 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.605 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' SG ' ' NE1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.66 -53.34 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.531 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HD3' ' SG ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.3 161.85 22.77 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.786 2.324 . . . . 0.0 112.275 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 62.3 Cg_endo -77.49 156.51 32.4 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.958 2.439 . . . . 0.0 112.2 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.774 ' SG ' ' CG ' ' A' ' 36' ' ' HIS . 1.1 p 156.72 45.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.487 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.28 149.58 28.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.11 -35.94 3.22 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.808 ' CZ ' ' NE2' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.532 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.66 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.66 HD13 ' OE2' ' A' ' 63' ' ' GLU . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' SER . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.547 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.862 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.866 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.808 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.78 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.908 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.997 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.997 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.808 ' NE2' ' CZ ' ' A' ' 44' ' ' PHE . 30.9 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.722 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.722 ' HB2' ' CD1' ' A' ' 133' ' ' LEU . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.933 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 10.7 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.04 169.82 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.535 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -175.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -53.53 -51.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.644 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 96' ' ' PRO . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 91' ' ' PRO . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' CE ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 26.4 t-20 -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 1.0 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.736 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -31.57 -47.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.824 ' CE1' ' HG1' ' A' ' 45' ' ' THR . 1.3 t60 65.15 -21.74 0.08 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.783 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.3 p-90 -91.64 -49.36 6.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.686 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.783 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -75.57 -49.59 3.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 110.196 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 92.8 Cg_endo -87.97 112.81 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.288 2.659 . . . . 0.0 112.15 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 50.3 Cg_exo -48.98 151.85 5.28 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.667 2.245 . . . . 0.0 112.189 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.46 45.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.454 ' HB3' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -81.43 149.6 28.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.08 -36.07 3.19 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.824 ' HG1' ' CE1' ' A' ' 36' ' ' HIS . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.1 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.81 ' HD2' HD22 ' A' ' 55' ' ' LEU . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.491 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.634 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.879 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.74 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.732 ' HG2' HG21 ' A' ' 7' ' ' ILE . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.666 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 114' ' ' ILE . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 112' ' ' LEU . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.447 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.909 HD11 ' CE ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.936 HG23 ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.936 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.909 ' CE ' HD11 ' A' ' 121' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.6 t-20 -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.45 ' C ' ' OE1' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 133' ' ' LEU . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.2 m120 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 52.57 -125.3 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -148.48 -179.63 7.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.538 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -72.95 -44.84 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.744 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.752 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 ' OE2' ' A' ' 63' ' ' GLU . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.702 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -6.6 -61.21 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER 68.26 -10.9 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.04 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.776 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -95.31 -51.2 4.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.611 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.776 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.44 -50.34 10.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.397 . . . . 0.0 110.153 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 86.1 Cg_endo -86.28 150.95 9.29 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.171 2.581 . . . . 0.0 112.195 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.09 135.87 19.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.797 2.331 . . . . 0.0 112.163 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . 0.1 OUTLIER 174.41 49.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -81.35 149.31 28.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 120.15 -35.76 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.538 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.08 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.969 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.935 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.67 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.702 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.671 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' CD ' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.969 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.844 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 16.4 m-20 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.791 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.791 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.816 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.417 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.036 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.036 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.816 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.419 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.2 t-20 -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.742 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.564 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.516 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.556 ' O ' HD13 ' A' ' 122' ' ' ILE . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' PHE . 35.4 mt-10 -73.52 -166.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.522 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' GLU . 16.0 m-85 33.21 -148.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.26 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.626 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 5.5 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.592 HD13 ' OG ' ' A' ' 94' ' ' SER . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.661 ' N ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.772 HD23 ' CB ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 7.2 m-20 -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.738 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 62' ' ' PHE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 29' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.71 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -60.69 68.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.684 ' CG ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-70 -78.4 24.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.391 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -90.5 -43.02 10.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.627 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.06 -51.0 1.34 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.292 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.8 Cg_endo -83.21 164.46 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.865 2.376 . . . . 0.0 112.044 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 Cg_endo -67.74 -87.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.724 2.283 . . . . 0.0 112.245 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.684 ' SG ' ' CG ' ' A' ' 36' ' ' HIS . 1.8 p 43.22 38.81 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 43' ' ' GLY . 4.0 ttt-85 -81.33 149.93 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.804 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . 123.51 -35.45 3.32 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.89 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.416 HG21 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.595 HG22 HG13 ' A' ' 90' ' ' ILE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.513 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.842 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.772 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.595 HG13 HG22 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.661 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.771 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.934 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.005 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.005 ' H ' HG23 ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.641 ' O ' ' ND2' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' CD ' ' OD1' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.559 HD22 ' CD ' ' A' ' 136' ' ' ARG . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.559 ' CD ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.496 ' OD1' ' CD ' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.582 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 28.7 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.588 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.547 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -46.89 124.61 6.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -60.65 -59.65 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 96' ' ' PRO . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.772 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.813 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.77 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.66 ' HH ' ' CE1' ' A' ' 36' ' ' HIS . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 101' ' ' THR . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.719 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . . . -27.15 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 63.66 -24.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.904 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.3 p-90 -93.29 -47.63 6.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.614 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.83 -51.63 1.13 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.253 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 91.4 Cg_endo -87.74 143.92 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.107 2.538 . . . . 0.0 112.171 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 60.5 Cg_endo -76.28 146.25 28.07 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.78 2.32 . . . . 0.0 112.036 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 40' ' ' PRO . 0.9 OUTLIER 159.35 15.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -61.04 149.66 36.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.75 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.33 -33.35 4.02 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.112 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.688 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.715 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.715 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 29' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 37' ' ' TRP . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.807 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.858 ' CD2' HG22 ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.727 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.964 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.747 ' O ' HG23 ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.612 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.857 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.732 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.558 ' HB2' ' H ' ' A' ' 120' ' ' THR . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.558 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.893 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.04 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.04 ' H ' HG23 ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.857 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.705 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.672 HD12 ' ND2' ' A' ' 140' ' ' ASN . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG2' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 40.5 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.672 ' ND2' HD12 ' A' ' 133' ' ' LEU . 2.8 m-20 -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.654 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.7 tmm? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.24 -51.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.61 -178.99 5.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -61.84 -27.46 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.54 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.59 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.715 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 16' ' ' GLU . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.619 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.674 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.48 77.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.699 ' CG ' ' O ' ' A' ' 36' ' ' HIS . 1.7 t60 -86.12 26.33 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -92.32 -42.31 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.475 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -87.68 -50.59 0.43 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.526 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' CYS . 71.1 Cg_endo -80.15 151.79 20.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.956 2.437 . . . . 0.0 112.267 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 41' ' ' CYS . 58.0 Cg_endo -74.74 140.65 26.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.406 . . . . 0.0 112.303 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.679 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 17.0 t 173.34 48.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.413 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -81.27 149.32 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.8 -36.09 3.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.706 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.545 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.099 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.872 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.674 ' OE1' HG23 ' A' ' 29' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.021 HG12 ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.021 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.991 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.04 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.828 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.687 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.4 t-20 -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.456 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.903 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.458 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.007 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.007 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.991 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.986 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.816 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.6 ' OD1' ' N ' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.651 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -67.49 34.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.58 ' H ' ' C ' ' A' ' 1' ' ' MET . 4.6 m-85 -46.25 -174.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -82.14 -52.29 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 96' ' ' PRO . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.801 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.082 HD13 ' HB2' ' A' ' 19' ' ' ALA . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.75 HG22 ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.75 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.082 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 65' ' ' ILE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.668 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.788 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.73 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -27.85 -48.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.73 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.9 p-80 60.71 -26.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.308 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.689 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -85.65 -45.74 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.882 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.51 -49.85 11.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.987 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 91.2 Cg_endo -86.35 164.99 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.208 2.606 . . . . 0.0 112.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.37 -101.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.762 2.308 . . . . 0.0 112.092 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 t 49.62 43.56 24.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.409 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 2.2 ptm85 -81.37 149.27 28.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.7 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.96 -34.17 4.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.744 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.983 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.714 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 68' ' ' SER . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.674 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.545 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.668 ' CE1' HG22 ' A' ' 45' ' ' THR . 12.7 m-70 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.455 HG23 ' CE2' ' A' ' 33' ' ' PHE . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.788 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.788 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.913 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.788 ' HA ' HG22 ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.718 ' CG2' HD11 ' A' ' 106' ' ' ILE . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.751 HD11 HD22 ' A' ' 112' ' ' LEU . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.891 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 133' ' ' LEU . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.782 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.593 ' O ' HD13 ' A' ' 122' ' ' ILE . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -46.31 -61.04 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.24 171.27 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -85.01 -41.52 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.735 HG21 ' HG2' ' A' ' 96' ' ' PRO . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.768 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.01 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 17' ' ' VAL . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 16' ' ' GLU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.01 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG21 ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.669 ' O ' HD23 ' A' ' 112' ' ' LEU . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -29.17 -50.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' HE ' ' A' ' 42' ' ' ARG . 20.1 t-160 64.79 -22.16 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.307 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.678 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -88.62 -45.52 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -83.91 -50.8 0.63 Allowed Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.396 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 95.0 Cg_endo -87.78 154.95 7.43 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.191 2.594 . . . . 0.0 112.201 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 60.3 Cg_endo -76.43 147.33 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.853 2.369 . . . . 0.0 112.054 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.2 m 158.7 37.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.663 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.524 ' HE ' ' CE1' ' A' ' 36' ' ' HIS . 8.8 mtp180 -81.27 149.48 28.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -35.29 3.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.083 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.925 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.803 ' OE1' HD21 ' A' ' 88' ' ' LEU . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.451 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.868 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.959 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.461 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.891 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 113' ' ' VAL . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 112' ' ' LEU . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.846 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.976 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.976 ' H ' HG23 ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.665 ' HE1' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 8.6 t-20 -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.663 ' HE ' ' CD ' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.75 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.663 ' CD ' ' HE ' ' A' ' 127' ' ' ARG . 27.0 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 133' ' ' LEU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.639 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 55' ' ' LEU . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.639 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.752 ' O ' HD13 ' A' ' 122' ' ' ILE . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 62.68 147.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.599 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' C ' ' OE1' ' A' ' 5' ' ' GLN . 67.6 m-85 -89.05 -137.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -77.92 -46.0 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.482 ' OE1' ' C ' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 4' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.838 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.991 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 91' ' ' PRO . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.457 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.776 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -41.03 118.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.635 ' CD2' ' HG1' ' A' ' 45' ' ' THR . 1.0 OUTLIER -96.76 19.11 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.867 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.781 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 2.5 p-90 -124.59 -50.36 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.567 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.781 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.35 -57.05 7.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.943 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 38' ' ' CYS . 85.7 Cg_endo -91.94 149.83 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.01 2.474 . . . . 0.0 112.305 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.39 140.94 22.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.778 2.319 . . . . 0.0 111.988 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.481 ' O ' ' CE1' ' A' ' 36' ' ' HIS . 1.7 p 172.7 45.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.748 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' HA ' ' HE1' ' A' ' 36' ' ' HIS . 4.9 tmm_? -81.31 149.66 28.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.21 -35.4 3.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.532 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.635 ' HG1' ' CD2' ' A' ' 36' ' ' HIS . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.071 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 130' ' ' VAL . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 2.1 tp60 -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 36' ' ' HIS . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.688 ' SD ' ' O ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.795 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.742 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.717 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.806 ' C ' HG23 ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 114' ' ' ILE . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.777 HG13 ' HE1' ' A' ' 124' ' ' MET . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 112' ' ' LEU . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.009 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.777 ' HE1' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 1.2 t-20 -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.601 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.532 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 133' ' ' LEU . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.6 m120 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.663 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 122' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 102.8 9.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.57 -163.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -98.85 -50.82 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 96' ' ' PRO . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.774 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.063 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' A' ' 16' ' ' GLU . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.526 ' CG ' HG22 ' A' ' 10' ' ' VAL . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' HD21 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.797 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -24.87 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.797 ' CE1' ' CG ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 61.7 -28.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.185 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.629 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.4 p-90 -89.94 -47.29 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.951 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.92 -50.23 9.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.393 . . . . 0.0 110.078 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 93.8 Cg_endo -86.15 165.07 9.87 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.159 2.573 . . . . 0.0 112.103 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.66 -101.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.783 2.322 . . . . 0.0 112.034 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.8 m 42.5 28.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.25 149.38 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.623 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.06 -32.35 4.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.673 ' CE1' ' CD ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.081 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.823 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.863 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 68' ' ' SER . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.797 ' CB ' ' H ' ' A' ' 34' ' ' SER . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.797 ' CG ' ' CE1' ' A' ' 36' ' ' HIS . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.626 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.626 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.69 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.427 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.73 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.704 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.73 HD11 ' CD2' ' A' ' 112' ' ' LEU . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.449 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.009 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.979 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 127' ' ' ARG . 7.2 t-20 -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.673 ' CD ' ' CE1' ' A' ' 44' ' ' PHE . 34.3 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.802 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.554 ' CZ2' HD22 ' A' ' 112' ' ' LEU . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 60.1 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 81.48 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.486 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -114.84 -151.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -71.32 -43.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.582 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 4' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.734 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.532 ' H ' HD23 ' A' ' 9' ' ' LEU . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' LEU . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 65' ' ' ILE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.663 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -67.85 40.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.55 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -61.63 20.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.102 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.785 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -86.33 -42.63 13.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.573 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.785 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -78.1 -48.96 1.99 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 110.439 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 70.9 Cg_endo -87.4 164.89 8.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.089 2.526 . . . . 0.0 112.303 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.668 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.2 Cg_endo -75.87 163.19 33.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.89 2.393 . . . . 0.0 112.251 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.668 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.79 47.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.33 149.15 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.23 3.56 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.967 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.781 HD22 ' HD2' ' A' ' 61' ' ' PRO . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' HD22 ' A' ' 55' ' ' LEU . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.784 HD11 HG23 ' A' ' 29' ' ' ILE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.593 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.831 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 9' ' ' LEU . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' C ' HD21 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.788 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.1 t30 -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 113' ' ' VAL . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.472 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.904 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.015 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.015 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 124' ' ' MET . 1.1 m-20 -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.551 HD22 ' CD ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.551 ' CD ' HD22 ' A' ' 133' ' ' LEU . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.588 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -125.69 20.08 7.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.547 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.21 -165.03 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -82.73 -47.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.584 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' ILE . 15.2 mm100 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.771 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.619 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.764 HD23 ' OE1' ' A' ' 63' ' ' GLU . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.765 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.717 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . . . -26.49 128.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.791 ' CD2' ' CE2' ' A' ' 79' ' ' TYR . 22.4 m80 -89.15 -2.99 58.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.217 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 38' ' ' CYS . 25.6 p-90 -115.86 -32.37 5.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.025 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.568 ' SG ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.02 -71.08 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.191 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.703 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 72.9 Cg_endo -75.33 165.02 31.67 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.32 2.013 . . . . 0.0 112.213 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.678 ' O ' ' N ' ' A' ' 42' ' ' ARG . 64.5 Cg_endo -78.66 -69.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.876 2.384 . . . . 0.0 111.976 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.638 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 41.5 t 28.8 32.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.3 ptp180 -81.29 136.95 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.583 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.94 -35.27 3.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.514 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.088 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.665 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.764 ' OE1' HD23 ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.137 HG12 ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.137 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.442 ' O ' ' NE1' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.791 ' CE2' ' CD2' ' A' ' 36' ' ' HIS . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.837 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.771 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 24.0 m-20 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.782 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.782 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.659 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.729 HG13 ' CE ' ' A' ' 124' ' ' MET . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.455 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 42.8 t-20 -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.735 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.761 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.735 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 133' ' ' LEU . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 129' ' ' GLU . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CG ' HD21 ' A' ' 55' ' ' LEU . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.761 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' C ' ' A' ' 2' ' ' GLU . 2.8 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 1' ' ' MET . 2.0 pt-20 34.93 68.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.521 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -93.78 -178.52 4.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -56.67 -47.04 83.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.592 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.734 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.025 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD23 ' OE2' ' A' ' 63' ' ' GLU . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.831 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -41.98 116.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.672 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -100.44 21.17 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.821 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.693 ' CZ2' ' OG ' ' A' ' 72' ' ' SER . 1.7 p-90 -118.11 -50.74 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.674 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.99 -54.37 0.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 55.4 Cg_endo -90.74 158.59 4.18 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 112.224 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.67 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 57.6 Cg_endo -75.09 152.12 39.97 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.871 2.381 . . . . 0.0 112.225 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.62 33.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.34 149.46 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.44 3.07 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.741 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.548 HD12 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.706 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 29' ' ' ILE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.115 HG12 ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.115 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.583 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 72' ' ' SER . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' CZ ' ' O ' ' A' ' 36' ' ' HIS . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 12' ' ' LYS . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.82 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.59 ' CB ' HD23 ' A' ' 9' ' ' LEU . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.664 HG23 HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.734 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 76.7 m-20 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 98' ' ' SER . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.781 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.907 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.725 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.825 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 ' CD2' ' A' ' 112' ' ' LEU . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.893 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.825 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ARG . 61.7 t-20 -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 133' ' ' LEU . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.508 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 13.0 m120 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.575 ' O ' HD13 ' A' ' 122' ' ' ILE . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' PHE . 9.3 mt-10 -71.53 3.56 3.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.7 m-85 -44.99 -179.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.575 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -93.74 -39.74 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.545 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.755 HG21 ' HG2' ' A' ' 96' ' ' PRO . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.811 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HZ3' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.809 ' HB1' HD22 ' A' ' 88' ' ' LEU . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.775 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -35.97 -62.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER 70.54 -14.88 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.128 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.717 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.2 p-90 -90.5 -48.0 7.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.513 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.652 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.26 -50.65 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.207 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.72 164.23 20.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.951 2.434 . . . . 0.0 111.989 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.56 -98.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.706 2.27 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.13 37.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.631 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -81.17 149.46 29.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -33.29 4.07 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.521 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 1.053 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.633 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG13 ' HB1' ' A' ' 97' ' ' ALA . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.717 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.787 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.635 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.812 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.458 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.927 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 114' ' ' ILE . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.981 HG13 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 112' ' ' LEU . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.025 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.981 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.587 ' OD1' ' CD ' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.587 ' CD ' ' OD1' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.535 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.676 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.7 tp10 -37.55 -37.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -91.66 89.34 7.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.563 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -71.27 -43.11 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.633 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.704 HG21 ' HG2' ' A' ' 96' ' ' PRO . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.861 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.742 ' N ' HG22 ' A' ' 17' ' ' VAL . 13.6 m-20 -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.896 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 19' ' ' ALA . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.685 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.26 26.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 34' ' ' SER . 1.8 m-70 -60.23 24.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.786 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.709 ' CZ3' ' OD2' ' A' ' 75' ' ' ASP . 3.1 p-90 -79.88 -38.63 32.26 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.325 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.78 -52.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.511 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 81.4 Cg_endo -82.81 164.45 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.817 2.345 . . . . 0.0 112.21 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.657 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.3 Cg_endo -75.78 164.64 31.6 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.96 43.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 79' ' ' TYR . 12.1 mmt-85 -81.4 149.62 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.3 -36.38 3.07 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.854 ' CD2' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.64 ' CG2' ' CE1' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.521 HD12 ' OE1' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.877 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.848 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.61 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.709 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 9.1 m-70 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.719 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.803 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.803 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.886 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.796 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.718 HG21 HD11 ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 112' ' ' LEU . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.033 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.718 ' CE ' HD21 ' A' ' 121' ' ' LEU . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' ARG . 65.2 t30 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.653 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.854 ' NE2' ' CD2' ' A' ' 44' ' ' PHE . 21.9 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.663 HD22 ' HG2' ' A' ' 136' ' ' ARG . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.687 ' O ' ' NE ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.8 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 4.1 mm-40 -28.74 140.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.558 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 1' ' ' MET . 94.5 m-85 -128.29 -89.92 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -89.69 -35.91 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG21 ' HG2' ' A' ' 96' ' ' PRO . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.85 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 91' ' ' PRO . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.485 ' O ' ' OD1' ' A' ' 13' ' ' ASN . 61.7 t-20 -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 65' ' ' ILE . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.716 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -19.19 -60.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.625 ' NE2' ' O ' ' A' ' 41' ' ' CYS . 0.2 OUTLIER 77.48 -25.35 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.796 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 1.5 p-90 -87.85 -45.76 10.01 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -81.17 -51.41 0.9 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.344 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 96.9 Cg_endo -85.65 148.63 9.85 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.041 2.494 . . . . 0.0 112.254 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.54 134.09 14.98 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.337 . . . . 0.0 112.102 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 35.5 t 176.89 38.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.35 149.66 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.28 -36.22 3.12 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.69 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.419 ' CG2' ' HG3' ' A' ' 131' ' ' GLN . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.085 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.987 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.964 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.666 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.558 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 23' ' ' LEU . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.645 ' OE1' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.482 ' HG3' ' O ' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.987 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.843 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.784 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.784 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.872 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.741 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.79 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 116' ' ' LYS . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.999 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.999 ' H ' HG23 ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.79 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.544 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.603 ' N ' HG12 ' A' ' 130' ' ' VAL . 17.9 mp0 -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.513 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.3 m120 -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 3.0 pt-20 -103.28 10.06 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.626 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.65 -103.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.598 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -125.28 -52.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 10.3 pt20 -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.8 HG21 ' HG2' ' A' ' 96' ' ' PRO . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.929 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' PRO . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.69 ' H ' ' HZ2' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.617 ' H ' ' CB ' ' A' ' 68' ' ' SER . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.732 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -68.03 23.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.6 m80 -59.72 23.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.367 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.789 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.3 p-90 -78.69 -39.1 37.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.789 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.21 -52.94 14.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.439 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 71.8 Cg_endo -83.01 164.53 15.36 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.991 2.461 . . . . 0.0 112.273 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 41' ' ' CYS . 50.1 Cg_endo -72.74 172.62 14.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.78 2.32 . . . . 0.0 112.188 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.667 ' SG ' ' O ' ' A' ' 41' ' ' CYS . 0.5 OUTLIER 149.3 -4.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -37.05 149.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.957 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.19 -36.6 3.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.066 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.5 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.609 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.706 ' OD2' ' CG ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.786 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.641 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.451 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.808 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HZ2' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.021 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.947 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.795 ' CE ' HG13 ' A' ' 113' ' ' VAL . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 51.8 t-20 -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.496 ' CG ' ' OD1' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' N ' ' HG2' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OE2' ' A' ' 2' ' ' GLU . 9.8 tmm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.636 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -163.2 11.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.58 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.636 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 69.55 165.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.626 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -66.54 -55.56 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.613 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.678 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.748 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 91' ' ' PRO . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.419 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 8.0 t30 -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.812 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.8 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 65' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.581 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.781 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -65.55 35.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.64 ' H ' ' C ' ' A' ' 34' ' ' SER . 46.5 m170 -58.94 14.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.081 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.787 ' CE2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -81.6 -42.29 20.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.787 ' SG ' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -77.58 -48.24 2.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.325 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 38.4 Cg_endo -88.12 167.05 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.261 2.641 . . . . 0.0 112.076 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.63 -95.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.774 2.316 . . . . 0.0 112.189 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m 51.52 29.45 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 0.0 110.481 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 42' ' ' ARG . 5.3 ttm180 -81.35 150.26 28.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.869 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.11 3.08 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.655 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.559 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.868 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.537 HG21 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 68' ' ' SER . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.488 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.485 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.681 ' SD ' ' O ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.891 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 80' ' ' MET . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.781 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 106' ' ' ILE . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.769 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.924 ' N ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.723 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HE2' ' A' ' 124' ' ' MET . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.723 HD11 ' CD2' ' A' ' 112' ' ' LEU . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.981 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.981 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.782 ' HE3' HD11 ' A' ' 121' ' ' LEU . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 127' ' ' ARG . 64.9 t-20 -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' CD ' HD22 ' A' ' 133' ' ' LEU . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.623 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -107.41 -91.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -112.35 154.21 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -53.61 -55.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.487 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.638 ' C ' HD23 ' A' ' 9' ' ' LEU . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.673 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 88' ' ' LEU . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.82 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.646 ' H ' ' CB ' ' A' ' 68' ' ' SER . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.761 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.54 19.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.625 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -58.13 20.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.521 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.795 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.7 p-90 -76.31 -38.49 55.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.795 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -67.46 -54.35 18.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.438 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 38' ' ' CYS . 73.7 Cg_endo -80.2 164.69 21.84 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.953 2.435 . . . . 0.0 112.17 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.665 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 55.5 Cg_endo -74.02 164.86 33.45 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.827 2.351 . . . . 0.0 112.27 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.665 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.82 42.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -81.34 149.74 28.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.25 -36.62 3.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.651 ' CG2' ' CE1' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.472 ' HB ' ' NE2' ' A' ' 131' ' ' GLN . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.867 ' SD ' HG22 ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' C ' ' CD ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.625 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CB ' ' CE3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.659 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.651 ' CE1' ' CG2' ' A' ' 45' ' ' THR . 8.1 m-70 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.739 ' O ' HD23 ' A' ' 88' ' ' LEU . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.82 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.797 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.797 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.726 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 1.023 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 1.023 ' H ' HG23 ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.726 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.429 ' C ' ' H ' ' A' ' 127' ' ' ARG . 1.9 t-20 -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.516 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.867 HG22 ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.607 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 4.0 mt-30 -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.632 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.768 0.318 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 ' HG2' ' A' ' 96' ' ' PRO . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.769 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.968 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.8 m120 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.589 HD12 ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.67 ' H ' ' HB3' ' A' ' 68' ' ' SER . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.599 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.861 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.788 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.788 HD13 ' OE2' ' A' ' 63' ' ' GLU . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.57 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.881 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.787 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.764 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.921 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 109' ' ' ILE . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.715 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.645 HG22 ' HE2' ' A' ' 124' ' ' MET . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.715 HD11 ' CD2' ' A' ' 112' ' ' LEU . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.648 ' HZ3' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.452 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.002 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.002 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.676 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.4 OUTLIER -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' OE1' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.633 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.893 0.377 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 96' ' ' PRO . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.862 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 ' HG3' ' A' ' 91' ' ' PRO . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.6 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.6 ' HE ' ' C ' ' A' ' 13' ' ' ASN . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.965 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 25' ' ' ASP . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.685 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.679 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.544 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.66 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.66 HD13 ' OE2' ' A' ' 63' ' ' GLU . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.642 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' SER . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.547 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.862 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.866 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.808 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.78 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.908 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.997 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.997 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.679 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 9.5 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.722 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.722 ' HB2' ' CD1' ' A' ' 133' ' ' LEU . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.933 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 1.4 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.8 m-80 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.886 0.374 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 96' ' ' PRO . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 91' ' ' PRO . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' CE ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.491 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.736 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.648 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.1 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.534 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.81 ' HD2' HD22 ' A' ' 55' ' ' LEU . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.491 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.879 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.74 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.732 ' HG2' HG21 ' A' ' 7' ' ' ILE . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.666 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 114' ' ' ILE . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 112' ' ' LEU . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.447 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.909 HD11 ' CE ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.936 HG23 ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.936 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.909 ' CE ' HD11 ' A' ' 121' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.516 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.48 ' HG2' HD22 ' A' ' 125' ' ' ASN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 133' ' ' LEU . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.4 m-80 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.631 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.891 0.377 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.744 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.752 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 1.1 m-80 -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 ' OE2' ' A' ' 63' ' ' GLU . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.702 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.538 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.08 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.969 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.935 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.67 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.636 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.519 ' C ' ' CD ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.969 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.844 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.0 m120 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.791 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.791 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.816 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.417 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.036 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.036 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.816 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.471 ' ND2' ' HG2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.742 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.564 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.516 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.556 ' O ' HD13 ' A' ' 122' ' ' ILE . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.592 HD13 ' OG ' ' A' ' 94' ' ' SER . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.661 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.772 HD23 ' CB ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.738 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 62' ' ' PHE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 29' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.71 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.89 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.416 HG21 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.595 HG22 HG13 ' A' ' 90' ' ' ILE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.513 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.545 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.842 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.772 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.595 HG13 HG22 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.661 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.771 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.934 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.005 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.005 ' H ' HG23 ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.767 HD12 HD21 ' A' ' 140' ' ' ASN . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.559 ' CD ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.767 HD21 HD12 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.582 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 96' ' ' PRO . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.772 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HZ2' ' HB3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.413 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.813 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.77 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 101' ' ' THR . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.719 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.112 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.688 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.715 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.715 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 29' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.807 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.858 ' CD2' HG22 ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.727 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.964 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.747 ' O ' HG23 ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.612 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.857 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.732 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.558 ' HB2' ' H ' ' A' ' 120' ' ' THR . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.558 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.893 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.04 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.04 ' H ' HG23 ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.857 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.705 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.522 HD12 ' OD1' ' A' ' 140' ' ' ASN . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG2' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.2 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.693 ' N ' HD22 ' A' ' 140' ' ' ASN . 0.8 OUTLIER -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.897 0.38 . . . . 0.0 110.54 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.59 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.715 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 16' ' ' GLU . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.619 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.674 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.706 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.545 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.099 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.872 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.674 ' OE1' HG23 ' A' ' 29' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.021 HG12 ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.021 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.991 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.04 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.828 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.687 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.456 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.903 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.458 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.007 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.007 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.991 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.986 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.816 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.883 0.373 . . . . 0.0 110.668 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 96' ' ' PRO . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.801 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.082 HD13 ' HB2' ' A' ' 19' ' ' ALA . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.75 HG22 ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.75 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.082 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 65' ' ' ILE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.668 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.788 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.568 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.744 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.983 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.714 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 68' ' ' SER . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.644 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.545 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.681 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.6 m80 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.455 HG23 ' CE2' ' A' ' 33' ' ' PHE . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.788 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.788 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.913 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.788 ' HA ' HG22 ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.718 ' CG2' HD11 ' A' ' 106' ' ' ILE . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.751 HD11 HD22 ' A' ' 112' ' ' LEU . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.891 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 133' ' ' LEU . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.782 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.593 ' O ' HD13 ' A' ' 122' ' ' ILE . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.867 0.365 . . . . 0.0 110.519 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.735 HG21 ' HG2' ' A' ' 96' ' ' PRO . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.768 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.01 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 17' ' ' VAL . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 16' ' ' GLU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.01 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG21 ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.669 ' O ' HD23 ' A' ' 112' ' ' LEU . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.083 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.925 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.803 ' OE1' HD21 ' A' ' 88' ' ' LEU . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' CG ' ' OG ' ' A' ' 72' ' ' SER . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.451 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.868 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.959 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.461 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.891 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 113' ' ' VAL . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 112' ' ' LEU . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.846 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.976 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.976 ' H ' HG23 ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.665 ' HE1' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.2 OUTLIER -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.737 ' HE ' ' NE2' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.75 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.737 ' NE2' ' HE ' ' A' ' 127' ' ' ARG . 81.6 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 133' ' ' LEU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.639 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 55' ' ' LEU . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.639 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.752 ' O ' HD13 ' A' ' 122' ' ' ILE . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.673 ' C ' HE21 ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.864 0.364 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.732 ' N ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 4' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.838 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.991 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 91' ' ' PRO . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.457 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.776 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.568 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.603 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.071 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 130' ' ' VAL . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.688 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.795 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.742 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.717 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.806 ' C ' HG23 ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 114' ' ' ILE . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.777 HG13 ' HE1' ' A' ' 124' ' ' MET . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 112' ' ' LEU . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.009 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.777 ' HE1' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.568 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 2.6 mt-30 -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 133' ' ' LEU . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 9.1 m-80 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.663 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 122' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.913 0.387 . . . . 0.0 110.623 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 96' ' ' PRO . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.774 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.063 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' A' ' 16' ' ' GLU . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.526 ' CG ' HG22 ' A' ' 10' ' ' VAL . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' HD21 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.797 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.557 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.752 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.081 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.823 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.863 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 68' ' ' SER . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.797 ' CB ' ' H ' ' A' ' 34' ' ' SER . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.626 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.626 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.628 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.69 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.427 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.73 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.704 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.73 HD11 ' CD2' ' A' ' 112' ' ' LEU . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.449 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.009 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.979 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.752 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 51.7 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.802 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.554 ' CZ2' HD22 ' A' ' 112' ' ' LEU . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.834 0.349 . . . . 0.0 110.582 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 4' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.734 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.532 ' H ' HD23 ' A' ' 9' ' ' LEU . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' LEU . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 65' ' ' ILE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.663 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.967 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.781 HD22 ' HD2' ' A' ' 61' ' ' PRO . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' HD22 ' A' ' 55' ' ' LEU . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.784 HD11 HG23 ' A' ' 29' ' ' ILE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.593 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.635 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.831 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 9' ' ' LEU . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' C ' HD21 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.788 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 113' ' ' VAL . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.472 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.904 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.015 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.015 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.551 HD22 ' CD ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.551 ' CD ' HD22 ' A' ' 133' ' ' LEU . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.588 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.895 0.379 . . . . 0.0 110.584 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.625 HE22 HD12 ' A' ' 23' ' ' LEU . 47.4 mm-40 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.771 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.619 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.764 HD23 ' OE1' ' A' ' 63' ' ' GLU . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.717 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.514 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.088 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.665 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.764 ' OE1' HD23 ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.137 HG12 ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.137 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.6 ' CG ' ' OE2' ' A' ' 82' ' ' GLU . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.837 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.771 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.9 m120 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.782 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.782 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.659 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.729 HG13 ' CE ' ' A' ' 124' ' ' MET . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.455 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.735 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.761 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.735 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 133' ' ' LEU . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 129' ' ' GLU . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CG ' HD21 ' A' ' 55' ' ' LEU . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.761 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.924 0.392 . . . . 0.0 110.592 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.734 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.025 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.706 HD23 ' OE2' ' A' ' 63' ' ' GLU . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.831 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.741 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.548 HD12 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.706 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 29' ' ' ILE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.115 HG12 ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.115 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 72' ' ' SER . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.404 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.82 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.59 ' CB ' HD23 ' A' ' 9' ' ' LEU . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.664 HG23 HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.734 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 10.5 m120 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 98' ' ' SER . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.781 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.725 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.825 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 ' CD2' ' A' ' 112' ' ' LEU . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.893 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.825 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 140' ' ' ASN . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.508 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 23.6 m-80 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.575 ' O ' HD13 ' A' ' 122' ' ' ILE . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.882 0.372 . . . . 0.0 110.545 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.755 HG21 ' HG2' ' A' ' 96' ' ' PRO . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.811 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.809 ' HB1' HD22 ' A' ' 88' ' ' LEU . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.775 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.521 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 1.053 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.633 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG13 ' HB1' ' A' ' 97' ' ' ALA . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.624 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.787 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.635 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.812 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.458 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 114' ' ' ILE . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.981 HG13 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 112' ' ' LEU . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.025 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.981 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.733 ' ND2' ' CD ' ' A' ' 127' ' ' ARG . 0.6 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.733 ' CD ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.535 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.676 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.633 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.704 HG21 ' HG2' ' A' ' 96' ' ' PRO . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.861 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.742 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.896 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 19' ' ' ALA . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.685 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.794 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.652 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.671 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.877 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.848 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.61 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.721 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.654 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.652 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.4 m80 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.719 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.803 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.803 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.796 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.718 HG21 HD11 ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 112' ' ' LEU . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.033 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.718 ' CE ' HD21 ' A' ' 121' ' ' LEU . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.3 t-20 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.653 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.794 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 4.5 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.663 HD22 ' HG2' ' A' ' 136' ' ' ARG . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.8 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.87 0.367 . . . . 0.0 110.55 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 20' ' ' ASN . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG21 ' HG2' ' A' ' 96' ' ' PRO . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.85 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 91' ' ' PRO . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 6' ' ' GLY . 0.6 OUTLIER -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 65' ' ' ILE . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.716 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.611 ' C ' ' O ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.69 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.419 ' CG2' ' HG3' ' A' ' 131' ' ' GLN . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.085 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.987 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.964 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.666 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.558 ' OE2' HD12 ' A' ' 23' ' ' LEU . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 23' ' ' LEU . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.645 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.987 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.843 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.784 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.784 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.741 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.79 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 116' ' ' LYS . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.999 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.999 ' H ' HG23 ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.79 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.698 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.815 HE21 ' H ' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.513 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.883 0.373 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.8 HG21 ' HG2' ' A' ' 96' ' ' PRO . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.929 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' PRO . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.69 ' H ' ' HZ2' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.617 ' H ' ' CB ' ' A' ' 68' ' ' SER . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.066 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.5 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.495 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.609 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.578 ' OD1' ' CB ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.786 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.641 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.451 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.808 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HZ2' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.021 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.947 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.795 ' CE ' HG13 ' A' ' 113' ' ' VAL . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.666 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.645 ' CG ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.5 ' N ' ' HG2' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.945 0.403 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.837 ' H ' HD22 ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.678 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.748 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 91' ' ' PRO . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.812 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.837 HD22 ' H ' ' A' ' 6' ' ' GLY . 0.5 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 65' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.781 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.655 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.559 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.868 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.504 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.537 HG21 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 68' ' ' SER . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.488 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.598 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.485 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.681 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.891 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.955 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 80' ' ' MET . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.781 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 106' ' ' ILE . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.769 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.924 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.723 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HE2' ' A' ' 124' ' ' MET . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.723 HD11 ' CD2' ' A' ' 112' ' ' LEU . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.981 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.981 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.782 ' HE3' HD11 ' A' ' 121' ' ' LEU . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' CD ' HD22 ' A' ' 133' ' ' LEU . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.679 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.623 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.078 0 CA-C-O 120.925 0.393 . . . . 0.0 110.487 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' HD22 ' A' ' 20' ' ' ASN . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.638 ' C ' HD23 ' A' ' 9' ' ' LEU . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.673 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 88' ' ' LEU . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.0 t-20 -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.82 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.646 ' H ' ' CB ' ' A' ' 68' ' ' SER . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 69' ' ' SER . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.719 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.867 ' SD ' HG22 ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.625 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.548 ' OD1' ' C ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.632 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 5.5 m80 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.739 ' O ' HD23 ' A' ' 88' ' ' LEU . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.82 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.902 ' HB3' ' HZ2' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.902 ' HZ2' ' HB3' ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.797 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.797 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.726 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 1.023 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 1.023 ' H ' HG23 ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.726 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.473 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.516 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.867 HG22 ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.632 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.489 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 3.0 pt-20 -142.31 115.11 8.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 95.5 m-85 -157.37 173.86 16.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.542 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -66.26 -44.81 91.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.502 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.87 122.51 0.46 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.38 -11.56 8.53 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 ' HG2' ' A' ' 96' ' ' PRO . 19.1 pt -100.56 174.5 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 120.775 0.321 . . . . 0.0 110.658 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.769 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -112.68 132.06 55.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.598 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.968 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.7 mp -100.27 168.12 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.62 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 10.7 t -115.4 124.58 72.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.884 0.373 . . . . 0.0 110.806 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 2.2 mtpt -80.16 139.96 36.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.494 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.0 pttp -42.55 -24.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.616 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -79.72 24.74 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.419 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' LYS . 9.2 mtt180 58.18 25.53 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.56 171.41 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.607 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -127.02 143.8 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.513 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.0 173.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.624 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.8 m120 -90.27 100.88 13.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.451 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -38.62 -24.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.992 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.1 t30 -51.55 -58.09 7.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 110.473 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.41 -25.91 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -65.34 -33.82 76.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.818 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' O ' ' C ' ' A' ' 24' ' ' LYS . 54.8 mt -70.14 -3.98 19.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.729 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER 28.0 -101.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.38 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.778 ' OD1' ' N ' ' A' ' 28' ' ' ILE . 13.9 t0 56.07 -69.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.519 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.683 ' N ' ' O ' ' A' ' 24' ' ' LYS . 5.8 mtpt 41.63 13.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 68.4 m-20 -144.71 -72.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.775 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.778 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -136.86 155.64 33.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.883 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.589 HD12 ' OD2' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -138.72 144.76 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.445 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.6 119.68 2.65 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 71.5 m-85 -91.16 122.43 33.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 0.0 110.351 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 44.5 t80 -107.19 128.86 54.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.909 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 2.4 m-85 -122.3 116.57 24.32 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.321 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.67 ' H ' ' HB3' ' A' ' 68' ' ' SER . 1.9 t 167.52 79.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.603 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.683 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -65.95 36.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.8 m-70 -60.12 25.12 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.916 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.793 ' CH2' ' SG ' ' A' ' 38' ' ' CYS . 1.9 p-90 -83.91 -40.99 17.88 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.793 ' SG ' ' CH2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -79.29 -49.1 1.47 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.299 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 61.6 Cg_endo -89.34 165.21 5.48 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 123.255 2.636 . . . . 0.0 112.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.658 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 41.5 Cg_endo -71.07 156.63 59.48 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.711 2.274 . . . . 0.0 112.154 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.84 40.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.463 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' NH1' ' HA ' ' A' ' 40' ' ' PRO . 2.3 mpt_? -81.32 149.8 28.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.815 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.66 3.27 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.654 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 16.9 t80 -85.74 -36.07 20.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.052 0.454 . . . . 0.0 110.522 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.599 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -56.39 -58.91 13.86 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.116 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.1 Cg_endo -51.71 -11.58 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.438 2.092 . . . . 0.0 112.032 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 1.2 mt -85.26 -51.8 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 109.964 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.09 -30.86 70.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.718 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -68.66 -29.69 68.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.893 0.378 . . . . 0.0 110.259 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -79.68 -28.76 40.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.8 tmm? -75.75 -53.29 8.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.861 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.64 -25.07 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.759 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 7.1 t -68.62 -43.16 76.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.95 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.33 -55.3 12.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.3 mt -56.55 -38.09 71.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.143 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 52' ' ' TYR . 14.5 t -61.03 -45.24 98.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -55.94 -30.92 62.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.48 21.23 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.169 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.61 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 71.38 23.98 3.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.321 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 5.36 94.22 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.8 Cg_exo -60.04 37.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.128 2.552 . . . . 0.0 112.698 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.89 154.48 3.56 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.556 179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.788 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -115.14 148.58 38.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.309 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.07 125.66 56.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.445 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.788 HD13 ' OE2' ' A' ' 63' ' ' GLU . 2.1 mm -86.14 135.89 24.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 2.5 t80 -96.12 111.47 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.943 0.402 . . . . 0.0 111.102 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.607 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.12 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.909 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.791 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER 83.59 149.93 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.589 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.57 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -47.12 68.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.335 -179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.934 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.3 m-20 -95.93 10.88 35.82 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 6.6 mtp180 -31.46 -11.46 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.461 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.934 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -84.86 111.69 19.87 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.406 -0.518 . . . . 0.0 109.69 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.1 pt-20 -67.03 -29.03 68.73 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.076 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -81.02 -48.32 12.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.995 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.716 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 4.8 m-20 -70.55 -18.48 62.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.433 ' CB ' ' O ' ' A' ' 72' ' ' SER . 1.1 ttp -76.26 -54.04 7.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.917 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.54 -32.21 67.89 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.545 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 23.6 mm-40 -64.82 -51.95 59.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.686 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 3.1 m-85 -61.39 -40.4 94.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.239 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 89' ' ' ALA . 65.1 mtp -64.28 -43.35 95.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.466 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -18.54 45.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.783 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.6 mm-40 -63.8 -15.52 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.795 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.753 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 54.7 p 127.79 3.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.644 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.881 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.44 124.21 38.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.762 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.26 131.15 0.01 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.7 62.67 0.7 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.155 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.645 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.5 m-90 -157.19 -109.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.106 0 C-N-CA 120.431 -0.507 . . . . 0.0 111.607 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.787 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.4 mp -128.36 176.12 7.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.79 0.805 . . . . 0.0 112.592 -177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' SD ' ' A' ' 80' ' ' MET . . . -139.15 123.61 18.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.239 -1.346 . . . . 0.0 109.836 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.38 114.34 27.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.589 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.4 Cg_exo -49.41 110.24 0.35 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.529 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.6 p90 -29.76 -26.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 110.43 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.784 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.6 mtt85 -84.12 22.04 1.27 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.319 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.6 m -105.98 63.16 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.795 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.36 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.813 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.05 -25.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.773 2.315 . . . . 0.0 112.55 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.62 -38.9 62.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 109.905 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 95' ' ' GLY . 85.5 p -71.01 -63.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 98.7 m-20 -45.07 -33.22 2.04 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.62 -55.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.901 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.514 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.7 m -61.59 -46.09 91.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.577 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.82 -21.2 61.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.504 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.612 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.4 tttm -81.95 -38.03 25.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.141 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.4 -10.98 59.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.557 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.74 32.06 59.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.764 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -71.69 -115.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.682 0.277 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.0 OUTLIER 72.05 -3.55 2.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.655 179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.35 16.35 49.31 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.921 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -46.27 142.53 4.2 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 110.707 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.677 ' HA ' HG22 ' A' ' 109' ' ' ILE . 58.0 Cg_endo -75.15 138.0 53.45 Favored 'Cis proline' 0 C--N 1.309 -1.509 0 C-N-CA 123.33 -1.529 . . . . 0.0 112.099 -0.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.74 159.6 30.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.715 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -127.36 125.02 39.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.353 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.645 HG22 ' HE2' ' A' ' 124' ' ' MET . 1.2 t -107.77 136.82 41.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.895 0.379 . . . . 0.0 110.666 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.715 HD11 ' CD2' ' A' ' 112' ' ' LEU . 38.3 mm -121.79 124.65 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -136.09 152.66 30.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.246 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.3 mttm -75.92 144.72 40.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.648 ' HZ3' ' HA ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -45.99 -45.48 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.563 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -13.84 18.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.519 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 102.41 16.24 23.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.452 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.05 144.07 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 110.622 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.986 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -88.01 141.86 28.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.032 0.444 . . . . 0.0 110.247 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.002 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.7 -64.75 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.517 -179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.002 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -149.24 118.21 6.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.251 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.676 ' O ' ' N ' ' A' ' 126' ' ' GLY . 2.0 mmt -79.19 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.75 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.4 OUTLIER -61.56 49.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.83 0.348 . . . . 0.0 110.317 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.23 15.06 7.25 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -43.7 -86.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.803 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.67 -31.2 1.7 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.577 ' N ' ' OE1' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -59.97 -49.69 76.67 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.25 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.3 OUTLIER -68.26 -50.46 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.654 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 1.9 mt-30 -58.49 -27.51 64.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.349 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 128' ' ' GLY . 38.2 t -79.9 -49.4 11.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.454 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.9 mt -86.44 -8.52 57.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.68 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.72 -146.73 30.4 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 19.9 Cg_exo -60.77 -13.3 25.74 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.723 2.282 . . . . 0.0 111.951 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.2 mtt180 -83.24 -9.95 58.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.087 0.47 . . . . 0.0 109.798 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.636 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.33 -23.72 65.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.086 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.719 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.51 -23.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.173 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.729 ' O ' ' N ' ' A' ' 143' ' ' ARG . 9.0 pt20 -74.66 -45.84 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 137' ' ' ALA . 50.2 m-20 -73.27 -41.91 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.633 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.0 m0 -69.48 -22.08 63.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.959 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.84 6.96 9.33 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.241 0.543 . . . . 0.0 110.915 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.729 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.518 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -47.64 120.57 3.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 62.57 121.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.532 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -53.7 -49.52 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.551 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 16.0 mt-30 -33.65 121.67 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.656 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.93 -5.87 20.1 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.654 HG21 ' HG2' ' A' ' 96' ' ' PRO . 33.6 pt -97.57 173.11 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 120.751 0.31 . . . . 0.0 110.709 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.862 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -86.11 169.33 13.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.27 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.965 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.55 159.41 37.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.325 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG23 ' HG3' ' A' ' 91' ' ' PRO . 93.6 t -119.24 134.72 61.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.13 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -97.28 144.79 26.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.174 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 14' ' ' ARG . 2.5 ptpp? -42.06 -28.27 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.635 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.6 ' C ' ' HE ' ' A' ' 14' ' ' ARG . 5.3 m120 -73.08 21.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.6 ' HE ' ' C ' ' A' ' 13' ' ' ASN . 3.9 mtm180 54.73 29.01 10.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.286 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -108.13 171.29 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.958 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.89 141.22 52.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -148.33 172.72 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 20' ' ' ASN . 7.4 m120 -90.43 105.1 17.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.965 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.89 -24.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.091 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -50.57 -58.13 6.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.294 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -96.55 -25.96 15.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.621 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -60.88 -30.46 70.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.701 ' O ' ' N ' ' A' ' 25' ' ' ASP . 4.3 mp -69.99 -8.24 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.772 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 27.16 -84.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.502 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.5 p30 45.74 94.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 7.8 tptm -37.08 -21.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 159.13 7.12 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.513 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -140.35 155.07 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.519 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CG ' ' A' ' 25' ' ' ASP . 1.1 mp -145.45 148.55 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.03 118.52 2.31 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 39.5 m-85 -91.29 122.93 34.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.744 0.307 . . . . 0.0 110.89 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 68.5 t80 -100.69 123.44 44.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.039 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.616 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -115.58 117.52 30.57 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.744 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.685 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 151.18 81.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.809 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.596 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.84 68.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.045 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.774 ' CG ' ' SG ' ' A' ' 41' ' ' CYS . 2.9 m-70 -80.05 23.99 0.44 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.113 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.788 ' NE1' ' SG ' ' A' ' 38' ' ' CYS . 1.6 p-90 -88.31 -41.95 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.605 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.788 ' SG ' ' NE1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.66 -53.34 0.63 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.531 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.54 ' HD3' ' SG ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.3 161.85 22.77 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.786 2.324 . . . . 0.0 112.275 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.641 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 62.3 Cg_endo -77.49 156.51 32.4 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.958 2.439 . . . . 0.0 112.2 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.774 ' SG ' ' CG ' ' A' ' 36' ' ' HIS . 1.1 p 156.72 45.94 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.487 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -81.28 149.58 28.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.11 -35.94 3.22 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.679 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 13.1 t80 -86.03 -52.1 5.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.466 . . . . 0.0 110.321 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.685 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.4 -58.43 5.1 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.319 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.5 Cg_endo -48.78 -11.95 0.18 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.5 2.133 . . . . 0.0 112.11 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.544 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.7 mt -86.79 -46.78 16.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.4 -34.38 74.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.778 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.56 -26.88 67.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.212 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.11 -32.39 39.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 6.3 tmm? -74.56 -49.92 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.82 -25.35 62.82 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.764 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.8 t -67.5 -43.1 81.73 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.893 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.3 OUTLIER -68.24 -55.24 12.92 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.746 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -55.51 -38.1 68.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.067 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 17.9 t -59.71 -49.44 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -51.27 -33.52 28.82 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.35 21.2 4.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.156 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.623 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.7 p 70.52 23.87 4.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.321 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.746 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.94 94.72 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 26.0 Cg_exo -59.79 37.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 123.077 2.518 . . . . 0.0 112.747 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.15 154.14 3.29 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.268 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.66 ' OE2' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -114.14 148.4 37.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.428 -179.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -101.35 128.94 53.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.398 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.66 HD13 ' OE2' ' A' ' 63' ' ' GLU . 1.3 mm -89.95 134.91 27.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 1.8 t80 -99.63 109.73 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.892 0.377 . . . . 0.0 110.927 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -152.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.885 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.29 149.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.357 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 2.9 m -41.43 66.24 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.315 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.926 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -104.12 10.52 35.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.735 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.49 -9.5 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.471 -179.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.926 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.8 OUTLIER -81.18 111.37 17.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.555 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.696 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 4.0 mt-10 -68.34 -28.21 66.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.909 0.385 . . . . 0.0 110.112 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.62 -46.79 13.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.08 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 7.1 m-20 -69.29 -17.95 63.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' SER . 27.2 ttm -77.99 -57.94 3.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.956 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.696 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -65.87 -21.82 66.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.5 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -76.19 -50.83 13.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.468 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.25 -25.79 68.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.456 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 4.2 mtm -81.16 -47.73 13.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.529 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 26.0 mmm -68.98 -21.23 64.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.318 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.547 ' O ' ' OG ' ' A' ' 83' ' ' SER . 5.7 mt-10 -65.06 -54.27 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 165.05 3.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.332 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.862 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.56 113.61 25.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.615 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 58.57 135.24 0.01 OUTLIER Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.609 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 2.2 t70 -120.84 66.74 0.85 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.547 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.561 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 29.3 m-90 -153.29 -111.48 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.358 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.866 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.9 mp -128.02 175.89 8.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.801 0.81 . . . . 0.0 112.566 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.32 123.78 20.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.761 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.689 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -72.13 114.36 28.56 Favored Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.318 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.778 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.8 Cg_exo -46.36 108.94 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 121.717 1.611 . . . . 0.0 111.167 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -29.94 -25.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.514 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.778 ' N ' ' O ' ' A' ' 91' ' ' PRO . 14.8 mtm180 -88.04 22.0 2.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.362 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.762 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 t -102.07 63.29 0.91 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.803 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.58 -63.24 0.01 OUTLIER Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.808 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.13 -25.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.622 2.215 . . . . 0.0 112.55 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.95 -37.94 54.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.911 0.386 . . . . 0.0 110.054 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 95' ' ' GLY . 48.0 t -70.22 -64.09 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.625 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 14.9 t-20 -45.82 -32.21 2.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.449 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.0 -54.38 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.921 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 m -63.07 -46.43 87.5 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.54 0.686 . . . . 0.0 110.405 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.22 61.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.408 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 27.9 tttp -78.89 -35.84 43.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.121 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -78.76 -17.19 56.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.74 37.51 45.01 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.78 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -64.5 -110.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.651 0.262 . . . . 0.0 110.71 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.1 p 73.88 3.55 4.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -98.77 16.88 59.06 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.908 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.24 139.95 34.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 141.75 72.35 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.254 0.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.6 154.64 16.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.705 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.9 tt -120.85 124.2 44.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.317 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.807 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -105.0 134.79 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.705 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.2 mm -119.56 121.89 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.65 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.25 148.74 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.486 ' HB2' ' H ' ' A' ' 120' ' ' THR . 13.7 mttp -69.63 161.12 30.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.671 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.6 ' CD ' ' C ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -54.25 -49.38 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.565 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -64.0 -9.38 15.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.351 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.21 21.03 18.77 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.486 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.41 123.87 28.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.652 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.942 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.6 143.96 54.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.416 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.997 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -135.68 -64.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.387 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.997 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -144.46 118.52 9.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.358 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -77.65 -96.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.714 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.03 51.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.051 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -75.98 8.07 25.04 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -43.95 -87.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.058 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.643 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.02 -30.0 0.97 Allowed Glycine 0 CA--C 1.518 0.281 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.594 ' O ' ' CD1' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -57.84 -53.24 60.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.763 0.316 . . . . 0.0 110.323 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.1 t -66.07 -49.64 75.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.679 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 9.5 mt-30 -67.89 -16.96 64.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.078 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 3.7 m -74.06 -45.12 51.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.888 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.722 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -114.64 -13.41 12.11 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.184 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 79.59 -146.71 28.89 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.533 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 50.7 Cg_exo -49.76 -24.81 10.52 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.828 2.352 . . . . 0.0 112.614 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.65 ' CD ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -63.25 -14.06 45.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.967 0.413 . . . . 0.0 110.112 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.722 ' HB2' ' CD1' ' A' ' 133' ' ' LEU . . . -62.63 -26.2 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.933 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 10.9 t80 -36.19 -25.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.157 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.743 ' O ' ' N ' ' A' ' 143' ' ' ARG . 1.4 pt20 -78.89 -48.91 13.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.608 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.8 m-80 -70.73 -43.88 68.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.106 0.479 . . . . 0.0 109.961 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.647 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -70.38 -26.26 63.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.137 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.933 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -117.28 7.17 12.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.214 0.531 . . . . 0.0 110.91 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.743 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.827 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.542 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.04 169.82 18.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.535 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -175.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -53.53 -51.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.644 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.64 116.93 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.686 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 121.31 -4.25 11.19 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 96' ' ' PRO . 24.6 pt -101.58 176.6 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 120.828 0.346 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.849 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.91 169.55 12.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.52 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.913 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -158.46 160.19 36.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.359 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 91' ' ' PRO . 60.5 t -117.76 134.39 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.984 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' CE ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -95.95 144.0 26.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.246 179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' ARG . 3.9 ptpp? -42.18 -24.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.714 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -75.67 23.38 0.12 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.041 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 52.95 31.4 10.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.192 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.55 171.48 7.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.803 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -117.06 153.12 33.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.594 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.57 HG21 ' CD2' ' A' ' 88' ' ' LEU . 25.6 m -156.88 171.5 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.722 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' ASN . 4.5 m-80 -92.31 105.58 17.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.913 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -41.58 -24.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.686 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -47.49 -56.79 6.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.981 0.42 . . . . 0.0 110.419 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -96.41 -26.04 15.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.577 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -60.86 -26.85 67.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.058 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.9 mp -83.62 25.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 26' ' ' LYS . 36.7 ttpt -13.7 -93.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' GLU . 14.3 m-20 56.69 -68.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.725 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.665 ' N ' ' O ' ' A' ' 24' ' ' LYS . 31.0 mttm 43.41 12.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 31.0 m-20 -143.58 -73.03 0.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.06 -179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -139.46 155.85 26.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.968 0.414 . . . . 0.0 111.657 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -134.38 150.32 30.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.318 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.23 119.35 1.5 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.491 ' CE2' HG13 ' A' ' 65' ' ' ILE . 42.7 m-85 -93.65 124.98 38.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.665 0.269 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 53.3 t80 -100.92 123.72 45.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.193 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.3 m-85 -115.72 113.18 23.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.832 0.348 . . . . 0.0 110.787 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.736 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.87 93.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -31.57 -47.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.018 0.437 . . . . 0.0 110.295 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' CE1' ' OG1' ' A' ' 45' ' ' THR . 1.2 t-80 65.15 -21.74 0.08 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.158 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.783 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.3 p-90 -91.64 -49.36 6.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.686 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.783 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -75.57 -49.59 3.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 110.196 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 92.8 Cg_endo -87.97 112.81 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 123.288 2.659 . . . . 0.0 112.15 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.659 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 50.3 Cg_exo -48.98 151.85 5.28 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.667 2.245 . . . . 0.0 112.189 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.659 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 155.46 45.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.581 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -81.43 149.6 28.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.08 -36.07 3.19 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 3.7 t80 -86.03 -46.64 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.125 0.488 . . . . 0.0 110.406 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.681 ' OG1' ' CE1' ' A' ' 36' ' ' HIS . 1.2 m -44.17 -58.47 4.87 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 45' ' ' THR . 1.0 OUTLIER -45.92 -12.17 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.688 2.259 . . . . 0.0 112.298 -179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.3 mt -85.16 -46.37 17.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.458 . . . . 0.0 110.147 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.1 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.86 -33.44 75.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.91 -19.08 65.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.658 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -38.77 23.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.055 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 20.0 ptm -73.54 -40.71 63.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.92 -29.07 58.27 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.883 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.811 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.0 t -68.06 -39.66 82.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.016 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.534 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -72.62 -47.4 48.05 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.81 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.1 mt -58.42 -40.47 82.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.159 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.6 t -60.51 -47.41 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.92 -32.65 46.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.2 21.33 5.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.138 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.6 ' O ' ' C ' ' A' ' 60' ' ' ALA . 4.5 t 70.55 24.37 4.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.79 113.28 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.434 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.81 ' HD2' HD22 ' A' ' 55' ' ' LEU . 79.5 Cg_endo -81.66 38.37 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.962 2.442 . . . . 0.0 112.366 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.8 154.16 3.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.7 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -114.54 148.63 37.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.102 -179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -102.85 130.1 53.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.566 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.491 HG13 ' CE2' ' A' ' 31' ' ' PHE . 2.9 mm -89.93 135.13 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.5 t80 -99.75 104.55 16.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.986 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.613 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -126.17 -162.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.659 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.763 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 81.12 150.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.528 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.88 69.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.284 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.922 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -103.52 10.61 37.02 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -31.98 -11.73 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.3 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.922 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -78.58 111.74 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.669 179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.2 pt-20 -63.49 -27.67 69.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.452 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -50.33 11.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.509 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.8 m-20 -59.84 -26.31 65.71 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 80' ' ' MET . 1.1 tpp -69.57 -64.08 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.984 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -67.58 -19.64 65.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -76.22 -56.01 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 0.0 110.381 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -62.34 -26.32 68.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.873 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 76' ' ' MET . 30.8 mtp -81.3 -51.75 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.472 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -23.59 65.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.726 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' OG ' ' A' ' 83' ' ' SER . 13.6 mt-10 -67.61 -56.42 9.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.736 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.773 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.3 m 167.67 3.96 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.397 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.879 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.09 119.09 31.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.844 0.354 . . . . 0.0 110.562 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.85 126.23 0.01 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -113.79 60.52 0.66 Allowed 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.196 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 22.8 m-90 -156.65 -108.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.75 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.808 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -125.3 175.91 7.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.743 0.783 . . . . 0.0 112.446 -178.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.99 123.03 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.778 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.74 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.11 114.44 27.42 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.382 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.6 Cg_exo -46.8 109.28 0.2 Allowed 'Trans proline' 0 C--N 1.299 -2.027 0 C-N-CA 121.673 1.582 . . . . 0.0 111.212 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -29.85 -26.06 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 110.426 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.2 mtt180 -86.32 22.05 1.91 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.267 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.0 p -104.34 63.22 0.74 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.859 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.33 -63.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.732 ' HG2' HG21 ' A' ' 7' ' ' ILE . 83.6 Cg_exo -37.79 -24.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.683 2.255 . . . . 0.0 112.545 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.72 -46.21 22.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 0.0 109.927 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -67.94 -63.91 0.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.666 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.28 -32.39 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.583 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.0 OUTLIER -60.54 -53.49 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.774 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.513 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.9 m -63.94 -47.22 81.35 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.634 0.73 . . . . 0.0 110.308 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.68 -21.5 63.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.539 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.666 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 2.7 mmtp -76.63 -34.69 58.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.128 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -85.01 -3.95 58.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.56 24.6 76.12 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.642 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.96 131.89 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 110.94 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.13 20.3 0.16 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.584 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -99.52 11.45 61.36 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -41.7 137.0 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.8 Cg_endo -70.45 137.56 46.13 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.248 0.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -153.2 147.88 26.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.786 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.826 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.4 tt -114.53 119.78 37.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.309 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 114' ' ' ILE . 2.4 t -103.44 129.53 55.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.568 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.826 HD11 ' CD2' ' A' ' 112' ' ' LEU . 41.9 mm -122.53 121.29 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.003 0.43 . . . . 0.0 111.283 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.75 156.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.289 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 6.6 mttm -79.71 161.71 25.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 0.0 110.625 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.17 -49.84 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.3 -1.58 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.433 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.29 7.49 63.69 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.447 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -64.96 103.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.632 -179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.909 HD11 ' CE ' ' A' ' 124' ' ' MET . 0.1 OUTLIER -55.11 140.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.258 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.936 HG23 ' H ' ' A' ' 123' ' ' SER . 1.1 tt -132.74 -65.2 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.218 0.532 . . . . 0.0 110.633 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.936 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.5 OUTLIER -136.02 134.66 38.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.378 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.909 ' CE ' HD11 ' A' ' 121' ' ' LEU . 3.5 mmt -100.15 -112.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.516 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.32 42.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.316 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.49 19.71 3.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.48 ' HG2' HD22 ' A' ' 125' ' ' ASN . 0.2 OUTLIER -42.36 -83.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.576 -179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.73 -30.65 1.6 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tt0 -57.94 -54.61 44.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.622 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -64.53 -51.3 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.662 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.622 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 9.1 mp0 -65.39 -17.4 64.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.293 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 4.9 m -77.61 -46.9 20.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 133' ' ' LEU . 6.6 mt -93.85 -25.44 17.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.917 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 89.58 -146.04 18.69 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.27 -16.32 51.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.228 1.952 . . . . 0.0 111.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.19 -7.35 54.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.073 0.463 . . . . 0.0 109.915 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.39 -25.82 66.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.166 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 25.5 t80 -37.21 -20.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.795 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 30.3 mt-30 -74.12 -56.76 4.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.1 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 137' ' ' ALA . 7.4 m-80 -67.41 -37.43 83.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.784 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.631 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.1 m0 -70.94 -24.6 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.04 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.72 6.97 11.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 5.6 mtp180 . . . . . 0 C--N 1.317 -0.82 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.632 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 52.57 -125.3 2.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -148.48 -179.63 7.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.538 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -72.95 -44.84 56.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.568 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 4.0 mt-30 -33.84 121.19 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.56 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' N ' ' ND2' ' A' ' 20' ' ' ASN . . . 123.13 -4.42 9.65 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.744 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.0 pt -106.83 175.53 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.782 0.325 . . . . 0.0 110.576 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.752 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.03 131.89 55.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.674 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.034 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -100.02 170.06 8.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.6 t -115.64 126.84 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.851 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -83.66 143.03 30.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.414 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.19 -36.21 1.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.475 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.96 19.23 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.192 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 5.9 ttp180 61.96 25.59 15.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.355 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.84 171.21 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -126.01 133.68 51.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -145.03 172.46 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.77 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 20' ' ' ASN . 5.4 m-20 -89.73 103.58 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.672 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.034 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -39.61 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' ND2' ' N ' ' A' ' 6' ' ' GLY . 1.1 m-80 -51.73 -57.54 8.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.982 0.42 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -96.1 -25.98 15.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.481 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.644 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -63.86 -27.39 69.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 ' OE2' ' A' ' 63' ' ' GLU . 35.1 mt -70.19 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.669 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.54 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 36.38 -85.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.621 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.9 p-10 45.47 92.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 10.1 tptt -38.83 -18.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.058 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 3.8 m-20 161.38 -1.59 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.28 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -133.26 152.84 36.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.894 -179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.8 mp -132.41 159.98 42.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.553 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -132.39 149.09 19.39 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 64.4 m-85 -129.99 117.24 19.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.792 0.33 . . . . 0.0 110.766 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' CE1' ' OG ' ' A' ' 34' ' ' SER . 15.2 t80 -103.63 117.33 34.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.499 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.629 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -113.04 111.4 22.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.937 0.399 . . . . 0.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.702 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.7 p 148.75 69.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.387 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -6.6 -61.21 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.696 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER 68.26 -10.9 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.04 179.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.776 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.0 OUTLIER -95.31 -51.2 4.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.611 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.776 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.44 -50.34 10.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.935 0.397 . . . . 0.0 110.153 179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 86.1 Cg_endo -86.28 150.95 9.29 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 123.171 2.581 . . . . 0.0 112.195 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -75.09 135.87 19.49 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.797 2.331 . . . . 0.0 112.163 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 36' ' ' HIS . 0.1 OUTLIER 174.41 49.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -81.35 149.31 28.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.685 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 120.15 -35.76 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.687 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 18.3 t80 -85.53 -47.98 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.546 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.66 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -48.32 -59.62 5.72 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.114 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -46.97 -12.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.57 2.18 . . . . 0.0 112.244 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.538 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.8 mt -84.34 -48.02 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.021 0.439 . . . . 0.0 110.109 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.08 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -67.5 -33.93 76.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.9 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.969 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.53 -27.52 67.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.12 -31.53 39.09 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 6.1 tmm? -75.05 -50.55 16.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.628 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.935 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.74 -25.71 63.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.789 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.5 t -66.95 -44.49 80.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.5 OUTLIER -68.42 -53.32 24.45 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.738 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -54.27 -37.95 65.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.038 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 52' ' ' TYR . 24.7 t -58.94 -51.64 70.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -49.46 -33.74 14.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.14 21.16 4.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.195 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.608 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.53 23.55 4.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.288 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.67 91.83 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.231 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.16 41.87 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 123.169 2.58 . . . . 0.0 112.721 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.84 154.34 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.438 179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.67 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.2 tt0 -113.05 148.98 34.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.029 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.661 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -105.35 144.19 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.666 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -107.07 136.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.855 179.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.76 108.06 19.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.012 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.83 -154.17 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.808 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER 71.1 149.78 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.478 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 69' ' ' SER . 1.4 p -36.67 74.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.927 0.394 . . . . 0.0 111.328 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.959 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.7 OUTLIER -114.41 10.94 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.676 179.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.582 ' O ' ' CG ' ' A' ' 71' ' ' ARG . 28.5 ttt180 -32.91 -5.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.899 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.959 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -86.76 111.51 20.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.696 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.632 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 36.9 mt-10 -69.48 -28.55 66.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.005 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 78' ' ' GLN . 86.2 m-20 -78.92 -47.08 17.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.875 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.702 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 26.8 m-20 -63.62 -23.69 67.48 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.9 mtm -72.09 -62.6 1.37 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.819 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.671 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -61.37 -25.52 67.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.736 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.519 ' C ' ' CD ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -76.34 -55.04 5.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.949 0.404 . . . . 0.0 110.077 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -64.04 -24.12 67.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.112 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 -48.93 11.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.437 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.61 -26.21 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.673 ' CG ' ' N ' ' A' ' 83' ' ' SER . 4.9 pt-20 -61.56 -54.15 46.83 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.608 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.969 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 4.7 t 168.43 4.18 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.844 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.72 118.43 30.14 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.672 -179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.547 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.41 133.32 0.01 OUTLIER Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.542 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -116.09 62.1 0.71 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.332 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.547 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 23.8 m-90 -156.56 -109.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.687 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 2.5 mp -129.61 176.58 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.813 0.816 . . . . 0.0 112.698 -178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.81 123.7 17.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.047 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.47 114.32 18.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.319 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.786 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.9 Cg_exo -48.48 109.28 0.23 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 121.77 1.646 . . . . 0.0 111.215 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.2 p90 -30.02 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.488 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.786 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.4 mmp_? -87.18 22.03 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.349 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.752 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -106.17 63.28 0.66 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.691 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.44 -63.27 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.744 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.8 Cg_exo -38.12 -19.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.672 2.248 . . . . 0.0 112.454 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -81.34 -48.03 12.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 109.986 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -67.64 -64.06 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.589 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.0 m120 -44.8 -31.2 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.528 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.1 t -64.16 -47.82 88.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.0 109.669 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.1 m -67.19 -48.66 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 0.0 110.242 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.78 -21.57 63.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.486 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.3 ttpm? -77.49 -35.3 53.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.093 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.64 -18.81 56.36 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.495 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.67 36.42 29.44 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.791 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -62.52 -106.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.718 0.294 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.791 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.9 3.54 4.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.47 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.99 15.77 60.22 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.19 140.35 33.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HA ' HG22 ' A' ' 109' ' ' ILE . 54.5 Cg_endo -72.7 138.36 54.57 Favored 'Cis proline' 0 N--CA 1.494 1.534 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.285 0.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.95 19.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.779 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.9 tt -112.39 119.96 40.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.198 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.816 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -105.16 124.68 60.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.049 0.452 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.779 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.3 mm -114.57 130.94 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.064 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 m -142.24 147.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.73 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 23.0 mttt -69.41 172.81 6.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.693 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HA ' ' CD1' ' A' ' 29' ' ' ILE . 4.2 tttm -60.9 -49.87 75.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.721 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -68.43 -3.37 11.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.386 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.99 15.92 46.68 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.417 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -71.85 114.72 10.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.36 . . . . 0.0 110.718 -179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.975 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -61.71 141.84 57.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.055 0.455 . . . . 0.0 110.279 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.036 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -130.7 -64.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.445 -179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.036 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.3 m -150.87 118.17 6.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.148 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.816 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.3 mmt -79.4 -104.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.639 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.471 ' ND2' ' HG2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -59.05 45.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 0.0 110.473 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.742 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.07 17.06 5.05 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.564 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.3 OUTLIER -43.74 -85.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.587 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -42.98 -34.05 1.88 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.4 OUTLIER -56.4 -52.27 65.25 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.951 179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.609 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.5 -48.87 75.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.687 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 9.5 mt-30 -66.84 -14.95 63.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.197 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.625 ' N ' ' O ' ' A' ' 128' ' ' GLY . 19.2 m -85.09 -50.82 7.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.429 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.456 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 9.5 mt -95.9 -3.76 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.745 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.87 -146.45 31.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.516 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 32.1 Cg_exo -52.16 -26.32 25.97 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.624 2.216 . . . . 0.0 112.278 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -70.4 -13.63 62.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.247 0.546 . . . . 0.0 109.699 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.59 -27.05 66.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.085 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.0 t80 -36.91 -20.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.011 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 143' ' ' ARG . 47.0 mt-30 -71.93 -54.79 8.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.071 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 137' ' ' ALA . 3.0 m-20 -69.47 -30.11 67.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.556 ' O ' HD13 ' A' ' 122' ' ' ILE . 6.1 m0 -79.29 -18.09 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.058 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.01 6.86 6.57 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.245 0.545 . . . . 0.0 110.922 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.725 ' N ' ' O ' ' A' ' 139' ' ' GLN . 22.7 mmt180 . . . . . 0 C--N 1.317 -0.805 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.586 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.6 ttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' O ' ' C ' ' A' ' 3' ' ' PHE . 35.4 mt-10 -73.52 -166.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.522 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.48 ' C ' ' O ' ' A' ' 2' ' ' GLU . 16.0 m-85 33.21 -148.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.484 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.488 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -63.26 -37.62 79.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.626 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 4' ' ' ILE . 1.4 mt-30 -33.96 113.63 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.26 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.09 -17.63 7.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.592 HD13 ' OG ' ' A' ' 94' ' ' SER . 1.9 pt -109.72 174.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.813 0.339 . . . . 0.0 110.523 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.661 ' CD ' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -126.62 151.31 48.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.688 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.772 HD23 ' CB ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -98.5 168.38 10.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.263 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 91' ' ' PRO . 3.8 t -117.21 124.38 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.988 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.26 143.24 28.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.311 179.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.7 pttp -41.74 -31.94 0.35 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.647 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -68.88 19.63 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.957 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.598 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.5 mtm-85 60.61 20.79 10.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.393 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -99.03 171.64 7.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -132.7 134.34 44.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -146.85 133.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.903 0.383 . . . . 0.0 111.113 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -36.92 121.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.955 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.618 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.9 -24.26 6.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.929 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -59.14 4.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 0.0 110.731 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -87.78 -25.78 23.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.47 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.738 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -67.91 -7.17 26.16 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 25' ' ' ASP . 1.3 mp -93.89 -15.23 25.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.551 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.605 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 26.3 -84.86 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 41.94 94.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.564 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 9.7 mttm -34.87 -24.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.947 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 160.81 14.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.524 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' A' ' 62' ' ' PHE . 1.1 mt -142.25 146.96 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.197 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -137.07 152.37 28.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 111.027 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -140.9 111.97 0.76 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 29' ' ' ILE . 73.9 m-85 -86.82 127.08 35.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' OH ' ' OG ' ' A' ' 34' ' ' SER . 31.3 t80 -100.24 124.47 45.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.442 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 34' ' ' SER . 31.6 m-85 -116.75 108.65 16.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.72 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.71 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.6 OUTLIER 154.97 86.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.942 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.681 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -60.69 68.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.727 ' CD2' ' SG ' ' A' ' 41' ' ' CYS . 23.4 m170 -78.4 24.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.391 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -90.5 -43.02 10.51 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.627 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.06 -51.0 1.34 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.292 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.8 Cg_endo -83.21 164.46 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.865 2.376 . . . . 0.0 112.044 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 Cg_endo -67.74 -87.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.724 2.283 . . . . 0.0 112.245 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.727 ' SG ' ' CD2' ' A' ' 36' ' ' HIS . 1.8 p 43.22 38.81 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 43' ' ' GLY . 4.0 ttt-85 -81.33 149.93 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.804 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' A' ' 42' ' ' ARG . . . 123.51 -35.45 3.32 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 19.5 t80 -85.47 -52.88 5.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.646 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -44.18 -58.45 4.9 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.167 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.8 Cg_endo -49.1 -11.83 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.556 2.171 . . . . 0.0 112.162 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.8 mt -85.57 -49.36 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 0.0 110.087 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.094 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.52 -29.85 67.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.721 179.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.65 -31.56 70.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.033 0.444 . . . . 0.0 110.187 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 9.2 t0 -77.96 -29.12 49.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.466 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 4.2 tmm? -74.4 -54.5 7.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.494 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.89 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.94 -24.43 66.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -66.82 -47.27 72.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.2 mm-40 -64.15 -56.7 12.91 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.709 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.79 -39.86 65.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.879 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 52' ' ' TYR . 7.0 t -56.34 -50.46 71.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -50.7 -34.63 27.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.69 21.15 4.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.159 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.611 ' O ' ' C ' ' A' ' 60' ' ' ALA . 1.3 t 70.35 23.84 4.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.272 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.709 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.21 92.88 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.431 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.0 Cg_exo -62.41 43.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.947 2.431 . . . . 0.0 112.206 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.6 p90 -172.7 146.79 1.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.021 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' CG ' ' CG ' ' A' ' 87' ' ' TRP . 2.9 tm-20 -108.13 148.0 30.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.277 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.416 HG21 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -104.81 132.25 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.182 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.595 HG22 HG13 ' A' ' 90' ' ' ILE . 1.7 mm -95.13 139.1 19.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.752 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -101.69 105.4 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.978 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -122.07 -153.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.975 179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.859 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 72.12 149.97 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.435 179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.513 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 10.5 t -42.23 68.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 5.7 m-20 -102.05 10.8 39.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.464 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.06 -10.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.42 -179.271 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.5 m -85.06 111.95 20.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 48.8 mt-10 -69.55 -30.99 68.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 110.016 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' OD2' ' OD1' ' A' ' 75' ' ' ASP . 11.3 p-10 -80.06 -42.38 23.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.6 m-20 -76.6 -17.83 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' SER . 16.4 ttm -77.09 -48.63 17.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.047 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.4 m-85 -75.71 -25.23 56.48 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.317 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -73.72 -43.13 60.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.692 ' CD1' ' OE1' ' A' ' 82' ' ' GLU . 1.6 t80 -69.95 -34.43 73.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.759 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.539 ' CG ' ' CE1' ' A' ' 66' ' ' PHE . 2.8 mtm -69.6 -45.05 69.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.317 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.49 -29.02 63.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.713 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.4 OUTLIER -52.43 -25.46 10.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.464 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.787 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 9.0 p 137.39 3.24 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.886 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.842 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -92.92 114.04 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.04 135.6 0.01 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -119.86 66.29 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.167 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.577 ' CE3' ' N ' ' A' ' 86' ' ' ASP . 28.5 m-90 -157.57 -107.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.636 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.772 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.7 mp -131.84 176.83 8.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.405 0.622 . . . . 0.0 112.17 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.13 123.6 22.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.049 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.595 HG13 HG22 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -67.38 114.62 19.97 Favored Pre-proline 0 CA--C 1.518 -0.255 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 53.0 Cg_exo -48.02 108.36 0.17 Allowed 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 121.669 1.58 . . . . 0.0 111.372 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 4.9 p90 -31.53 -24.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.482 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -87.73 21.92 2.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.131 0.491 . . . . 0.0 110.526 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.712 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -106.49 63.04 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.651 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.35 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.661 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.27 -22.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.711 2.274 . . . . 0.0 112.612 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -80.26 -47.55 14.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.052 0.453 . . . . 0.0 109.988 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 95' ' ' GLY . 5.5 m -67.93 -63.81 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.8 OUTLIER -44.82 -31.81 1.35 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.468 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -61.42 -52.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.547 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.8 m -64.39 -49.04 73.15 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.574 0.702 . . . . 0.0 110.127 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.88 -20.97 64.28 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 19.3 tttp -72.37 -39.92 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.882 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -78.06 -16.61 57.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.488 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.34 26.29 40.36 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -72.89 135.61 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.782 0.325 . . . . 0.0 111.05 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -162.4 19.57 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.482 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -103.81 14.17 53.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -40.73 136.53 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.478 ' O ' ' CZ ' ' A' ' 127' ' ' ARG . 7.7 Cg_exo -69.77 140.32 59.87 Favored 'Cis proline' 0 N--CA 1.494 1.533 0 C-N-CA 123.743 -1.357 . . . . 0.0 112.37 -0.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 127' ' ' ARG . . . -154.52 146.16 23.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.587 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.771 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.6 tt -116.84 121.3 41.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.285 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CE ' ' A' ' 124' ' ' MET . 5.1 t -105.05 130.95 55.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.771 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.9 mm -119.08 126.0 74.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.45 150.79 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 119' ' ' GLY . 18.1 mttm -74.64 150.16 39.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -44.0 -49.79 8.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.88 -14.95 25.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.437 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.94 19.75 14.34 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.83 133.74 35.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.0 110.682 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.934 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -76.21 141.32 41.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.355 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.005 HG23 ' H ' ' A' ' 123' ' ' SER . 0.7 OUTLIER -130.71 -64.7 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.395 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.005 ' H ' HG23 ' A' ' 122' ' ' ILE . 13.1 m -143.77 118.29 9.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.479 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.818 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -78.64 -74.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.341 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 1.1 t30 -66.31 41.27 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -49.54 -13.25 0.45 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 110' ' ' PRO . 36.7 mtm180 -52.94 -90.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.043 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.574 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.11 -24.94 0.33 Allowed Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.645 ' OE2' ' ND2' ' A' ' 140' ' ' ASN . 0.0 OUTLIER -65.6 -55.38 17.92 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.237 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.9 OUTLIER -68.7 -41.92 82.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.589 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 3.8 mt-30 -66.96 -27.23 67.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.561 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 29.2 t -81.85 -45.88 14.91 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.576 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.767 HD12 HD21 ' A' ' 140' ' ' ASN . 10.3 mt -98.56 -5.03 32.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.308 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 58.71 -147.96 39.48 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 24.0 Cg_exo -60.08 -12.7 20.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.863 2.375 . . . . 0.0 112.518 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.559 ' CD ' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt180 -80.89 -15.29 56.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.039 0.447 . . . . 0.0 109.888 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -60.5 -19.44 56.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.588 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 1.7 t80 -36.81 -22.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.126 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.734 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -70.56 -57.85 4.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.767 HD21 HD12 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -64.08 -37.29 86.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.412 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.582 ' O ' HD13 ' A' ' 122' ' ' ILE . 8.6 m0 -73.13 -21.66 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.246 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -121.29 7.0 10.16 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.249 0.547 . . . . 0.0 110.926 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.734 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.56 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' O ' ' N ' ' A' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER 28.7 -92.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.588 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.547 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -46.89 124.61 6.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.567 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -60.65 -59.65 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.633 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.479 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.82 121.1 0.43 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.578 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.4 -3.67 9.53 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 96' ' ' PRO . 12.9 pt -108.7 -178.15 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 120.775 0.321 . . . . 0.0 110.559 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.772 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.0 mptt -87.05 169.19 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.322 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -156.95 158.98 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.102 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.8 t -121.69 115.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.456 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HZ2' ' HB3' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -73.15 139.99 46.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.349 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' ARG . 18.7 pttm -42.18 -34.13 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' N ' ' HG3' ' A' ' 12' ' ' LYS . 84.9 m-20 -68.79 19.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.138 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 16.8 ttt180 65.38 17.33 10.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.392 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 17' ' ' VAL . 12.7 pt-20 -125.73 145.3 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.586 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -156.27 171.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.593 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -94.58 113.04 24.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.462 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.813 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.8 -24.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -54.98 -58.98 5.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -96.34 -25.87 15.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.77 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -57.09 -49.92 74.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.676 ' O ' ' C ' ' A' ' 24' ' ' LYS . 1.2 mp -69.78 20.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.728 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -1.58 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.701 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.687 ' OD1' ' N ' ' A' ' 26' ' ' LYS . 1.3 p30 54.69 -63.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER 43.59 11.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -148.57 -73.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.676 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -136.73 155.87 34.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.029 0.442 . . . . 0.0 111.264 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -139.93 140.71 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.934 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.94 120.12 3.86 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 86.6 m-85 -89.61 121.88 32.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.764 0.316 . . . . 0.0 110.327 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' OH ' ' CD2' ' A' ' 36' ' ' HIS . 86.4 t80 -105.91 127.14 52.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.828 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 101' ' ' THR . 5.0 m-85 -119.45 118.09 30.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.438 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.719 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.1 t 156.23 79.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.452 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.808 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . . . -27.15 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.44 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.681 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.1 OUTLIER 63.66 -24.94 0.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.904 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.3 p-90 -93.29 -47.63 6.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.544 -0.463 . . . . 0.0 111.006 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.614 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.83 -51.63 1.13 Allowed Pre-proline 0 C--N 1.327 -0.383 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.253 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.808 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 91.4 Cg_endo -87.74 143.92 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 123.107 2.538 . . . . 0.0 112.171 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.62 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 60.5 Cg_endo -76.28 146.25 28.07 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.78 2.32 . . . . 0.0 112.036 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.62 ' SG ' ' C ' ' A' ' 40' ' ' PRO . 0.9 OUTLIER 159.35 15.82 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.755 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -61.04 149.66 36.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.75 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.33 -33.35 4.02 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.689 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 2.3 t80 -85.17 -25.72 27.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.858 HG22 ' CD2' ' A' ' 84' ' ' HIS . 0.2 OUTLIER -58.49 -54.62 54.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.15 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 45' ' ' THR . 8.6 Cg_endo -52.52 -11.82 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.315 2.01 . . . . 0.0 111.829 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.6 mt -90.37 -47.07 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 0.0 109.875 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.112 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -71.03 -21.96 62.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.431 179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.807 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -71.95 -27.68 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -80.71 -32.6 35.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.463 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.636 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.3 ppp? -74.19 -44.86 51.75 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.741 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -72.8 -27.43 61.97 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.983 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.801 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.2 m -68.89 -41.76 77.85 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.893 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.72 -45.31 71.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.688 HD22 ' HD2' ' A' ' 61' ' ' PRO . 8.9 mt -59.42 -46.13 89.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.259 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 62.3 t -57.89 -38.93 68.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -62.34 -30.15 70.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.63 21.11 7.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.566 ' O ' ' C ' ' A' ' 60' ' ' ALA . 2.8 t 73.04 19.97 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.635 0.731 . . . . 0.0 109.163 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.34 91.39 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.649 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.5 Cg_exo -63.19 35.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 122.872 2.382 . . . . 0.0 111.835 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.715 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.73 154.4 3.64 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.454 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -116.61 148.72 40.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.928 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.715 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -95.41 129.69 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.446 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 29' ' ' ILE . 1.9 mm -94.42 134.75 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.87 118.17 33.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.145 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.605 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -132.61 -158.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.721 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 74.68 150.31 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.627 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.4 m -54.36 65.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.199 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.927 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -93.98 11.06 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 22.1 mtm-85 -31.83 -10.88 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.541 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.927 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -79.26 111.2 15.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.667 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 9.0 mt-10 -65.26 -28.21 69.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.265 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -79.63 -50.73 10.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.704 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 37' ' ' TRP . 9.9 m-20 -61.72 -24.03 66.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -72.14 -61.75 1.68 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.11 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.667 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -66.53 -18.93 65.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.91 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.89 -55.85 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.323 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -62.67 -23.59 67.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 12.8 mtp -81.16 -50.14 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.303 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.0 mmm -62.06 -27.88 69.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.496 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' OG ' ' A' ' 83' ' ' SER . 2.5 mm-40 -56.17 -57.02 13.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.623 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.807 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 3.1 m 161.29 4.4 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.24 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.858 ' CD2' HG22 ' A' ' 45' ' ' THR . 4.9 m80 -99.21 106.85 19.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.707 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.03 118.42 1.17 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.686 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -120.36 59.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.223 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.727 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 16.4 m-90 -159.64 -108.72 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.302 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.964 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -120.14 175.69 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.76 0.791 . . . . 0.0 112.54 -178.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.74 124.87 12.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG23 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -71.36 121.26 83.8 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.7 Cg_endo -61.41 112.16 1.35 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.637 1.558 . . . . 0.0 111.263 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 p90 -29.74 -27.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.421 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.3 mtm-85 -83.37 22.14 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.088 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.746 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -108.06 63.22 0.61 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.866 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.41 -63.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.81 -0.516 . . . . 0.0 111.81 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.747 ' O ' HG23 ' A' ' 100' ' ' VAL . 89.5 Cg_exo -38.15 -20.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.735 2.29 . . . . 0.0 112.405 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -79.02 -40.83 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.978 0.418 . . . . 0.0 109.972 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 95' ' ' GLY . 13.6 p -69.54 -64.02 0.96 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.621 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.8 m120 -45.28 -32.25 1.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.46 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.747 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.9 t -62.0 -51.57 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.809 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.612 HG23 ' CE2' ' A' ' 33' ' ' PHE . 2.3 m -64.85 -47.08 79.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.46 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.81 -21.51 61.69 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.563 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.621 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 7.9 ttpt -79.97 -35.63 37.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.13 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -82.38 -5.63 58.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.52 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.15 31.31 74.59 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.693 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -73.79 133.45 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.677 0.275 . . . . 0.0 110.804 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -164.55 25.36 0.06 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.786 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -112.96 22.21 16.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -51.28 133.81 32.34 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 121.266 -0.173 . . . . 0.0 110.6 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.85 140.99 70.15 Favored 'Cis proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.495 -1.46 . . . . 0.0 112.065 -0.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.99 151.67 20.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.732 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.7 tt -122.28 121.9 37.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.389 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.857 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.4 t -105.79 134.45 47.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.732 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.3 mm -119.91 126.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.229 0.538 . . . . 0.0 111.645 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.3 m -137.98 148.97 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.077 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.558 ' HB2' ' H ' ' A' ' 120' ' ' THR . 23.4 mttt -69.13 164.19 23.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.541 ' CG ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -46.79 -49.72 19.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.512 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -71.45 -7.44 47.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.321 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 95.56 25.68 13.24 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.558 ' H ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.76 111.57 15.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.805 0.336 . . . . 0.0 110.617 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.893 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -54.03 144.29 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.04 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -137.83 -64.82 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.379 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.04 ' H ' HG23 ' A' ' 122' ' ' ILE . 50.3 m -142.99 118.52 10.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.857 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -79.29 -68.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.762 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.449 ' C ' ' N ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -66.68 42.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.033 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -46.76 -16.11 0.19 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.449 ' N ' ' C ' ' A' ' 125' ' ' ASN . 25.3 ttt-85 -52.93 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -42.45 -31.4 1.01 Allowed Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.42 -51.52 69.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.736 -0.386 . . . . 0.0 109.981 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.705 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 69.6 t -67.75 -47.72 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.313 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.446 ' OE1' ' CZ ' ' A' ' 127' ' ' ARG . 19.6 mt-30 -67.43 -20.27 65.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.409 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.583 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 40.6 m -82.79 -48.59 10.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.559 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.522 HD12 ' OD1' ' A' ' 140' ' ' ASN . 10.3 mt -102.99 0.37 32.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.02 -146.98 31.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -60.31 -13.76 26.13 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.728 2.285 . . . . 0.0 112.076 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.513 ' HG2' HD22 ' A' ' 133' ' ' LEU . 5.1 ttt85 -84.93 -6.74 59.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.108 0.48 . . . . 0.0 109.737 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.74 -25.86 68.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.856 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 137' ' ' ALA . 10.6 t80 -38.01 -20.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.769 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.2 mt-30 -73.93 -53.93 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.916 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.693 ' N ' HD22 ' A' ' 140' ' ' ASN . 0.8 OUTLIER -67.19 -38.75 85.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.611 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.5 m0 -65.16 -29.71 70.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.769 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -114.37 6.79 16.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.683 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.701 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.654 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.7 tmm? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.24 -51.89 0.95 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.523 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.61 -178.99 5.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -61.84 -27.46 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.54 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' OE1' ' OD1' ' A' ' 20' ' ' ASN . 60.6 mm-40 -66.45 113.52 4.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.207 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.12 -13.26 8.47 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 4' ' ' ILE . 1.6 pt -106.74 -177.66 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 120.719 0.295 . . . . 0.0 110.526 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.59 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -126.85 147.38 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.715 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 7.4 mt -109.29 176.36 5.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.653 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 16' ' ' GLU . 54.0 t -119.34 111.75 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.648 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' CG ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -68.7 140.85 55.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.764 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.71 -32.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.745 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 13' ' ' ASN . 14.1 t-20 -68.76 19.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.592 ' H ' ' C ' ' A' ' 12' ' ' LYS . 4.1 ttp180 62.46 22.91 13.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.415 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 7.8 t -103.74 171.06 7.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.633 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.752 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 47.6 mt-10 -126.61 138.48 53.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.62 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.45 HG22 ' CG ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -143.33 172.04 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.7 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.624 ' O ' ' N ' ' A' ' 20' ' ' ASN . 39.9 m-20 -89.26 101.61 14.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.296 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -35.64 -24.35 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.898 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.8 t-20 -50.17 -57.07 8.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 110.15 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -96.32 -25.81 15.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.477 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -58.99 -36.6 75.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.678 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.665 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.2 mm? -70.06 20.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.506 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.665 ' C ' ' O ' ' A' ' 23' ' ' LEU . 1.4 ttpm? -9.05 -100.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.623 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.701 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 60.36 -59.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.839 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.689 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 42.3 mttp 41.05 14.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 25' ' ' ASP . 17.3 t0 -149.75 -71.67 0.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.619 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -139.04 151.59 23.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.928 0.394 . . . . 0.0 111.481 -178.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.674 HG23 ' OE1' ' A' ' 63' ' ' GLU . 1.8 mm -119.4 156.59 21.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.712 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.1 149.41 18.53 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -136.61 114.47 11.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -101.68 127.36 48.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.612 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.567 ' O ' ' CB ' ' A' ' 34' ' ' SER . 27.9 m-85 -121.58 108.83 14.05 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.397 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.721 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.7 OUTLIER 155.71 85.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.915 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.698 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -57.48 77.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.038 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.699 ' O ' ' CG ' ' A' ' 36' ' ' HIS . 1.7 t60 -86.12 26.33 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.695 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -92.32 -42.31 9.88 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.475 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -87.68 -50.59 0.43 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.526 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 38' ' ' CYS . 71.1 Cg_endo -80.15 151.79 20.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.956 2.437 . . . . 0.0 112.267 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 41' ' ' CYS . 58.0 Cg_endo -74.74 140.65 26.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.91 2.406 . . . . 0.0 112.303 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.679 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 17.0 t 173.34 48.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.413 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -81.27 149.32 29.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.8 -36.09 3.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.652 ' CE2' ' CD ' ' A' ' 131' ' ' GLN . 17.3 t80 -86.17 -53.15 5.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.158 0.504 . . . . 0.0 110.414 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.706 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.2 -59.03 4.14 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.123 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 45' ' ' THR . 4.4 Cg_endo -48.55 -12.17 0.18 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.503 2.135 . . . . 0.0 112.069 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.545 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.6 mt -86.39 -48.31 15.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.099 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.28 -33.54 73.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.785 179.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.991 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -67.8 -30.73 70.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.06 0.457 . . . . 0.0 110.203 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 21.1 t70 -78.49 -29.07 46.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.6 ttp -76.1 -52.3 10.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.872 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.36 -25.35 66.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.778 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 6.8 t -68.17 -47.54 67.7 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.7 mm-40 -64.07 -54.67 30.37 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.35 -40.59 74.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 52' ' ' TYR . 22.3 t -59.68 -43.21 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -58.34 -30.22 66.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.21 21.11 7.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.143 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER 71.83 22.88 3.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.322 -178.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.08 94.3 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.651 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.8 Cg_exo -60.47 36.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 123.138 2.558 . . . . 0.0 112.584 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.87 154.64 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.044 0.45 . . . . 0.0 111.526 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.674 ' OE1' HG23 ' A' ' 29' ' ' ILE . 2.7 tm-20 -115.25 148.39 39.2 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.13 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.13 134.76 43.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.656 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -94.33 136.4 25.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.932 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 1.5 t80 -97.51 113.47 25.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.021 HG12 ' H ' ' A' ' 68' ' ' SER . 10.3 t -134.36 -160.22 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.251 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.021 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 78.62 149.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.508 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.516 ' OG ' ' NH1' ' A' ' 71' ' ' ARG . 3.5 t -42.36 66.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.932 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -101.02 10.44 41.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.902 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.516 ' NH1' ' OG ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -32.18 -9.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.437 -179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.932 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.4 m -83.45 111.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.697 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 83.4 mt-10 -69.36 -30.74 68.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.038 0.446 . . . . 0.0 109.867 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.54 -45.05 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.0 m-20 -74.05 -17.81 60.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -76.91 -51.02 11.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.191 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.697 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.2 m-85 -73.41 -22.06 60.32 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -76.61 -50.7 13.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.521 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -65.98 -30.74 71.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.453 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 89' ' ' ALA . 84.6 mtp -72.99 -39.68 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.344 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.5 -18.66 58.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.335 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.1 OUTLIER -62.02 -19.06 62.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.431 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.991 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 29.4 t 130.27 3.38 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.57 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.849 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -89.3 124.61 34.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.91 130.59 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.65 57.82 0.74 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.054 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.622 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.6 m-90 -154.19 -109.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.424 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.04 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.32 176.29 6.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.694 0.759 . . . . 0.0 112.299 -178.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.828 ' HB2' ' CE ' ' A' ' 80' ' ' MET . . . -137.69 122.69 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.55 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.687 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.81 123.66 89.53 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.287 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 93' ' ' ARG . 15.0 Cg_endo -60.99 112.05 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.778 1.652 . . . . 0.0 111.455 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.3 p90 -29.82 -26.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.5 mtp-105 -85.82 21.98 1.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.486 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.74 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 p -104.02 63.1 0.75 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.92 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.753 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.9 Cg_exo -38.23 -27.86 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.802 2.335 . . . . 0.0 112.583 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.03 -44.97 44.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 0.0 109.948 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 95' ' ' GLY . 84.4 p -69.03 -63.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.62 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.88 -33.28 1.9 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.558 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.47 -55.03 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.775 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.456 ' N ' HG12 ' A' ' 100' ' ' VAL . 2.7 m -62.79 -48.09 80.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.512 0.672 . . . . 0.0 110.457 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -21.24 63.28 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.308 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 13.3 tptt -75.48 -36.99 60.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.832 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -83.87 -4.17 58.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.535 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.63 27.78 73.6 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -74.52 132.78 32.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.96 22.72 0.11 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.586 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.06 15.7 43.45 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.903 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -44.22 137.82 3.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 12.4 Cg_exo -67.43 140.26 51.69 Favored 'Cis proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.697 -1.376 . . . . 0.0 112.273 0.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.18 151.24 28.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.594 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -118.22 123.61 45.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.42 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.5 t -110.32 119.9 60.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.877 0.37 . . . . 0.0 110.511 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.1 mm -113.99 126.07 71.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.937 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 116' ' ' LYS . 0.9 OUTLIER -140.79 150.68 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.564 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.478 ' O ' HG23 ' A' ' 115' ' ' VAL . 38.0 mttt -69.84 179.52 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.3 -49.93 65.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -68.76 -3.83 13.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.401 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.14 12.75 48.13 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.458 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -66.76 132.57 48.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.721 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.007 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -78.05 143.12 37.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 110.333 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.007 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -134.02 -64.25 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.19 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.991 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -147.71 118.17 7.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.208 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.986 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -79.33 -107.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.628 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -61.25 41.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.663 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -71.62 13.8 2.15 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 125' ' ' ASN . 41.5 ttp180 -42.63 -84.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.711 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.599 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.69 -26.45 0.73 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.5 OUTLIER -61.46 -53.46 56.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -64.52 -51.55 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.652 ' CD ' ' CE2' ' A' ' 44' ' ' PHE . 5.8 mt-30 -62.72 -24.86 67.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.319 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.3 m -73.14 -49.85 25.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.379 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 3.6 mt -90.39 -25.84 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.572 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 81.17 -146.93 26.86 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.02 -20.21 44.23 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.75 2.3 . . . . 0.0 112.223 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -76.92 -9.17 58.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.987 0.422 . . . . 0.0 110.176 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -63.3 -27.2 69.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.106 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.816 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 49.5 t80 -36.22 -25.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' ARG . 13.6 mm-40 -72.75 -50.73 22.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.282 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.6 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 0.5 OUTLIER -70.65 -42.87 70.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.668 179.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.611 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.8 m0 -69.54 -19.74 63.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.276 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.7 7.07 8.8 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.245 0.545 . . . . 0.0 110.673 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.726 ' N ' ' O ' ' A' ' 139' ' ' GLN . 2.0 ttt-85 . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.531 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.651 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' PHE . 1.0 OUTLIER -67.49 34.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.58 ' H ' ' C ' ' A' ' 1' ' ' MET . 4.6 m-85 -46.25 -174.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.48 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -82.14 -52.29 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -33.46 118.49 0.33 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.518 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -13.67 7.04 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 96' ' ' PRO . 15.3 pt -101.15 174.39 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.886 0.374 . . . . 0.0 110.65 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.801 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -115.33 134.97 54.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.492 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.082 HD13 ' HB2' ' A' ' 19' ' ' ALA . 2.2 mp -98.13 166.39 11.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.624 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -109.94 148.03 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.782 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 36.4 mtpt -108.16 143.34 37.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.275 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.29 -27.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.55 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -77.46 23.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.142 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 12' ' ' LYS . 64.3 mtp180 55.23 33.33 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.264 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -108.41 171.17 7.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.972 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -124.0 146.13 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.75 HG22 ' N ' ' A' ' 18' ' ' ASN . 3.6 p -153.76 172.52 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.005 0.431 . . . . 0.0 110.816 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.75 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 t-20 -89.21 103.71 16.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.744 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.082 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -46.81 -24.54 0.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.002 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -48.95 -56.58 8.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 0.0 110.374 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' H ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -96.29 -25.86 15.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.23 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -63.93 -26.65 68.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.721 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.694 ' O ' ' N ' ' A' ' 25' ' ' ASP . 30.5 mt -69.29 -12.39 61.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.549 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.7 tppm? 25.17 -83.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.734 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.6 p30 45.85 94.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.304 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 14.5 mtpt -34.7 -23.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.734 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 160.51 6.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.422 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -140.02 155.11 23.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.9 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -142.39 145.31 23.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -124.76 113.09 1.89 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 65' ' ' ILE . 68.9 m-85 -89.7 119.26 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.766 0.317 . . . . 0.0 110.719 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.668 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 84.1 t80 -105.45 117.97 35.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.506 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 31' ' ' PHE . 10.8 m-30 -111.95 118.12 34.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.489 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.788 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 p 156.35 93.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.434 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.73 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -27.85 -48.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.389 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.73 ' CG ' ' O ' ' A' ' 35' ' ' ALA . 1.9 p-80 60.71 -26.69 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.308 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.689 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.4 p-90 -85.65 -45.74 11.41 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.882 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.51 -49.85 11.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.987 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 91.2 Cg_endo -86.35 164.99 9.61 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.208 2.606 . . . . 0.0 112.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.37 -101.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.762 2.308 . . . . 0.0 112.092 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 t 49.62 43.56 24.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.409 ' CZ ' ' CB ' ' A' ' 42' ' ' ARG . 2.2 ptm85 -81.37 149.27 28.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.7 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.96 -34.17 4.98 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.805 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 16.2 t80 -77.05 -54.14 6.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.008 0.433 . . . . 0.0 110.681 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.681 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -44.88 -59.43 4.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 45' ' ' THR . 3.6 Cg_exo -42.13 -15.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.893 2.395 . . . . 0.0 112.277 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.1 mt -83.08 -44.22 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.045 0.45 . . . . 0.0 110.042 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -64.67 -31.55 72.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.108 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.744 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -65.65 -28.46 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.022 0.439 . . . . 0.0 110.326 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 0.1 OUTLIER -79.78 -32.85 40.92 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 7.2 tmm? -75.29 -48.0 25.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.748 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.983 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.7 -26.25 63.32 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.781 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 21.8 p -68.92 -42.95 76.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.0 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.515 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -68.09 -50.38 55.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -58.1 -40.47 81.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.338 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 52' ' ' TYR . 56.1 t -59.51 -46.49 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -54.28 -32.67 56.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.17 21.24 5.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.139 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 5.8 t 71.03 23.43 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.305 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.43 93.16 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.648 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.4 Cg_exo -61.11 37.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.01 2.474 . . . . 0.0 112.508 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.52 154.45 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.657 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -113.28 149.04 34.45 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.942 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -97.13 128.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.665 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.714 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -95.06 138.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.018 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' HB2' ' CB ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -105.28 119.58 39.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.903 0.382 . . . . 0.0 110.974 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 68' ' ' SER . 1.9 t -141.59 -151.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.009 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 70' ' ' ASP . 18.5 t 61.7 149.92 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -36.78 72.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.937 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.3 m-20 -114.53 10.37 16.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.727 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -33.55 -6.24 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.662 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.937 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -81.0 111.61 17.64 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.389 -0.524 . . . . 0.0 109.738 179.397 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.3 pt-20 -67.72 -29.54 68.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 110.042 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.0 -47.71 23.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.779 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 67.3 m-20 -58.02 -31.31 66.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 80' ' ' MET . 3.4 mtm -67.86 -61.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.11 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -66.96 -19.64 65.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.017 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -78.05 -55.63 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.437 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 2.1 m-85 -65.97 -20.06 66.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.961 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 76' ' ' MET . 15.8 mtp -81.35 -50.14 9.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.124 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 mmt -67.09 -26.41 66.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.588 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.545 ' O ' ' OG ' ' A' ' 83' ' ' SER . 4.0 mm-40 -64.58 -57.46 9.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.701 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.781 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.1 m 166.73 3.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.681 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.6 m80 -102.83 106.84 17.5 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.888 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.08 118.43 0.26 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 1.8 m-20 -121.91 60.98 0.96 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.302 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.567 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 18.8 m-90 -156.88 -105.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.644 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.691 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.3 mt -127.32 176.0 7.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.665 0.745 . . . . 0.0 112.579 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -146.43 127.24 14.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.448 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.32 116.05 47.2 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.253 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.6 Cg_exo -47.9 108.89 0.19 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.748 1.632 . . . . 0.0 111.275 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.545 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.5 p90 -30.21 -25.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.503 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 7.3 mtp180 -88.03 21.93 2.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.34 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.756 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -101.96 63.23 0.91 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.798 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.613 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.35 -63.29 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.1 Cg_exo -38.2 -27.34 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.767 2.312 . . . . 0.0 112.527 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.45 -40.44 57.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.069 0.462 . . . . 0.0 110.029 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -70.05 -64.1 0.95 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 8.7 m120 -45.39 -32.22 2.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.575 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -61.57 -53.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.752 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.455 HG23 ' CE2' ' A' ' 33' ' ' PHE . 3.9 m -63.54 -47.7 80.51 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.601 0.715 . . . . 0.0 110.341 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -21.25 63.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.158 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -74.93 -34.88 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.879 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -80.2 -19.08 47.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.358 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.32 29.28 45.63 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.788 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -64.28 -104.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.788 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 70.35 -2.19 2.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.909 0.385 . . . . 0.0 110.494 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -95.54 17.82 58.57 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.913 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.1 146.95 1.31 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.788 ' HA ' HG22 ' A' ' 109' ' ' ILE . 46.1 Cg_endo -71.05 141.24 68.66 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.408 -1.497 . . . . 0.0 112.347 0.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.9 154.04 25.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.674 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -116.35 124.99 51.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.601 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.718 ' CG2' HD11 ' A' ' 106' ' ' ILE . 2.5 t -109.58 102.08 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.751 HD11 HD22 ' A' ' 112' ' ' LEU . 43.1 mm -94.15 127.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.944 0.402 . . . . 0.0 111.031 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.65 148.09 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.672 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 41.3 mttt -69.83 154.07 42.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.637 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 13.2 ttpp -46.67 -49.84 18.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.646 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.42 -11.21 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.358 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.49 20.96 18.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -81.57 126.96 32.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.786 0.327 . . . . 0.0 110.689 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.979 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -69.98 141.78 52.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.397 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -131.1 -64.78 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.418 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -147.3 118.26 7.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.324 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.891 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -76.0 -96.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.573 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.61 46.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.262 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -72.6 6.08 13.56 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.765 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -44.33 -88.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.599 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.585 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.46 -30.42 1.36 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.2 mm-40 -59.66 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -68.53 -50.2 58.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.871 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.805 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 21.2 mt-30 -64.79 -21.63 66.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.317 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 49.2 m -82.76 -51.61 7.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.153 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 133' ' ' LEU . 7.8 mt -90.23 0.2 57.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.586 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.45 30.78 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.485 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 10.7 Cg_exo -65.13 -12.8 36.44 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.571 2.181 . . . . 0.0 111.68 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.7 mtt-85 -79.44 -9.32 59.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.149 0.5 . . . . 0.0 109.753 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -69.48 -20.43 63.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.931 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.782 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.15 -24.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' ARG . 5.0 pt20 -72.4 -45.61 58.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.131 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.586 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 1.2 m120 -75.34 -36.52 61.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.788 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.593 ' O ' HD13 ' A' ' 122' ' ' ILE . 7.3 m0 -77.33 -17.3 58.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.962 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.09 6.72 6.52 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.271 0.558 . . . . 0.0 110.864 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.544 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -46.31 -61.04 1.96 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.592 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -106.24 171.27 7.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -85.01 -41.52 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.46 ' C ' ' O ' ' A' ' 4' ' ' ILE . 12.5 mt-30 -33.58 119.78 0.38 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.609 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.06 -15.22 6.95 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.735 HG21 ' HG2' ' A' ' 96' ' ' PRO . 22.9 pt -98.09 173.12 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 110.641 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.768 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.75 131.46 55.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.553 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.01 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.5 mp -100.58 165.6 11.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.762 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 t -119.66 111.39 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' ARG . 4.5 mtpt -61.73 139.59 58.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.597 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.592 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -42.68 -31.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.516 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.675 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 2.6 m-20 -69.27 20.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.209 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER 61.85 23.32 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.477 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.2 t -98.8 171.06 8.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.553 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 17' ' ' VAL . 24.7 pt-20 -120.18 141.59 49.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 16' ' ' GLU . 3.5 m -156.87 171.32 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -92.33 103.62 16.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.602 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.01 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.93 -24.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.79 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.617 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.7 OUTLIER -49.9 -56.07 11.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.044 0.45 . . . . 0.0 110.212 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -25.81 15.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.773 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -59.6 -38.34 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 24' ' ' LYS . 4.8 mp -70.02 18.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.5 tptt -7.78 -76.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.731 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.619 ' OD2' ' O ' ' A' ' 23' ' ' LEU . 1.3 p30 47.42 104.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.668 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 15.0 tttt -46.48 -19.02 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 26' ' ' LYS . 1.3 p30 154.1 12.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.147 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.1 148.39 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.443 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG21 ' CE1' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -136.27 144.13 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 110.872 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.58 110.35 1.31 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.669 ' O ' HD23 ' A' ' 112' ' ' LEU . 62.3 m-85 -87.2 120.38 28.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.639 0.257 . . . . 0.0 110.654 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 34' ' ' SER . 73.1 t80 -102.94 124.55 48.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.362 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' O ' ' CB ' ' A' ' 34' ' ' SER . 20.7 m-85 -119.51 117.61 28.87 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.444 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.708 ' H ' ' CB ' ' A' ' 68' ' ' SER . 2.2 t 154.15 88.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.713 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.693 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -29.17 -50.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.089 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.524 ' CE1' ' HE ' ' A' ' 42' ' ' ARG . 20.1 t-160 64.79 -22.16 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.307 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.678 ' CD2' ' OD2' ' A' ' 75' ' ' ASP . 1.6 p-90 -88.62 -45.52 9.79 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.063 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -83.91 -50.8 0.63 Allowed Pre-proline 0 C--N 1.328 -0.356 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.396 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 95.0 Cg_endo -87.78 154.95 7.43 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.191 2.594 . . . . 0.0 112.201 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 60.3 Cg_endo -76.43 147.33 28.66 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.853 2.369 . . . . 0.0 112.054 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.662 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.2 m 158.7 37.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.663 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.524 ' HE ' ' CE1' ' A' ' 36' ' ' HIS . 8.8 mtp180 -81.27 149.48 28.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.636 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -35.29 3.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.507 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 12.9 t80 -85.43 -10.8 55.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.58 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -70.26 -60.24 3.54 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.059 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 45' ' ' THR . 9.7 Cg_endo -52.45 -11.5 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.356 2.037 . . . . 0.0 111.605 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mt -86.53 -54.75 7.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.955 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.083 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.2 -23.44 64.83 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -73.65 -23.39 59.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -82.67 -30.71 29.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.661 ' CG ' ' N ' ' A' ' 52' ' ' TYR . 5.1 ptm -72.58 -51.49 19.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.925 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.75 -31.17 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.925 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.786 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 13.4 t -67.5 -37.22 82.5 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.07 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' N ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -73.49 -55.27 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.772 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -55.79 -35.49 66.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.181 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 52' ' ' TYR . 25.2 t -61.8 -50.65 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -49.18 -34.66 15.09 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.2 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 69.89 24.7 5.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -178.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.17 112.33 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.827 -1.078 . . . . 0.0 111.258 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.669 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.9 Cg_endo -81.56 42.85 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.876 2.384 . . . . 0.0 112.105 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -171.95 154.46 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.388 . . . . 0.0 111.319 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.803 ' OE1' HD21 ' A' ' 88' ' ' LEU . 32.3 mt-10 -113.97 148.6 36.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.959 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.482 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -99.87 126.95 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.552 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG21 ' CE2' ' A' ' 31' ' ' PHE . 1.5 mm -90.52 138.22 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' ' HG2' ' A' ' 80' ' ' MET . 0.6 OUTLIER -107.96 105.74 15.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.384 . . . . 0.0 110.961 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -131.08 -154.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.968 179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 70.35 149.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.514 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -39.4 71.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.924 ' O ' ' N ' ' A' ' 72' ' ' SER . 1.6 m-20 -114.26 10.34 17.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.919 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.486 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 14.1 mtm180 -34.3 -6.08 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.474 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.924 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -78.98 111.78 15.51 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.716 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 35.2 mt-10 -65.66 -29.43 69.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.967 0.413 . . . . 0.0 110.144 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.65 -49.56 14.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.956 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 19.6 m-20 -64.41 -19.07 65.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.5 tpp -74.87 -59.58 2.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.184 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -75.32 -20.52 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.856 -179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.1 tt0 -75.45 -55.99 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.968 0.414 . . . . 0.0 110.383 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -64.16 -31.65 72.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.888 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.451 ' HG2' ' CE1' ' A' ' 66' ' ' PHE . 18.2 mtp -72.69 -44.57 61.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.559 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 46.2 mtp -79.61 -18.64 51.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.978 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.716 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.5 mt-10 -65.97 -24.2 66.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.094 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.769 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 20.2 m 136.92 3.34 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.926 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.868 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.12 106.83 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.759 0.314 . . . . 0.0 110.675 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 139.02 0.01 OUTLIER Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' OD1' ' CZ2' ' A' ' 87' ' ' TRP . 8.1 p30 -135.37 66.99 1.5 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.073 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' OD1' ' A' ' 86' ' ' ASP . 20.8 m-90 -150.98 -105.05 0.06 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.345 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.959 HD22 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -122.04 176.3 5.88 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.43 0.633 . . . . 0.0 111.83 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 66' ' ' PHE . . . -149.8 126.81 11.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.298 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.76 HG23 HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -72.99 114.62 32.49 Favored Pre-proline 0 CA--C 1.517 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.607 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.787 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.7 Cg_exo -49.08 109.76 0.29 Allowed 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 121.786 1.657 . . . . 0.0 111.266 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.3 p90 -30.59 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.479 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.787 ' N ' ' O ' ' A' ' 91' ' ' PRO . 52.5 mtm-85 -88.45 21.86 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.385 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -101.79 63.14 0.93 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.649 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.49 -63.35 0.01 OUTLIER Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.794 -0.523 . . . . 0.0 111.794 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.796 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.0 Cg_exo -38.43 -27.85 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.687 2.258 . . . . 0.0 112.439 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -74.54 -42.08 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.0 109.873 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 t -69.87 -63.79 1.01 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 7.9 t-20 -44.75 -33.44 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.5 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -60.41 -55.85 21.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.83 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.461 HG22 ' HB ' ' A' ' 106' ' ' ILE . 3.4 m -62.45 -48.31 80.21 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.542 0.687 . . . . 0.0 110.355 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.31 -21.19 63.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 10.6 ttpp -72.89 -36.97 67.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.842 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -83.32 -7.12 59.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.444 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 71.24 29.6 68.31 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -71.85 137.52 23.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.846 0.355 . . . . 0.0 110.989 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -163.34 22.02 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.507 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.82 12.77 50.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.891 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -43.79 136.97 3.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 42.3 Cg_endo -69.94 143.63 74.72 Favored 'Cis proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.525 -1.448 . . . . 0.0 112.333 0.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.64 160.88 34.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.004 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -122.59 125.28 45.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.303 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 113' ' ' VAL . 2.5 t -110.4 105.06 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.9 HD11 HD22 ' A' ' 112' ' ' LEU . 7.3 mm -96.07 127.09 48.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.913 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -141.12 150.11 20.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -74.25 162.58 28.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.771 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -54.21 -50.21 67.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.92 -6.81 4.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.387 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.05 12.46 52.28 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 123.19 24.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.761 0.315 . . . . 0.0 110.741 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.846 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -71.3 140.34 50.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.119 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.976 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -125.46 -64.86 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.516 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.976 ' H ' HG23 ' A' ' 122' ' ' ILE . 28.7 m -139.57 118.37 12.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.665 ' HE1' HD21 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -86.48 14.24 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.32 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.2 OUTLIER -131.2 44.51 2.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.502 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -44.85 -37.36 5.3 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.737 ' HE ' ' NE2' ' A' ' 131' ' ' GLN . 9.2 ttt180 -83.84 -0.77 52.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.259 0.552 . . . . 0.0 110.113 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.45 -62.2 1.49 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' OE1' ' O ' ' A' ' 125' ' ' ASN . 31.8 mp0 -69.42 -27.86 65.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.127 -0.537 . . . . 0.0 109.669 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.75 ' O ' ' N ' ' A' ' 134' ' ' GLY . 16.5 t -71.63 -51.12 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.737 ' NE2' ' HE ' ' A' ' 127' ' ' ARG . 81.6 mt-30 -65.66 -33.82 76.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.4 m -75.54 -44.29 44.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.37 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 133' ' ' LEU . 11.8 mt -106.34 -2.53 22.13 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.829 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.75 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.73 -146.16 31.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.14 -24.48 50.03 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.755 2.303 . . . . 0.0 112.266 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.8 OUTLIER -74.45 -7.05 51.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.118 0.485 . . . . 0.0 109.863 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.639 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -72.1 -20.72 61.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.28 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 55' ' ' LEU . 3.6 t80 -40.14 -32.3 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.032 0.444 . . . . 0.0 109.854 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.04 -34.74 78.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.947 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.639 ' N ' ' O ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -75.71 -38.81 58.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.85 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.752 ' O ' HD13 ' A' ' 122' ' ' ILE . 12.8 m0 -68.35 -19.63 64.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.222 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -117.82 7.04 12.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.374 0.606 . . . . 0.0 110.584 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 142' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.563 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 62.68 147.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.599 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.634 ' C ' ' NE2' ' A' ' 5' ' ' GLN . 67.6 m-85 -89.05 -137.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.673 ' C ' HE21 ' A' ' 5' ' ' GLN . 0.3 OUTLIER -77.92 -46.0 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.648 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.732 ' N ' HE21 ' A' ' 5' ' ' GLN . 0.0 OUTLIER -33.74 127.12 0.39 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.632 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.669 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 109.96 -0.59 30.13 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 4' ' ' ILE . 25.6 pt -102.11 176.25 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.838 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.98 169.37 11.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.349 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.991 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.33 160.42 36.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.289 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 91' ' ' PRO . 17.9 t -116.65 136.22 54.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 111.017 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -95.08 144.27 25.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.283 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -41.78 -33.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -71.77 18.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.98 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 12' ' ' LYS . 6.8 mmt180 60.88 27.26 17.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.32 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.74 171.26 8.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.031 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -122.48 137.7 54.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.456 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.34 172.52 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -94.3 111.8 23.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.608 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.991 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.81 -24.47 0.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.669 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.01 -57.52 9.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.455 -179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -96.26 -25.77 15.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.669 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.13 -29.6 69.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.709 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' ' N ' ' A' ' 25' ' ' ASP . 43.2 mt -69.57 -11.13 60.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.663 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.573 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.3 OUTLIER 26.35 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.691 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.717 ' N ' ' O ' ' A' ' 23' ' ' LEU . 1.4 p30 46.37 94.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.553 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 5.9 mtpm? -35.88 -22.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.986 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 158.59 11.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.129 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -141.31 151.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.457 HD11 ' OD2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.41 150.92 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.034 0.445 . . . . 0.0 110.8 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.85 144.7 15.95 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.5 m-85 -123.65 117.82 25.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.925 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -101.29 127.09 48.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.424 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.4 m-85 -125.55 112.71 16.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.44 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.776 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.5 p 149.73 86.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -41.03 118.39 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.012 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.688 ' CE1' ' OG1' ' A' ' 45' ' ' THR . 0.2 OUTLIER -96.76 19.11 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.867 -179.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.781 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 2.5 p-90 -124.59 -50.36 1.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.567 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.781 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.35 -57.05 7.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.943 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 38' ' ' CYS . 85.7 Cg_endo -91.94 149.83 3.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 123.01 2.474 . . . . 0.0 112.305 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.39 140.94 22.27 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.778 2.319 . . . . 0.0 111.988 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p 172.7 45.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.748 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -81.31 149.66 28.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.665 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.21 -35.4 3.37 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.568 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 11.0 t80 -85.44 -44.13 13.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.015 0.435 . . . . 0.0 110.497 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.688 ' OG1' ' CE1' ' A' ' 36' ' ' HIS . 1.3 m -44.27 -54.29 12.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.006 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 45' ' ' THR . 11.0 Cg_endo -56.34 -11.53 6.4 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.203 1.935 . . . . 0.0 112.067 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -86.68 -53.72 9.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.831 179.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.071 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.31 -27.26 67.02 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.656 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.795 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -70.66 -30.29 66.86 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.02 0.438 . . . . 0.0 109.912 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 39.2 t0 -78.66 -27.55 45.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.616 ' HG3' HG13 ' A' ' 130' ' ' VAL . 3.2 tmm? -73.63 -57.83 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.252 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.995 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -61.77 -28.62 69.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.575 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.72 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 2.4 t -63.69 -47.47 81.04 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.978 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.5 mm-40 -63.5 -56.11 18.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.719 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.0 mt -52.93 -38.91 62.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.219 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.995 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.4 t -58.09 -50.88 76.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -48.76 -35.9 15.27 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.75 21.15 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.16 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.607 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 70.22 22.66 5.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.247 -179.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.94 92.12 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.268 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HD2' HD22 ' A' ' 55' ' ' LEU . 24.7 Cg_exo -60.85 40.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 123.086 2.524 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.63 154.51 3.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.491 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' CG ' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -111.03 148.65 32.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.939 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -100.56 130.99 48.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.696 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.6 mm -97.61 137.02 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.584 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.9 109.77 20.93 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.987 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.73 -153.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.02 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 71.54 149.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.405 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -36.85 71.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.19 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.936 ' O ' ' N ' ' A' ' 72' ' ' SER . 6.3 m-20 -114.61 9.93 16.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.945 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.53 -8.45 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.682 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.936 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER -77.3 111.78 13.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.708 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 23.7 mt-10 -67.47 -29.67 69.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.057 0.456 . . . . 0.0 109.954 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -79.14 -47.72 15.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.0 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.632 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 1.2 m-20 -68.56 -17.93 64.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 31.6 ttm -75.67 -56.87 4.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.055 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 3.3 m-85 -76.09 -26.18 56.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.669 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -70.57 -54.31 12.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.507 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CE2' ' O ' ' A' ' 36' ' ' HIS . 13.0 m-85 -63.83 -35.69 81.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' HIS . 5.1 mmm -66.3 -40.09 89.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.688 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -81.78 -22.17 37.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.694 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.6 mt-10 -62.08 -24.97 67.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.171 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.795 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 7.9 t 140.42 3.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.742 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -97.88 106.89 19.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.726 0.298 . . . . 0.0 110.347 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 59.88 133.85 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 5.9 m-20 -126.42 62.11 1.29 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.813 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.3 m-90 -151.07 -96.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.832 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.1 mt -131.78 176.54 8.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.799 0.809 . . . . 0.0 112.562 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.56 128.69 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.93 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.717 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.48 114.35 29.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.588 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.779 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.2 Cg_exo -49.24 110.73 0.39 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 C-N-CA 121.771 1.647 . . . . 0.0 111.259 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.4 p90 -29.73 -26.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.779 ' N ' ' O ' ' A' ' 91' ' ' PRO . 35.7 mtt180 -84.74 21.95 1.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.298 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.73 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 t -104.43 63.19 0.73 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.685 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.619 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.4 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.5 Cg_exo -38.25 -26.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.666 2.244 . . . . 0.0 112.456 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.53 -44.15 45.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 110.138 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 95' ' ' GLY . 10.5 t -69.6 -63.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.611 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 3.9 m-80 -44.73 -33.63 1.94 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.22 -55.64 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.767 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -61.28 -47.31 86.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.537 0.684 . . . . 0.0 110.522 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.15 -21.3 62.2 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.678 -1.147 . . . . 0.0 110.411 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 3.6 tmtm? -80.13 -39.14 30.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.199 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.82 -18.93 61.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.421 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.61 36.79 32.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.806 ' C ' HG23 ' A' ' 107' ' ' THR . 1.4 mm -60.99 -101.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.718 0.294 . . . . 0.0 110.709 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.806 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 69.81 3.1 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.553 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.94 14.36 64.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.63 139.65 59.5 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 55.4 Cg_endo -72.39 147.19 88.39 Favored 'Cis proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.452 -1.478 . . . . 0.0 112.25 0.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.85 5.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.991 0.424 . . . . 0.0 111.05 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.805 HD22 HD11 ' A' ' 114' ' ' ILE . 1.3 tt -121.98 128.77 51.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.872 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.777 HG13 ' HE1' ' A' ' 124' ' ' MET . 2.2 t -111.52 124.69 68.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.018 0.437 . . . . 0.0 110.733 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.805 HD11 HD22 ' A' ' 112' ' ' LEU . 31.7 mm -111.52 129.37 67.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.089 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.15 148.5 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 119' ' ' GLY . 19.9 mttt -71.66 153.61 41.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -45.01 -49.92 11.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.745 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.44 -12.35 21.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.435 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.9 15.96 29.69 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.413 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -78.5 125.97 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.916 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -68.47 145.66 53.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.343 179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.009 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -132.34 -64.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.255 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.7 m -142.65 118.22 10.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.433 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.777 ' HE1' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -86.19 21.7 1.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.365 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.631 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -136.99 45.92 2.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.486 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.61 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -43.64 -40.61 5.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 127' ' ' ARG . 2.3 ttt180 -83.94 -2.28 56.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 0.0 109.977 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.631 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -86.84 -61.91 1.56 Allowed Glycine 0 C--N 1.321 -0.277 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 19.4 mm-40 -70.2 -25.86 63.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.005 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 134' ' ' GLY . 9.7 t -74.14 -49.88 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.009 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.568 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 2.6 mt-30 -66.34 -33.16 75.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.155 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -75.34 -45.14 41.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.228 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' A' ' 133' ' ' LEU . 11.9 mt -106.62 -3.5 20.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.743 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.46 -146.44 29.9 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 36.6 Cg_exo -55.98 -23.99 46.17 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.698 2.265 . . . . 0.0 112.074 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.1 mtm-85 -76.71 -7.56 55.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.168 0.509 . . . . 0.0 109.77 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -70.66 -22.84 62.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.098 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' C ' ' O ' ' A' ' 137' ' ' ALA . 46.2 t80 -36.86 -30.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.982 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.4 pp0? -63.63 -37.69 88.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.664 ' N ' ' O ' ' A' ' 137' ' ' ALA . 9.1 m-80 -74.92 -35.94 62.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.663 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 13.0 m0 -71.32 -17.81 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.425 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.91 7.18 9.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.126 0.489 . . . . 0.0 111.191 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.518 ' N ' HD11 ' A' ' 122' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.535 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 mmt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.51 102.8 9.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.6 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.57 -163.46 1.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.512 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.5 OUTLIER -98.85 -50.82 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.623 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -33.64 116.23 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.657 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.08 -7.03 7.71 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 96' ' ' PRO . 40.5 pt -101.59 174.38 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 120.876 0.369 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.774 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -111.94 131.7 55.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.063 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.4 mp -100.02 168.65 9.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.314 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' A' ' 16' ' ' GLU . 20.0 t -120.67 123.39 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.973 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -84.63 142.27 30.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.31 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' ARG . 6.3 pttp -42.24 -32.81 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.585 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -68.89 19.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.899 0.381 . . . . 0.0 110.108 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm180 61.99 21.68 12.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.341 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 171.51 8.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.526 ' CG ' HG22 ' A' ' 10' ' ' VAL . 10.2 mt-10 -136.32 129.91 32.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.517 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' HD21 ' A' ' 88' ' ' LEU . 16.1 m -152.19 136.3 8.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.912 0.386 . . . . 0.0 111.224 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -42.35 117.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -54.16 -24.05 16.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.997 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -47.36 -56.69 6.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.977 0.418 . . . . 0.0 110.758 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.33 -25.9 15.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.791 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -63.64 -27.14 69.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.076 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 25' ' ' ASP . 3.8 mp -72.35 -14.94 61.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.735 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 7.7 ttpt 40.37 -82.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.677 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 23' ' ' LEU . 3.4 p-10 46.36 92.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.662 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.7 ttmt -40.29 -16.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER 164.75 -8.57 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.44 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -130.52 154.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.133 -179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -133.24 158.74 43.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.2 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -130.41 149.01 18.87 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' HB3' ' CE1' ' A' ' 33' ' ' PHE . 55.4 m-85 -130.35 117.09 19.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.635 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -106.1 116.24 31.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.592 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.618 ' O ' ' CB ' ' A' ' 34' ' ' SER . 11.4 m-30 -108.77 118.01 35.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.511 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.797 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 t 150.78 91.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.294 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' O ' ' CG ' ' A' ' 36' ' ' HIS . . . -24.87 -38.17 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.645 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.797 ' CE1' ' CG ' ' A' ' 79' ' ' TYR . 0.4 OUTLIER 61.7 -28.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.185 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.629 ' H ' ' C ' ' A' ' 35' ' ' ALA . 1.4 p-90 -89.94 -47.29 7.96 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.951 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -71.92 -50.23 9.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.393 . . . . 0.0 110.078 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 93.8 Cg_endo -86.15 165.07 9.87 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.159 2.573 . . . . 0.0 112.103 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.66 -101.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.783 2.322 . . . . 0.0 112.034 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.8 m 42.5 28.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.25 149.38 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.623 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.06 -32.35 4.41 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.752 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -85.1 -42.84 14.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.349 . . . . 0.0 110.608 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.4 m -44.19 -59.18 4.0 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.5 Cg_exo -41.69 -16.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.716 2.277 . . . . 0.0 111.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.552 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.6 mt -83.4 -40.85 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.099 0.475 . . . . 0.0 110.02 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.081 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -67.35 -31.69 72.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.299 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.823 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.37 -31.86 72.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.97 0.414 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.85 -28.88 50.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.524 ' SD ' HG22 ' A' ' 130' ' ' VAL . 6.4 ttp -74.76 -54.11 7.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.452 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.863 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -65.52 -24.59 67.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.822 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.808 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.8 t -70.5 -44.13 68.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.941 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.59 -52.81 34.14 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 mt -58.08 -40.55 81.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.106 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 52' ' ' TYR . 21.1 t -59.5 -45.71 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.19 -31.81 61.71 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.91 21.2 5.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.111 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.604 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 71.24 23.52 4.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.254 -178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.29 93.33 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.272 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.2 Cg_exo -60.19 36.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 123.097 2.531 . . . . 0.0 112.601 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.44 154.45 3.18 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.383 179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' OE1' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -112.91 148.5 34.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.08 -179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.5 138.92 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.315 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -103.92 139.73 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.975 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.31 98.95 8.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 68' ' ' SER . 1.3 t -114.84 -160.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.846 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.797 ' CB ' ' H ' ' A' ' 34' ' ' SER . 0.2 OUTLIER 81.03 150.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.485 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 m -48.88 68.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.158 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 0.3 OUTLIER -99.37 10.94 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 6.3 mtm180 -31.7 -11.32 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.457 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.91 111.41 12.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 3.4 mm-40 -65.21 -27.83 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.394 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.13 -49.8 12.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.769 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.601 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 55.9 m-20 -60.6 -25.84 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 80' ' ' MET . 0.8 OUTLIER -70.49 -63.71 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.974 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.0 OUTLIER -66.35 -18.83 65.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.736 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.42 -56.05 4.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 110.478 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.797 ' CG ' ' CE1' ' A' ' 36' ' ' HIS . 1.1 m-85 -64.87 -20.66 66.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.055 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.501 ' CG ' ' O ' ' A' ' 76' ' ' MET . 12.2 mmm -81.07 -49.7 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.364 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.406 ' HB3' ' O ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -29.1 70.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.26 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.577 ' O ' ' CB ' ' A' ' 83' ' ' SER . 11.4 mt-10 -57.38 -56.23 24.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.658 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.846 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.9 m 157.53 4.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.24 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 7.3 m80 -87.48 106.84 18.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.37 124.41 0.26 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.626 ' N ' ' CE3' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -112.69 61.15 0.63 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.031 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.626 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 26.0 m-90 -158.21 -109.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.473 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.628 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 3.1 mp -130.5 176.68 7.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 112.596 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -140.28 126.4 19.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.396 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.69 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -69.2 114.63 24.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.228 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.79 ' O ' ' N ' ' A' ' 93' ' ' ARG . 52.1 Cg_exo -47.84 109.2 0.21 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 121.674 1.582 . . . . 0.0 111.241 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.3 p90 -29.99 -25.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.79 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 tpt180 -86.71 22.03 2.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.146 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.741 ' N ' ' O ' ' A' ' 91' ' ' PRO . 47.6 t -104.01 63.02 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.75 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -10.16 -63.01 0.01 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.797 ' O ' HG23 ' A' ' 100' ' ' VAL . 79.8 Cg_exo -38.23 -24.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.708 2.272 . . . . 0.0 112.467 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.55 -41.29 55.26 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' GLY . 73.8 p -69.8 -63.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.624 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.9 OUTLIER -45.92 -32.13 2.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.552 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.1 -54.91 28.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.917 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.427 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.9 m -63.17 -47.37 82.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.621 0.724 . . . . 0.0 110.24 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.84 -21.36 63.37 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.199 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 24.5 tttm -74.35 -35.1 63.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.965 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -80.1 -19.02 48.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.5 28.8 42.18 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 107' ' ' THR . 1.2 mm -75.44 140.47 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 120.775 0.321 . . . . 0.0 110.828 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -161.16 20.56 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.556 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.9 16.58 36.32 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.897 ' H ' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -42.82 136.32 2.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 110.351 -0.241 . . . . 0.0 110.351 179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 39.9 Cg_endo -69.48 142.4 69.42 Favored 'Cis proline' 0 N--CA 1.496 1.627 0 C-N-CA 123.516 -1.451 . . . . 0.0 112.357 0.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.31 153.01 33.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.73 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -118.72 120.8 38.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.545 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.704 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.7 t -108.65 121.57 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.515 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.73 HD11 ' CD2' ' A' ' 112' ' ' LEU . 42.4 mm -113.14 128.66 69.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.113 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.52 150.49 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.684 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 13.6 mttm -70.63 164.37 25.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.856 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -55.18 -49.87 70.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.3 -10.28 22.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.412 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.28 17.65 23.95 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.449 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -77.83 144.1 37.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.801 0.334 . . . . 0.0 110.685 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.009 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -82.22 143.01 31.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.155 0.503 . . . . 0.0 110.52 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.009 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -134.36 -64.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.277 -179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.009 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.7 OUTLIER -145.41 118.37 8.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.318 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.979 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -78.32 -106.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.659 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -60.64 43.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.973 0.416 . . . . 0.0 110.085 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -67.76 14.14 0.59 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 125' ' ' ASN . 11.9 ttm180 -44.64 -86.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.567 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.12 -31.48 1.33 Allowed Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -58.3 -50.05 74.99 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.129 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.674 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.5 OUTLIER -68.38 -47.8 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.747 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.752 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 51.7 mt-30 -63.49 -23.07 67.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 128' ' ' GLY . 43.8 t -81.53 -52.87 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.9 mt -87.73 -11.45 48.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.48 -146.65 29.6 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.41 -20.44 15.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.642 2.228 . . . . 0.0 112.037 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.5 mtt-85 -81.01 -9.45 59.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.126 0.489 . . . . 0.0 109.824 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.633 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -65.06 -24.74 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.105 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.802 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.8 t80 -36.78 -23.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.689 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.9 pt20 -72.64 -49.11 34.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.601 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 19.1 m-20 -72.58 -37.3 68.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.905 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.554 ' CZ2' HD22 ' A' ' 112' ' ' LEU . 8.7 m0 -76.62 -15.92 59.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.132 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.13 7.3 6.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.158 0.504 . . . . 0.0 110.934 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.689 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.7 ppt_? . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' CB ' ' A' ' 2' ' ' GLU . 60.1 mmm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 81.48 -76.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.486 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -114.84 -151.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.537 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -71.32 -43.0 74.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.582 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 4' ' ' ILE . 25.9 mt-30 -33.79 125.62 0.43 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.618 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' HA2' ' ND2' ' A' ' 20' ' ' ASN . . . 112.56 -7.72 26.24 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 4' ' ' ILE . 40.3 pt -93.97 170.55 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 110.708 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.734 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 2.7 mptt -80.94 167.26 20.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.339 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -151.36 149.49 29.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.508 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.532 ' H ' HD23 ' A' ' 9' ' ' LEU . 13.1 t -118.6 130.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.753 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -90.29 141.35 28.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.392 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.35 -27.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.581 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -70.77 16.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.124 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 63.03 25.29 14.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.327 -179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.5 171.04 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.764 ' O ' HG13 ' A' ' 17' ' ' VAL . 51.1 mt-10 -119.9 153.74 35.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.654 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 16' ' ' GLU . 6.9 m -164.21 171.92 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.508 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 20' ' ' ASN . 63.7 m-80 -93.49 100.99 13.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' LEU . . . -37.44 -24.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.792 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 18' ' ' ASN . 1.3 m-20 -51.96 -57.04 10.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.1 -25.85 16.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.463 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 24' ' ' LYS . . . -66.12 -34.13 77.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' O ' ' C ' ' A' ' 24' ' ' LYS . 79.5 mt -71.41 21.7 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.491 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 23' ' ' LEU . 7.0 tttt -12.02 -86.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.843 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.718 ' O ' ' N ' ' A' ' 27' ' ' ASP . 10.9 m-20 59.15 99.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.525 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.591 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -36.09 -22.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 25' ' ' ASP . 2.0 m-20 153.65 16.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.137 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.596 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -142.58 153.14 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.561 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.784 HG23 HD11 ' A' ' 65' ' ' ILE . 1.1 mp -138.35 146.15 27.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.814 0.34 . . . . 0.0 110.595 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -131.94 110.58 0.97 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 29' ' ' ILE . 77.4 m-85 -87.89 119.79 28.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.726 0.298 . . . . 0.0 110.758 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -102.53 123.15 45.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.282 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 34' ' ' SER . 21.2 m-85 -116.87 120.72 39.35 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.886 0.374 . . . . 0.0 110.609 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.663 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.4 OUTLIER 155.72 94.61 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.75 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.657 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -67.85 40.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.161 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.55 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -61.63 20.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.102 -179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.785 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -86.33 -42.63 13.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.573 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.785 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -78.1 -48.96 1.99 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 0.0 110.439 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 70.9 Cg_endo -87.4 164.89 8.12 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.089 2.526 . . . . 0.0 112.303 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.668 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.2 Cg_endo -75.87 163.19 33.83 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.89 2.393 . . . . 0.0 112.251 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.668 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.79 47.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.45 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.33 149.15 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.23 3.56 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CZ ' ' CD ' ' A' ' 131' ' ' GLN . 26.2 t80 -86.36 -54.02 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.372 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -45.45 -59.0 4.97 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 2.3 Cg_endo -47.16 -12.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.614 2.209 . . . . 0.0 112.148 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 45' ' ' THR . 1.5 mt -85.48 -47.17 16.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.001 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.25 -33.64 73.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.778 179.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -66.89 -28.93 68.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.315 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -80.14 -29.94 38.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.495 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.5 tmm? -74.89 -51.5 13.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.967 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.45 -26.6 64.67 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.48 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.731 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.0 m -66.92 -43.02 84.37 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.061 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -69.43 -49.87 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.318 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.781 HD22 ' HD2' ' A' ' 61' ' ' PRO . 7.5 mt -57.83 -39.29 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.184 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 52' ' ' TYR . 55.4 t -59.64 -50.25 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -49.55 -35.45 20.44 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.79 21.09 3.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.19 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.621 ' O ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER 70.01 24.47 5.08 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.27 113.6 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.242 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.781 ' HD2' HD22 ' A' ' 55' ' ' LEU . 73.1 Cg_endo -80.21 38.59 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.893 2.395 . . . . 0.0 112.505 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.18 154.29 3.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 179.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.694 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 5.4 tt0 -112.94 148.57 34.73 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.046 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.561 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -100.05 128.83 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.784 HD11 HG23 ' A' ' 29' ' ' ILE . 1.3 mm -91.54 136.21 24.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t80 -105.5 107.26 18.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.93 0.395 . . . . 0.0 111.075 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -129.4 -151.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.863 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.879 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.37 149.71 0.05 Allowed 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.373 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.593 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -37.82 69.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.411 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.879 ' N ' ' O ' ' A' ' 68' ' ' SER . 4.3 m-20 -112.84 10.25 19.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.482 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.99 -3.06 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.564 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.864 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -79.65 111.65 16.15 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.655 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.689 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -68.88 -28.49 66.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.651 -0.42 . . . . 0.0 109.978 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -47.64 13.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.958 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.726 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 5.5 m-20 -68.93 -17.88 64.02 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.573 ' O ' ' CG ' ' A' ' 80' ' ' MET . 1.0 OUTLIER -77.15 -57.68 3.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.062 179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.689 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -69.51 -23.0 63.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.724 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -75.81 -54.47 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -65.88 -22.31 66.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.236 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.573 ' CG ' ' O ' ' A' ' 76' ' ' MET . 27.6 mmm -81.47 -46.44 14.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 48.6 mmm -76.4 -19.08 58.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.487 ' O ' ' OG ' ' A' ' 83' ' ' SER . 3.4 mt-10 -66.02 -55.9 14.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.547 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.744 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.6 m 170.06 3.17 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.359 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.831 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.94 107.03 19.47 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.323 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 60.12 131.88 0.01 OUTLIER Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -126.22 63.61 1.25 Allowed 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.049 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.597 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.3 m-90 -150.59 -102.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.803 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.651 ' HB3' HD22 ' A' ' 9' ' ' LEU . 1.5 mt -124.05 175.36 7.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.641 0.734 . . . . 0.0 112.403 -178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' C ' HD21 ' A' ' 9' ' ' LEU . . . -148.99 122.34 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.867 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -67.2 120.24 70.76 Favored Pre-proline 0 CA--C 1.517 -0.292 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.27 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.3 Cg_exo -49.41 108.95 0.23 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.001 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -31.79 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 0.0 110.619 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.77 ' N ' ' O ' ' A' ' 91' ' ' PRO . 19.9 ttt180 -91.62 22.14 4.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.276 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.759 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.4 m -99.47 63.27 1.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.873 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.51 -63.12 0.01 OUTLIER Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.788 ' O ' HG23 ' A' ' 100' ' ' VAL . 84.6 Cg_exo -38.15 -26.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.684 2.256 . . . . 0.0 112.574 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -75.36 -41.12 57.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.401 . . . . 0.0 109.984 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.99 -63.96 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.622 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -45.43 -32.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.468 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.1 t -61.89 -53.8 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.817 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.7 m -63.09 -47.44 82.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.633 0.73 . . . . 0.0 110.309 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.63 -21.14 62.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.221 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 6.7 tttp -75.35 -35.66 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.949 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -82.33 -19.05 40.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.52 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.26 19.28 59.14 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 107' ' ' THR . 1.3 mm -74.68 131.79 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.998 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.636 HG22 ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -160.36 16.24 0.13 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 109' ' ' ILE . . . -100.28 15.67 58.77 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -37.77 137.95 0.67 Allowed Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 13.6 Cg_exo -66.96 137.83 37.91 Favored 'Cis proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.414 0.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -150.94 149.98 30.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.565 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.77 ' CD2' HD11 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -118.66 121.67 40.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 113' ' ' VAL . 1.5 t -109.48 108.26 24.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.187 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 112' ' ' LEU . 39.0 mm -104.63 124.83 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.97 0.414 . . . . 0.0 111.134 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.16 150.13 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.226 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 119' ' ' GLY . 22.4 mttm -72.07 150.11 44.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.578 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -47.22 -48.47 24.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.668 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.472 ' N ' ' HD2' ' A' ' 117' ' ' LYS . 1.9 m-20 -60.96 -11.91 9.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.438 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 98.66 23.0 12.63 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.42 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -90.11 123.35 33.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 0.0 110.757 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.904 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -67.82 146.68 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.302 179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.015 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -137.66 -65.29 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.556 -179.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.015 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -141.66 118.26 10.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.051 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -82.33 -113.62 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.711 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.49 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -59.82 44.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 110.381 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.715 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.21 19.06 3.81 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.572 ' O ' ' OE1' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -42.47 -83.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.582 -179.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.63 -28.74 1.12 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -59.41 -53.81 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.644 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.4 OUTLIER -65.53 -50.88 69.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.644 ' N ' ' CG1' ' A' ' 130' ' ' VAL . 14.9 mp0 -62.61 -22.57 66.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.306 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 23.5 m -79.57 -52.02 8.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.499 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.551 HD22 ' CD ' ' A' ' 136' ' ' ARG . 7.3 mt -87.45 -6.99 58.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.702 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 63.38 -147.16 50.61 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 14.0 Cg_exo -63.84 -12.69 32.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.599 2.199 . . . . 0.0 112.021 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.551 ' CD ' HD22 ' A' ' 133' ' ' LEU . 1.5 ttt85 -80.25 -7.32 58.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.159 0.504 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -72.07 -24.64 61.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.996 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 13.0 t80 -36.66 -24.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.875 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.694 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -71.9 -47.17 54.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.957 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.635 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 1.4 m-80 -74.16 -39.15 63.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.588 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.3 m0 -72.1 -17.86 61.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.074 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -126.8 6.92 6.72 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.263 0.554 . . . . 0.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.694 ' N ' ' O ' ' A' ' 139' ' ' GLN . 4.0 mtt-85 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.523 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -125.69 20.08 7.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.547 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.21 -165.03 1.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.54 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -82.73 -47.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.584 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.625 HE22 HD12 ' A' ' 23' ' ' LEU . 47.4 mm-40 -33.73 121.72 0.43 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.678 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.26 -8.02 9.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.771 HG21 ' HG2' ' A' ' 96' ' ' PRO . 16.2 pt -104.72 177.99 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 120.783 0.325 . . . . 0.0 110.606 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.619 ' C ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -120.39 139.82 52.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.479 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.682 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 6.2 mt -110.85 179.48 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.736 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 2.7 t -118.83 129.31 75.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.891 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -85.81 142.84 28.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.197 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -42.15 -27.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.29 24.73 0.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 11' ' ' LYS . 14.5 mtt180 58.27 24.08 11.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.261 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -96.9 171.76 8.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -130.79 131.44 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.353 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -139.46 172.26 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.961 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -89.23 102.43 15.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.698 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -36.01 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.992 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -53.01 -58.47 6.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.927 0.394 . . . . 0.0 110.489 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 22' ' ' ALA . 1.5 pt-20 -96.29 -26.0 15.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.648 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -64.87 -30.39 71.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.754 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.764 HD23 ' OE1' ' A' ' 63' ' ' GLU . 35.2 mt -69.64 -7.79 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.6 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 2.4 ttmt 26.04 -83.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.703 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.4 p30 46.39 93.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.507 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 3.1 tttp -37.15 -20.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.855 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 161.14 0.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.148 179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -132.95 152.47 36.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.641 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -134.05 151.93 33.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.4 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -123.88 144.68 15.62 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 56.5 m-85 -123.31 115.85 22.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.765 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 71.1 t80 -103.67 121.97 44.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.56 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' O ' ' CB ' ' A' ' 34' ' ' SER . 34.4 m-85 -121.06 116.61 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.451 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.717 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.6 p 154.69 80.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.865 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' CD ' ' A' ' 39' ' ' PRO . . . -26.49 128.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.791 ' CD2' ' CE2' ' A' ' 79' ' ' TYR . 22.4 m80 -89.15 -2.99 58.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.217 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 38' ' ' CYS . 25.6 p-90 -115.86 -32.37 5.47 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.025 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.568 ' SG ' ' HD3' ' A' ' 39' ' ' PRO . 0.3 OUTLIER -79.02 -71.08 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.191 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.703 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 72.9 Cg_endo -75.33 165.02 31.67 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.32 2.013 . . . . 0.0 112.213 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.678 ' O ' ' N ' ' A' ' 42' ' ' ARG . 64.5 Cg_endo -78.66 -69.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.876 2.384 . . . . 0.0 111.976 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.638 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 41.5 t 28.8 32.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.678 ' N ' ' O ' ' A' ' 40' ' ' PRO . 6.3 ptp180 -81.29 136.95 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.583 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.94 -35.27 3.45 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 5.1 t80 -81.75 -14.21 56.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.355 . . . . 0.0 110.691 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.514 ' OG1' ' OH ' ' A' ' 79' ' ' TYR . 1.3 m -66.48 -61.13 5.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.962 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.1 Cg_endo -49.98 -11.82 0.35 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.436 2.091 . . . . 0.0 111.636 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.8 mt -86.24 -52.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.975 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.088 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -69.46 -26.01 64.37 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -70.61 -23.87 62.64 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.47 -29.91 27.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.665 ' HG3' ' N ' ' A' ' 52' ' ' TYR . 1.1 ppp? -75.1 -46.0 37.47 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.665 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 1.019 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -73.11 -31.38 64.28 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.796 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 11.1 t -66.2 -40.18 90.21 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.92 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' CD ' ' CB ' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -71.17 -50.39 33.79 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -55.22 -40.97 71.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.978 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG23 ' O ' ' A' ' 52' ' ' TYR . 72.5 t -57.36 -52.21 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -48.52 -34.68 11.72 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.94 21.4 4.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.165 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER 70.63 22.5 4.99 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.715 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.48 91.58 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.494 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.6 Cg_exo -62.14 38.64 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.966 2.444 . . . . 0.0 111.972 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.511 ' H ' ' C ' ' A' ' 60' ' ' ALA . 1.4 p90 -172.37 154.53 3.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.764 ' OE1' HD23 ' A' ' 23' ' ' LEU . 11.0 tt0 -112.47 148.74 33.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.713 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.34 133.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.5 mm -98.93 137.12 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.994 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.602 ' CD1' ' SD ' ' A' ' 80' ' ' MET . 0.2 OUTLIER -106.9 116.03 31.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 110.691 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.137 HG12 ' H ' ' A' ' 68' ' ' SER . 6.4 t -139.07 -153.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.188 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.137 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER 72.25 149.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.252 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.442 ' O ' ' NE1' ' A' ' 37' ' ' TRP . 0.3 OUTLIER -39.13 66.75 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.003 0.43 . . . . 0.0 111.133 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.968 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.0 m-20 -111.11 10.61 21.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.915 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.5 ppt_? -32.21 -8.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.416 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.968 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -76.74 111.72 12.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.547 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 52.8 mp0 -65.45 -28.03 68.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.124 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -78.99 -50.98 10.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.903 179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 72' ' ' SER . 26.1 m-20 -62.74 -21.13 65.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.632 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 36.8 ttm -73.76 -61.73 1.74 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.065 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 1.8 m-85 -72.16 -19.82 61.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.835 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 19.9 tt0 -79.07 -57.02 3.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.791 ' CE2' ' CD2' ' A' ' 36' ' ' HIS . 1.8 t80 -66.57 -19.73 65.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.4 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.602 ' SD ' ' CD1' ' A' ' 66' ' ' PHE . 4.8 mmm -81.15 -41.63 22.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.629 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -81.9 -18.1 44.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.172 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.718 ' O ' ' CB ' ' A' ' 83' ' ' SER . 5.7 pt-20 -63.91 -19.49 65.14 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.371 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.739 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 21.7 m 136.78 3.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.837 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -100.06 107.01 18.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.868 0.366 . . . . 0.0 110.7 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.72 131.51 0.02 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.6 m-20 -124.39 61.05 1.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.584 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.636 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -153.58 -101.12 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.813 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.648 ' CD1' ' O ' ' A' ' 22' ' ' ALA . 1.2 mp -128.35 176.03 8.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.75 0.786 . . . . 0.0 112.741 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -147.47 126.47 12.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.939 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.0 113.68 22.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.546 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.782 ' O ' ' N ' ' A' ' 93' ' ' ARG . 48.3 Cg_exo -49.06 109.84 0.3 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 121.737 1.625 . . . . 0.0 111.414 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.1 p90 -30.09 -25.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.946 0.403 . . . . 0.0 110.369 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.782 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.1 mtt-85 -85.63 21.85 1.74 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.346 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.732 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -104.94 63.08 0.7 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.731 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.66 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.771 ' HG2' HG21 ' A' ' 7' ' ' ILE . 79.9 Cg_exo -38.38 -24.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.659 2.239 . . . . 0.0 112.445 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.03 -45.03 24.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.147 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.4 m -68.97 -64.09 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.9 m120 -44.79 -31.82 1.34 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.5 t -63.44 -49.09 84.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.667 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 98' ' ' SER . 3.9 m -65.35 -47.95 74.68 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.447 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.24 -21.62 62.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.519 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.2 OUTLIER -81.91 -36.1 28.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.232 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -18.95 60.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.37 34.41 32.49 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.782 ' C ' HG23 ' A' ' 107' ' ' THR . 1.3 mm -66.17 -108.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.637 0.256 . . . . 0.0 110.543 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.782 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.24 0.89 3.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.622 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -90.88 14.13 64.11 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.928 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -50.78 140.18 20.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.58 0.228 . . . . 0.0 110.409 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.546 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.5 Cg_endo -72.78 144.15 79.92 Favored 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.177 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -171.72 160.84 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.747 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.659 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.3 tt -126.99 127.08 44.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.015 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.729 HG13 ' CE ' ' A' ' 124' ' ' MET . 1.9 t -107.99 128.01 63.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.018 0.437 . . . . 0.0 110.846 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' CD2' ' A' ' 112' ' ' LEU . 45.0 mm -113.01 124.82 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.947 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.72 149.96 22.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.409 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.9 mttm -72.1 146.16 47.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CD ' ' OD1' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -45.39 -46.77 13.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.586 -179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.97 -15.02 26.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.518 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 103.28 18.24 15.44 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.455 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -84.02 144.0 29.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.617 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.906 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -85.78 142.03 29.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.157 0.503 . . . . 0.0 110.416 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.01 HG23 ' H ' ' A' ' 123' ' ' SER . 0.6 OUTLIER -133.46 -64.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.29 -179.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.01 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.8 m -142.31 118.39 10.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.421 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.817 ' SD ' HD21 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -82.01 -42.33 19.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.601 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.707 ' O ' ' N ' ' A' ' 128' ' ' GLY . 0.7 OUTLIER -89.66 44.73 1.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 130' ' ' VAL . . . -41.15 -23.81 0.09 OUTLIER Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.735 HH11 ' NE2' ' A' ' 131' ' ' GLN . 0.6 OUTLIER -83.73 3.41 33.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.286 0.565 . . . . 0.0 110.009 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 125' ' ' ASN . . . -87.63 -61.44 1.53 Allowed Glycine 0 CA--C 1.516 0.128 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.652 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 11.5 mm-40 -72.11 -25.08 61.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.116 -0.542 . . . . 0.0 109.593 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.761 HG21 ' CZ2' ' A' ' 141' ' ' TRP . 3.1 t -73.82 -50.49 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.735 ' NE2' HH11 ' A' ' 127' ' ' ARG . 21.4 mt-30 -70.59 -30.48 67.18 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.8 m -76.95 -43.5 34.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.24 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 133' ' ' LEU . 12.2 mt -111.2 -1.55 16.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.75 -145.87 32.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.325 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' CB ' ' CD ' ' A' ' 54' ' ' GLU . 32.4 Cg_exo -52.75 -28.73 39.3 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.817 2.345 . . . . 0.0 112.574 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -70.59 -6.64 38.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 129' ' ' GLU . . . -75.19 -16.0 60.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.441 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CG ' HD21 ' A' ' 55' ' ' LEU . 5.1 t80 -40.76 -28.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.269 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 143' ' ' ARG . 4.5 pt20 -67.99 -35.81 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.379 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.59 ' N ' ' O ' ' A' ' 137' ' ' ALA . 34.0 m-80 -72.97 -42.08 63.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.343 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.761 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 18.5 m0 -67.51 -24.19 65.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.307 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.51 ' O ' ' C ' ' A' ' 143' ' ' ARG . . . -118.45 7.07 11.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.311 0.577 . . . . 0.0 110.65 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 139' ' ' GLN . 58.3 mtp180 . . . . . 0 C--N 1.318 -0.764 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.543 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' C ' ' A' ' 2' ' ' GLU . 2.8 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 1' ' ' MET . 2.0 pt-20 34.93 68.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.521 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -93.78 -178.52 4.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -56.67 -47.04 83.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.592 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -33.87 122.23 0.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.97 -7.47 10.08 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.734 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.4 pt -102.89 175.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 120.779 0.324 . . . . 0.0 110.594 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.748 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.16 132.41 55.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.554 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 19' ' ' ALA . 1.8 mp -101.28 170.17 8.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.557 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.43 124.61 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.75 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CG2' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -81.5 141.23 34.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.356 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -42.5 -31.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.05 20.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.257 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 60.35 25.05 14.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.369 -179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.772 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 6.1 t -103.7 171.11 7.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.772 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 9.5 pt-20 -124.24 146.18 48.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.547 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.44 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -154.52 172.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.531 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 20' ' ' ASN . 1.2 m120 -90.16 100.84 13.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.489 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.025 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -40.08 -24.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.14 -58.81 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.27 -29.65 13.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -61.34 -29.73 70.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.578 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.706 HD23 ' OE2' ' A' ' 63' ' ' GLU . 42.8 mt -69.93 -15.01 62.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.588 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 25' ' ' ASP . 12.0 tttm 38.05 -84.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.852 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.716 ' O ' ' N ' ' A' ' 27' ' ' ASP . 1.1 p-10 46.44 93.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 13.3 tttp -33.64 -24.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.437 . . . . 0.0 109.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.8 OUTLIER 159.28 12.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -139.56 152.96 23.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.365 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 65' ' ' ILE . 1.3 mp -142.87 147.62 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.79 118.9 1.74 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 26.7 m-85 -90.7 124.13 34.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 110.671 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.706 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 28.5 t80 -101.56 124.32 47.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.628 ' O ' ' CB ' ' A' ' 34' ' ' SER . 45.8 m-85 -118.62 116.43 26.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.81 0.338 . . . . 0.0 110.68 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.831 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.2 p 151.05 75.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.917 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.665 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -41.98 116.07 0.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.672 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -100.44 21.17 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.821 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.693 ' CZ2' ' OG ' ' A' ' 72' ' ' SER . 1.7 p-90 -118.11 -50.74 2.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.375 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.674 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -82.99 -54.37 0.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.089 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 55.4 Cg_endo -90.74 158.59 4.18 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.832 2.355 . . . . 0.0 112.224 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.67 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 57.6 Cg_endo -75.09 152.12 39.97 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.871 2.381 . . . . 0.0 112.225 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.62 33.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.553 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.34 149.46 28.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.44 3.07 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.694 ' CE1' ' OE1' ' A' ' 131' ' ' GLN . 2.0 t80 -86.45 -35.43 19.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.741 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.2 m -53.28 -58.65 11.74 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.187 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 45' ' ' THR . 5.2 Cg_endo -49.29 -12.1 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.366 2.044 . . . . 0.0 111.879 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.548 HD12 HE21 ' A' ' 131' ' ' GLN . 1.6 mt -89.5 -44.76 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.72 -33.62 72.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.954 179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -67.47 -28.84 68.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.06 0.457 . . . . 0.0 110.092 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -79.44 -30.31 42.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.508 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.4 tmm? -74.87 -52.45 11.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.492 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.919 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.18 -26.04 66.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.771 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 8.4 t -66.1 -46.79 76.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.6 mm-40 -64.21 -56.25 15.98 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' O ' ' N ' ' A' ' 60' ' ' ALA . 6.9 mt -53.1 -39.19 63.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.081 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 52' ' ' TYR . 23.3 t -57.93 -51.12 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -49.56 -34.31 17.28 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.99 21.16 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.122 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.615 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 70.39 23.39 4.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.368 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.97 92.99 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.174 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD2' HD22 ' A' ' 55' ' ' LEU . 25.5 Cg_exo -60.34 39.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.18 2.587 . . . . 0.0 112.742 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' CE2' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.05 153.94 3.29 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.379 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.706 ' OE2' HD23 ' A' ' 23' ' ' LEU . 1.1 tt0 -112.34 148.23 34.69 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.159 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -104.13 131.14 53.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.556 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 29' ' ' ILE . 1.6 mm -92.15 136.27 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.01 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.1 OUTLIER -97.31 113.81 25.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.849 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.115 HG12 ' H ' ' A' ' 68' ' ' SER . 8.2 t -135.83 -155.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.933 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.115 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER 71.94 150.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.74 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.566 ' OG ' ' CB ' ' A' ' 35' ' ' ALA . 5.2 p -38.36 67.45 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.906 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.6 m-20 -114.2 10.02 17.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.694 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -37.89 -4.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.352 -179.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 70' ' ' ASP . 58.5 m -84.63 112.02 20.07 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -67.98 -26.29 65.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.386 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.75 -48.31 11.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.583 ' OD2' ' CE3' ' A' ' 37' ' ' TRP . 0.5 OUTLIER -71.28 -17.79 62.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 72' ' ' SER . 1.2 ttp -76.07 -56.18 4.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.946 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.702 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -67.65 -20.08 65.28 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.591 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -78.71 -52.5 8.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.356 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' CZ ' ' O ' ' A' ' 36' ' ' HIS . 1.6 m-85 -66.7 -20.94 66.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.262 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.408 ' HB3' ' HZ2' ' A' ' 12' ' ' LYS . 2.3 mmm -81.23 -46.33 14.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.432 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -18.93 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.513 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' OG ' ' A' ' 83' ' ' SER . 12.7 mt-10 -64.54 -56.15 15.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.62 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.794 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 3.4 m 168.86 3.52 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.366 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.82 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.04 114.94 27.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.46 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 130.55 0.01 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 2.0 m-20 -117.44 63.74 0.74 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.773 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.578 ' CG ' ' CG ' ' A' ' 63' ' ' GLU . 27.0 m-90 -152.71 -109.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.889 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.59 ' CB ' HD23 ' A' ' 9' ' ' LEU . 2.6 mp -125.75 175.86 7.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.769 0.795 . . . . 0.0 112.757 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.75 124.36 19.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.136 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.664 HG23 HD11 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -70.97 114.55 28.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.512 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.764 ' O ' ' N ' ' A' ' 94' ' ' SER . 50.3 Cg_exo -47.86 109.09 0.2 Allowed 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 121.789 1.659 . . . . 0.0 111.208 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -29.94 -28.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.895 0.379 . . . . 0.0 110.452 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.739 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -86.07 22.01 1.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.371 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 t -101.99 63.04 0.9 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.82 -63.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.734 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.3 Cg_exo -38.31 -23.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.746 2.297 . . . . 0.0 112.417 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.27 -42.99 34.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.957 0.408 . . . . 0.0 110.001 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.7 OUTLIER -69.59 -64.11 0.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 10.5 m120 -44.95 -31.56 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.8 t -63.91 -48.94 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.62 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 98' ' ' SER . 2.5 m -65.39 -47.72 75.36 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.63 -21.29 61.85 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.509 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 4.8 ttmm -80.31 -35.87 35.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.183 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.37 -14.34 59.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.56 52.68 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.781 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -67.8 -113.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.679 0.276 . . . . 0.0 110.487 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.9 OUTLIER 71.49 0.19 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 110.573 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.34 16.19 60.44 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.907 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -48.24 140.39 9.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 109' ' ' ILE . 55.8 Cg_endo -73.14 141.34 71.45 Favored 'Cis proline' 0 N--CA 1.495 1.568 0 C-N-CA 123.407 -1.497 . . . . 0.0 112.231 0.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.29 146.74 6.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.71 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.725 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.1 tt -116.66 126.4 53.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.825 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.2 t -103.05 134.67 43.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.033 0.444 . . . . 0.0 110.912 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 ' CD2' ' A' ' 112' ' ' LEU . 46.5 mm -120.89 117.71 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.615 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.25 155.86 41.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.158 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.3 mttm -82.29 148.83 28.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.473 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -45.77 -49.72 14.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.667 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.23 -6.22 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.468 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 93.84 17.76 40.02 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.444 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -82.48 125.39 31.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.928 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -71.53 136.63 47.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.197 179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.928 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -123.54 -64.45 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.52 -179.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.893 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.4 m -148.27 118.32 7.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.825 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -73.83 -94.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.423 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.525 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -63.69 51.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -66.65 7.78 1.36 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' ASN . 10.1 ttm180 -48.44 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.693 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.577 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.21 -30.46 1.19 Allowed Glycine 0 CA--C 1.52 0.396 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 60.2 mt-10 -59.38 -49.93 75.92 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.174 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.682 ' O ' ' N ' ' A' ' 134' ' ' GLY . 1.0 OUTLIER -71.37 -46.06 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.326 -0.549 . . . . 0.0 109.698 179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.694 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 33.2 mt-30 -65.94 -21.01 66.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.259 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.577 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 37.1 m -82.03 -52.06 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.311 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.51 HD12 HD21 ' A' ' 140' ' ' ASN . 9.9 mt -96.12 -4.34 42.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.682 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.65 -146.5 30.54 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.508 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 38.9 Cg_exo -55.23 -21.82 30.1 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.567 2.178 . . . . 0.0 111.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -77.08 -11.31 59.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.131 0.491 . . . . 0.0 109.958 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.68 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -71.59 -20.94 61.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.954 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 12.4 t80 -37.55 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.155 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.745 ' O ' ' N ' ' A' ' 143' ' ' ARG . 8.8 pt20 -73.38 -46.64 47.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.274 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.576 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 23.6 m-80 -72.89 -30.37 63.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.902 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.575 ' O ' HD13 ' A' ' 122' ' ' ILE . 11.7 m0 -82.23 -18.59 42.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.068 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.63 6.91 6.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.003 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.745 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--N 1.317 -0.822 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.603 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.549 ' O ' ' O ' ' A' ' 3' ' ' PHE . 9.3 mt-10 -71.53 3.56 3.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.571 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.549 ' O ' ' O ' ' A' ' 2' ' ' GLU . 1.7 m-85 -44.99 -179.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.575 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -93.74 -39.74 11.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.545 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' C ' ' O ' ' A' ' 4' ' ' ILE . 18.5 mt-30 -33.56 118.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.593 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.21 -16.37 6.76 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.755 HG21 ' HG2' ' A' ' 96' ' ' PRO . 36.9 pt -100.25 173.98 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.0 110.71 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.811 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -113.94 134.72 54.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.714 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.815 HD23 ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.56 165.04 12.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.429 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -115.89 123.42 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' ARG . 11.7 mtpt -80.02 139.27 37.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.421 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -42.69 -28.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.531 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 12' ' ' LYS . 30.7 t30 -73.47 21.65 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.378 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' LYS . 55.1 mtt85 61.01 24.45 14.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.78 171.14 7.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.637 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -124.91 149.69 47.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.616 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 ' CD2' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -153.82 171.52 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.7 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 20' ' ' ASN . 71.0 m-20 -92.56 103.44 15.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.668 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . . . -38.27 -24.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.985 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.5 m-80 -50.84 -57.43 8.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.916 0.388 . . . . 0.0 110.317 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -96.49 -25.87 15.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.809 ' HB1' HD22 ' A' ' 88' ' ' LEU . . . -59.37 -37.98 79.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' O ' ' C ' ' A' ' 24' ' ' LYS . 2.5 mm? -70.21 20.45 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.5 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' C ' ' O ' ' A' ' 23' ' ' LEU . 13.9 tttp -7.73 -97.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 27' ' ' ASP . 12.3 m-20 60.19 -63.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.63 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.645 ' N ' ' O ' ' A' ' 24' ' ' LYS . 1.7 mmmt 42.83 12.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -147.34 -72.38 0.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -140.24 155.81 23.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.062 0.458 . . . . 0.0 111.614 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -127.97 145.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.795 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.55 108.99 1.0 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 29' ' ' ILE . 86.3 m-85 -87.29 115.99 25.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.762 0.315 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' OG ' ' A' ' 34' ' ' SER . 56.4 t80 -100.62 123.38 44.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.076 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.655 ' O ' ' CB ' ' A' ' 34' ' ' SER . 46.2 m-85 -114.27 111.24 21.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.792 0.329 . . . . 0.0 110.567 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.775 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.9 p 147.84 102.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.679 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -35.97 -62.01 0.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.051 0.453 . . . . 0.0 110.206 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.538 ' ND1' ' OH ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER 70.54 -14.88 0.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.128 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.717 ' CH2' ' OD2' ' A' ' 75' ' ' ASP . 1.2 p-90 -90.5 -48.0 7.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.513 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.652 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -79.26 -50.65 1.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.207 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 73.0 Cg_endo -80.72 164.23 20.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.951 2.434 . . . . 0.0 111.989 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.56 -98.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.706 2.27 . . . . 0.0 112.135 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.7 t 42.13 37.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.631 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -81.17 149.46 29.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.18 -33.29 4.07 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.682 ' CE2' ' OE1' ' A' ' 131' ' ' GLN . 7.3 t80 -85.21 -27.43 26.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.884 0.373 . . . . 0.0 110.563 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.521 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 1.3 m -60.79 -60.62 10.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.019 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.6 Cg_endo -50.55 -11.63 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.466 2.111 . . . . 0.0 111.788 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 45' ' ' THR . 1.5 mt -86.72 -51.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.106 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.67 -25.08 62.83 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' CD1' ' A' ' 52' ' ' TYR . . . -71.64 -24.92 61.95 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 8.8 t0 -81.59 -33.3 31.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.372 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.65 ' SD ' ' C ' ' A' ' 51' ' ' MET . 1.2 ppp? -72.68 -46.95 51.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.755 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 1.053 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.94 -30.09 66.3 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.664 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.783 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 1.7 m -64.01 -43.42 95.69 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.964 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 1.3 mm-40 -68.24 -49.95 57.23 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -54.64 -42.76 71.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 52' ' ' TYR . 98.4 t -57.3 -48.92 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -51.2 -34.39 31.65 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.15 21.17 4.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.156 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER 71.13 21.21 4.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.559 0.695 . . . . 0.0 109.175 -178.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 12.3 91.2 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.382 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.7 Cg_exo -62.16 37.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 123.073 2.515 . . . . 0.0 112.007 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' HD12 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.32 154.27 3.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.64 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -115.65 148.56 39.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.132 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.633 HD12 ' CE2' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -96.65 130.75 44.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.488 179.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 23' ' ' LEU . 1.3 mm -96.84 135.63 30.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.405 ' CE2' ' CG ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -96.69 101.68 13.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.712 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG13 ' HB1' ' A' ' 97' ' ' ALA . 3.0 t -133.02 91.89 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.172 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.858 ' O ' ' N ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -179.75 150.3 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -36.3 73.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.941 ' O ' ' N ' ' A' ' 72' ' ' SER . 38.3 m-20 -114.12 10.34 17.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.71 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -32.13 -10.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.253 -179.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.941 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -86.67 111.26 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.67 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.687 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 54.5 mt-10 -66.35 -30.27 70.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.06 0.457 . . . . 0.0 109.978 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.486 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -80.37 -48.46 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.064 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.717 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 4.3 m-20 -69.78 -18.0 63.46 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 72' ' ' SER . 22.6 ttm -76.27 -54.73 6.36 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.899 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 2.7 m-85 -73.31 -30.75 63.59 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.33 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -70.74 -56.31 6.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -64.18 -25.09 67.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.946 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 2.6 mmm -78.63 -34.4 46.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.889 0.376 . . . . 0.0 110.438 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.4 ttm -82.37 -19.0 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.425 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.734 ' O ' ' CB ' ' A' ' 83' ' ' SER . 16.5 mt-10 -58.28 -17.01 16.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.273 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.741 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 39.6 m 133.21 3.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.76 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.787 ' CE1' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -98.64 111.87 24.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.658 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.93 131.4 0.01 OUTLIER Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 5.5 t70 -126.41 62.95 1.27 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.765 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.635 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 17.5 m-90 -150.07 -98.53 0.07 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.689 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.815 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -126.93 175.84 7.76 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.714 0.769 . . . . 0.0 112.795 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.51 128.04 10.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.363 -1.29 . . . . 0.0 110.441 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.693 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -74.01 118.0 65.94 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.595 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.797 ' O ' ' N ' ' A' ' 93' ' ' ARG . 45.4 Cg_exo -49.67 110.28 0.36 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 121.776 1.651 . . . . 0.0 111.419 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.9 p90 -30.09 -24.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.797 ' N ' ' O ' ' A' ' 91' ' ' PRO . 2.1 mtm180 -89.68 22.09 3.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.441 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 39.4 m -100.89 63.22 1.02 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.759 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.627 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.44 -63.19 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.684 -0.567 . . . . 0.0 111.684 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 100' ' ' VAL . 80.5 Cg_exo -38.05 -28.46 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.717 2.278 . . . . 0.0 112.423 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -72.24 -36.74 69.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.107 0.479 . . . . 0.0 109.711 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 95' ' ' GLY . 4.9 t -71.13 -63.5 1.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 15.5 t-20 -46.37 -33.61 4.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.584 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.7 t -59.54 -58.93 4.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.079 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 m -59.53 -45.03 92.95 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.65 0.738 . . . . 0.0 110.513 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.291 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.619 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 2.6 ttpt -79.15 -38.11 36.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.124 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -76.16 -18.95 58.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.495 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.69 31.44 49.7 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.812 ' C ' HG23 ' A' ' 107' ' ' THR . 1.6 mm -60.35 -103.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.669 0.271 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.812 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.7 OUTLIER 71.08 0.92 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.668 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.458 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -95.02 16.33 61.57 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.927 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -52.35 141.05 33.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.519 0.2 . . . . 0.0 110.48 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.55 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.7 Cg_endo -74.79 144.36 80.72 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.433 -1.486 . . . . 0.0 112.151 -0.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -170.39 155.28 5.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.833 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 114' ' ' ILE . 3.3 tt -121.03 128.14 52.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.311 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.981 HG13 ' CE ' ' A' ' 124' ' ' MET . 3.0 t -108.23 135.91 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.916 0.389 . . . . 0.0 110.427 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 112' ' ' LEU . 27.8 mm -118.13 125.07 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.399 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.93 151.48 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.038 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 119' ' ' GLY . 20.0 mttt -75.17 151.16 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 0.0 110.709 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -44.58 -49.66 10.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.555 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.9 -15.17 27.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.429 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 100.61 29.93 6.39 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -94.42 128.02 40.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.796 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.929 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -70.29 143.38 52.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.281 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.025 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -133.84 -64.68 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.485 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.025 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.4 OUTLIER -141.33 130.57 23.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.59 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.981 ' CE ' HG13 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -90.96 -63.29 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.617 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.733 ' ND2' ' CD ' ' A' ' 127' ' ' ARG . 0.6 OUTLIER -66.5 37.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' A' ' 124' ' ' MET . . . -38.34 -23.84 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.733 ' CD ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -52.54 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.879 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.571 ' O ' ' OG ' ' A' ' 132' ' ' SER . . . -42.69 -29.11 0.73 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.535 ' OE1' ' OG ' ' A' ' 123' ' ' SER . 45.0 mt-10 -61.23 -51.9 67.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.088 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' ' N ' ' A' ' 134' ' ' GLY . 79.7 t -69.02 -46.91 78.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.559 -0.457 . . . . 0.0 109.968 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 44' ' ' PHE . 3.6 mt-30 -64.01 -26.03 68.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.105 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.571 ' OG ' ' O ' ' A' ' 128' ' ' GLY . 35.8 m -77.12 -53.43 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.47 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.448 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 8.5 mt -100.26 5.92 44.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.338 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.59 -146.03 31.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -65.24 -15.7 51.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.097 1.864 . . . . 0.0 111.577 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.1 mtm180 -78.0 -7.01 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.621 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -62.66 -26.3 68.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.685 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.1 t80 -36.51 -22.95 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.833 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' ARG . 0.4 OUTLIER -72.89 -49.9 27.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 137' ' ' ALA . 1.8 m120 -69.79 -43.13 72.72 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.676 ' CZ2' HG21 ' A' ' 130' ' ' VAL . 3.7 m0 -61.74 -26.73 68.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.772 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -118.96 6.96 11.36 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.682 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.8 mmt-85 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.579 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 1' ' ' MET . 1.7 tp10 -37.55 -37.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -91.66 89.34 7.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.563 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -71.27 -43.11 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.633 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -33.96 136.34 0.12 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.658 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.87 -9.16 37.07 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.704 HG21 ' HG2' ' A' ' 96' ' ' PRO . 50.9 pt -99.84 176.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.522 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.861 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.2 169.27 12.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.896 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -157.71 159.97 37.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.328 179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.09 129.34 72.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.982 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 13' ' ' ASN . 3.2 ptpt -92.76 141.37 28.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.332 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 14' ' ' ARG . 4.7 ptpp? -42.31 -19.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.568 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' LYS . 1.8 m-20 -76.03 19.81 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.927 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.2 OUTLIER 55.86 31.7 18.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.258 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -122.48 171.22 9.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -116.23 150.22 37.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.554 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.742 HG22 ' N ' ' A' ' 18' ' ' ASN . 2.6 p -154.34 172.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.739 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.742 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -87.92 106.39 18.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.896 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.91 -24.67 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.051 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -47.37 -55.94 7.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.187 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.51 -25.73 15.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.323 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 88' ' ' LEU . . . -64.12 -25.92 68.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.032 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 19' ' ' ALA . 1.6 mm? -70.11 -14.97 62.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 25' ' ' ASP . 1.8 ttpp 30.96 -90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.31 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.677 ' O ' ' N ' ' A' ' 27' ' ' ASP . 4.1 p30 45.3 89.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.587 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 25' ' ' ASP . 11.7 mmmt -36.09 -23.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.849 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 166.27 -1.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.945 179.65 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -134.21 155.1 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.903 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.848 HG23 HD11 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -145.38 153.26 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 114' ' ' ILE . . . -136.57 114.13 1.12 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 51.1 m-85 -89.01 124.83 34.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.813 0.34 . . . . 0.0 110.415 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.685 ' CE2' ' OG ' ' A' ' 34' ' ' SER . 33.5 t80 -99.58 122.7 43.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.043 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 16.4 m-85 -116.77 109.99 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.586 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.685 ' OG ' ' CE2' ' A' ' 32' ' ' TYR . 4.6 p 168.6 89.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.801 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.26 26.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.155 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 34' ' ' SER . 1.8 m-70 -60.23 24.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.786 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.709 ' CZ3' ' OD2' ' A' ' 75' ' ' ASP . 3.1 p-90 -79.88 -38.63 32.26 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.325 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' N ' ' CD2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.78 -52.47 13.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.511 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 81.4 Cg_endo -82.81 164.45 15.84 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.817 2.345 . . . . 0.0 112.21 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.657 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 58.3 Cg_endo -75.78 164.64 31.6 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.96 43.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.506 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' NH1' ' OH ' ' A' ' 79' ' ' TYR . 12.1 mmt-85 -81.4 149.62 28.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.3 -36.38 3.07 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.794 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 27.0 t80 -86.65 -54.54 4.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.416 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.652 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -55.22 -44.69 99.76 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.907 -179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 45' ' ' THR . 39.1 Cg_exo -49.95 -16.77 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.191 1.928 . . . . 0.0 111.79 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.671 HD12 ' NE2' ' A' ' 131' ' ' GLN . 1.9 mt -82.9 -37.9 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.274 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.095 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -68.59 -32.41 72.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.145 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -67.63 -29.68 69.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -79.75 -29.59 40.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 130' ' ' VAL . 9.7 ttp -76.41 -50.3 14.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.65 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.877 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.42 -26.14 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.959 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.775 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 47.8 p -71.05 -41.47 70.72 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.867 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' OE2' ' CB ' ' A' ' 135' ' ' PRO . 0.4 OUTLIER -67.99 -53.76 23.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.74 ' O ' ' N ' ' A' ' 60' ' ' ALA . 8.1 mt -58.31 -40.22 81.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 52' ' ' TYR . 37.4 t -61.22 -45.51 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -56.12 -29.73 61.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.61 21.15 7.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.985 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.618 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER 70.77 26.59 3.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.239 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 1.92 116.89 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.28 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 55' ' ' LEU . 71.8 Cg_endo -80.15 35.58 0.58 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.767 2.311 . . . . 0.0 112.734 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -172.61 154.64 3.12 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.652 179.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 64' ' ' ILE . 3.7 tt0 -113.43 148.4 35.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.975 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.25 131.64 46.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.491 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.848 HD11 HG23 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -96.97 139.17 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.966 179.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.519 ' CE1' ' OD2' ' A' ' 70' ' ' ASP . 1.2 t80 -107.02 103.21 12.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.661 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -125.25 -152.37 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.062 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.886 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 69.8 149.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.21 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.61 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -40.25 66.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.344 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.912 ' O ' ' N ' ' A' ' 72' ' ' SER . 4.1 m-20 -106.15 10.53 31.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.49 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -33.37 -8.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.456 -179.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.912 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -77.47 111.51 13.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.319 -0.552 . . . . 0.0 109.533 179.405 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.721 ' CD ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -67.39 -27.59 67.21 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.07 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.552 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -80.98 -49.12 11.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.827 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.709 ' OD2' ' CZ3' ' A' ' 37' ' ' TRP . 9.7 m-20 -65.62 -18.83 65.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.2 tpp -76.43 -61.26 2.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.82 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.673 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -67.51 -19.15 65.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.492 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -76.47 -54.63 6.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.359 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-85 -62.32 -27.04 68.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 9.6 mmm -78.79 -49.23 13.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.395 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.83 -29.31 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.558 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' CB ' ' A' ' 83' ' ' SER . 0.6 OUTLIER -56.38 -56.08 25.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.708 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.82 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.8 p 159.01 4.18 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.126 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.652 ' CD2' ' CG2' ' A' ' 45' ' ' THR . 5.4 m80 -97.55 106.96 19.36 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 122.136 -0.352 . . . . 0.0 110.669 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.71 118.11 1.1 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.615 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -113.09 63.01 0.64 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.085 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.615 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 23.9 m-90 -159.87 -110.06 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.246 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.832 ' HB3' HD23 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -131.22 176.27 8.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.753 0.787 . . . . 0.0 112.495 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -137.36 123.47 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.86 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.719 HG22 ' OG ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -70.51 113.76 20.84 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.302 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.772 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.2 Cg_exo -46.74 109.09 0.18 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.724 1.616 . . . . 0.0 111.172 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 91' ' ' PRO . 1.6 p90 -29.96 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.411 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.772 ' N ' ' O ' ' A' ' 91' ' ' PRO . 25.1 mtt85 -85.98 21.89 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.353 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.9 p -103.48 63.16 0.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.79 -63.33 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.736 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.8 Cg_exo -38.14 -25.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.687 2.258 . . . . 0.0 112.532 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -76.88 -44.92 30.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.982 0.42 . . . . 0.0 110.01 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -69.08 -63.84 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.594 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 2.9 m120 -44.87 -32.17 1.49 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.6 t -62.75 -50.54 79.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.735 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 m -64.93 -48.27 74.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.625 0.726 . . . . 0.0 110.386 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.56 62.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.516 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.594 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 17.9 tttt -78.72 -35.66 44.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.165 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -76.4 -18.98 58.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.478 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.02 37.0 30.24 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.803 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.99 -107.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.664 0.269 . . . . 0.0 110.734 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.803 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.2 p 74.95 4.38 4.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.593 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -100.49 16.86 57.47 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.886 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -54.44 140.49 55.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.2 Cg_endo -73.84 141.44 71.76 Favored 'Cis proline' 0 C--N 1.309 -1.517 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.195 0.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.28 157.3 27.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.937 0.398 . . . . 0.0 110.968 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.796 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -116.49 123.08 46.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.013 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.718 HG21 HD11 ' A' ' 106' ' ' ILE . 1.6 t -107.87 127.55 63.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.744 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.796 HD11 ' CD2' ' A' ' 112' ' ' LEU . 43.0 mm -118.99 123.17 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.828 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.9 151.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.4 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 20.5 mttt -73.23 153.14 40.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.718 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -45.72 -49.86 14.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.04 -15.12 28.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 101.97 21.9 10.59 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -83.96 135.78 34.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.758 0.313 . . . . 0.0 110.695 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.5 OUTLIER -77.75 143.14 38.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 110.302 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.033 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -134.87 -64.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.208 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.033 ' H ' HG23 ' A' ' 122' ' ' ILE . 16.6 m -144.91 118.12 8.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.098 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.718 ' CE ' HD21 ' A' ' 121' ' ' LEU . 6.0 mmt -82.49 -106.75 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.883 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 127' ' ' ARG . 2.3 t-20 -60.71 42.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.659 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.653 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.37 16.4 6.12 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.731 ' NE ' ' CE2' ' A' ' 44' ' ' PHE . 12.3 ttt180 -42.87 -84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.776 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.54 -29.35 1.18 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -58.22 -53.02 62.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.201 179.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 131' ' ' GLN . 0.5 OUTLIER -64.85 -51.55 65.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.988 179.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.794 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 4.5 mt-30 -65.66 -19.1 65.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.477 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.62 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 22.1 m -81.05 -48.73 11.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.244 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.663 HD22 ' HG2' ' A' ' 136' ' ' ARG . 6.9 mt -90.77 -19.12 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.577 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 73.42 -149.25 41.81 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' CB ' ' OE2' ' A' ' 54' ' ' GLU . 39.0 Cg_exo -56.38 -18.09 23.56 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.739 2.292 . . . . 0.0 112.035 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.687 ' NE ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -76.84 -13.87 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.991 0.424 . . . . 0.0 110.038 179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -61.71 -26.63 68.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.193 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.8 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 14.6 t80 -36.72 -23.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.862 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.736 ' O ' ' N ' ' A' ' 143' ' ' ARG . 3.6 mt-30 -72.66 -56.87 4.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.134 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' ALA . 5.0 m-20 -66.34 -39.63 89.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.819 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 6.1 m0 -72.08 -19.7 61.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.402 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -124.64 7.52 8.22 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.111 0.481 . . . . 0.0 111.365 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.727 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.658 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 4.1 mm-40 -28.74 140.26 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.558 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 1' ' ' MET . 94.5 m-85 -128.29 -89.92 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.9 OUTLIER -89.69 -35.91 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' ILE . 19.5 mp0 -33.72 115.45 0.23 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 20' ' ' ASN . . . 125.55 -8.22 7.84 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG21 ' HG2' ' A' ' 96' ' ' PRO . 32.2 pt -100.7 176.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 120.822 0.344 . . . . 0.0 110.649 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.85 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.04 169.31 12.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.359 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.014 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -158.35 160.27 36.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.337 179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 91' ' ' PRO . 74.1 t -119.36 135.05 60.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.579 -0.449 . . . . 0.0 110.985 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER -95.45 143.64 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.296 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.04 -28.64 0.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.484 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.636 ' ND2' ' O ' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -72.33 18.51 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.033 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.6 mtt85 59.11 27.68 16.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.284 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.91 171.19 7.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.851 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -122.66 142.41 50.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.517 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -153.25 172.84 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.742 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 110.01 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.506 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.014 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -43.11 -24.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.044 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.633 HD22 ' N ' ' A' ' 6' ' ' GLY . 0.6 OUTLIER -49.72 -58.15 5.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.055 0.455 . . . . 0.0 110.137 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -96.75 -25.84 15.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -63.68 -44.92 92.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 65' ' ' ILE . 2.3 tp -70.07 22.26 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.418 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.635 ' C ' ' O ' ' A' ' 23' ' ' LEU . 14.5 ttpt -2.17 -112.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.732 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 67.21 -60.72 0.36 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.127 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.671 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 3.0 mtpt 39.2 14.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.046 0.45 . . . . 0.0 109.997 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.732 ' N ' ' O ' ' A' ' 25' ' ' ASP . 39.0 t0 -145.41 -68.92 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.545 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.686 ' N ' ' OD2' ' A' ' 25' ' ' ASP . 0.8 OUTLIER -138.85 155.58 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.626 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -135.9 157.15 38.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.004 0.43 . . . . 0.0 110.801 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.514 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -129.49 149.27 18.62 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 62.5 m-85 -127.5 118.29 23.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.833 0.349 . . . . 0.0 110.655 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -103.68 119.54 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.097 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.624 ' O ' ' CB ' ' A' ' 34' ' ' SER . 23.8 m-85 -114.63 114.42 25.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.928 0.394 . . . . 0.0 110.675 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.716 ' H ' ' CB ' ' A' ' 68' ' ' SER . 1.8 p 151.03 87.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.611 ' C ' ' O ' ' A' ' 34' ' ' SER . . . -19.19 -60.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.703 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.625 ' NE2' ' O ' ' A' ' 41' ' ' CYS . 0.2 OUTLIER 77.48 -25.35 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.796 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.589 ' CG ' ' N ' ' A' ' 38' ' ' CYS . 1.5 p-90 -87.85 -45.76 10.01 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.925 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.589 ' N ' ' CG ' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -81.17 -51.41 0.9 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.82 0.343 . . . . 0.0 110.344 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 96.9 Cg_endo -85.65 148.63 9.85 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.041 2.494 . . . . 0.0 112.254 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.54 134.09 14.98 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.806 2.337 . . . . 0.0 112.102 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 35.5 t 176.89 38.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.567 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -81.35 149.66 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.931 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.28 -36.22 3.12 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.49 ' CE2' ' CG ' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -86.09 -26.58 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.044 0.45 . . . . 0.0 110.385 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.69 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -58.13 -60.47 10.01 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.097 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 45' ' ' THR . 6.7 Cg_endo -50.48 -11.77 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.309 2.006 . . . . 0.0 111.81 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.419 ' CG2' ' HG3' ' A' ' 131' ' ' GLN . 1.8 mt -87.5 -50.3 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.085 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -65.65 -32.57 74.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.505 179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.987 ' HB1' ' OG ' ' A' ' 83' ' ' SER . . . -66.48 -28.62 68.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.969 0.414 . . . . 0.0 110.159 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -28.9 42.31 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 135' ' ' PRO . 5.9 tmm? -75.11 -54.83 6.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.362 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.964 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.81 -25.08 66.28 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.785 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.774 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 9.1 t -70.49 -42.48 71.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.237 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.99 -49.86 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.711 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.5 mt -56.97 -41.09 77.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.971 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 52' ' ' TYR . 42.5 t -57.65 -48.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -52.8 -32.97 46.83 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.86 21.23 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.216 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.591 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER 71.23 22.84 4.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.246 -179.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 8.29 92.26 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.666 ' HD2' HD22 ' A' ' 55' ' ' LEU . 23.8 Cg_exo -61.61 37.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.082 2.521 . . . . 0.0 112.351 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -171.85 154.59 3.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.074 0.464 . . . . 0.0 111.645 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.558 ' OE2' HD12 ' A' ' 23' ' ' LEU . 1.1 tt0 -113.6 148.62 35.88 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.068 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.595 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -102.22 142.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.463 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.681 HD11 HD21 ' A' ' 23' ' ' LEU . 1.1 mm -106.39 138.42 32.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.974 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -107.43 106.9 17.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.948 0.404 . . . . 0.0 110.972 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.62 ' O ' ' CB ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -133.12 -172.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.939 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.844 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.9 OUTLIER 90.73 150.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.503 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -36.62 74.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.949 ' O ' ' N ' ' A' ' 72' ' ' SER . 34.9 m-20 -114.47 10.65 16.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.499 ' HA ' ' CG ' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -31.94 -9.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.357 -179.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.949 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.05 111.4 16.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.645 ' N ' ' OE1' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -66.81 -29.39 69.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.273 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 13.8 t70 -77.79 -45.61 24.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD2' ' CD2' ' A' ' 37' ' ' TRP . 62.3 m-20 -65.15 -25.18 67.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.662 ' O ' ' SD ' ' A' ' 80' ' ' MET . 9.9 ttm -70.34 -60.47 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.194 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -73.47 -23.42 60.07 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.877 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 74' ' ' ASP . 5.4 tt0 -77.58 -56.32 4.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.378 . . . . 0.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.688 ' CD2' ' OE2' ' A' ' 82' ' ' GLU . 2.5 t80 -67.7 -19.7 65.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.424 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.662 ' SD ' ' O ' ' A' ' 76' ' ' MET . 59.9 mtp -81.26 -38.34 27.05 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.354 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.5 ttm -81.63 -18.83 43.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.468 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.726 ' O ' ' CB ' ' A' ' 83' ' ' SER . 3.7 pt-20 -59.66 -21.73 60.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.926 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.987 ' OG ' ' HB1' ' A' ' 49' ' ' ALA . 23.9 t 133.12 3.35 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.843 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -91.02 121.36 32.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.72 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.552 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 55.0 131.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -115.17 64.41 0.68 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.319 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.625 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 25.0 m-90 -159.44 -105.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.845 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.869 ' HB3' HD23 ' A' ' 9' ' ' LEU . 1.3 mp -129.54 176.45 7.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.852 0.834 . . . . 0.0 112.704 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -141.31 124.64 16.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.695 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -71.53 114.52 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.434 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.791 ' O ' ' N ' ' A' ' 93' ' ' ARG . 51.3 Cg_exo -47.2 109.14 0.19 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 121.81 1.673 . . . . 0.0 111.281 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.501 ' C ' ' O ' ' A' ' 91' ' ' PRO . 2.8 p90 -30.29 -24.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.791 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.4 mtm180 -88.89 21.97 2.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.301 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.749 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.4 t -101.34 63.16 0.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.784 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.21 -63.28 0.01 OUTLIER Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.825 ' O ' HG23 ' A' ' 100' ' ' VAL . 82.1 Cg_exo -38.29 -26.77 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.712 2.274 . . . . 0.0 112.485 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 67' ' ' VAL . . . -75.01 -38.62 61.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.955 0.407 . . . . 0.0 110.115 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -70.5 -63.99 0.98 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.639 ' O ' ' CG ' ' A' ' 103' ' ' LYS . 2.7 m120 -44.95 -33.83 2.17 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.3 t -59.59 -55.85 21.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.786 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 m -61.36 -46.84 88.53 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.51 -21.41 62.75 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.434 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.639 ' CG ' ' O ' ' A' ' 99' ' ' ASN . 9.8 mmtt -77.58 -37.38 50.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.076 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -76.52 -17.07 59.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.522 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.11 37.37 43.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.784 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -61.93 -109.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.754 0.312 . . . . 0.0 110.761 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.784 HG23 ' C ' ' A' ' 106' ' ' ILE . 1.3 p 76.19 5.25 3.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.567 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -101.11 16.18 57.33 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.872 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.13 140.85 61.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 52.9 Cg_endo -72.17 139.11 58.15 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 C-N-CA 123.386 -1.506 . . . . 0.0 112.246 0.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.741 ' CD2' HD11 ' A' ' 114' ' ' ILE . 1.3 tt -118.59 124.84 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.312 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.79 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -109.36 121.53 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.343 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 112' ' ' LEU . 50.2 mm -111.38 130.5 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.269 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 116' ' ' LYS . 1.2 m -142.62 151.47 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 2.0 mptp? -70.11 -166.71 0.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.725 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 ttpp -79.24 -49.86 11.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 118' ' ' ASP . 7.0 t70 -71.16 -4.97 28.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.48 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.38 -9.16 35.6 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.1 OUTLIER -45.4 131.15 8.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 110.392 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -82.52 152.22 26.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.981 0.419 . . . . 0.0 110.191 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.999 HG23 ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -137.82 -64.85 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.827 -178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.999 ' H ' HG23 ' A' ' 122' ' ' ILE . 54.7 m -155.64 118.59 4.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.385 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.79 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.4 mmt -77.68 -102.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.72 41.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.73 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.3 12.0 15.16 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.426 -1.069 . . . . 0.0 110.426 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.698 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 18.9 ttp85 -42.51 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.753 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.51 -26.46 0.66 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -61.36 -52.16 65.81 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.291 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.647 ' CG2' ' CE2' ' A' ' 141' ' ' TRP . 1.0 OUTLIER -66.63 -50.76 63.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.461 -0.496 . . . . 0.0 109.689 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.815 HE21 ' H ' ' A' ' 131' ' ' GLN . 0.0 OUTLIER -62.74 -25.46 68.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.664 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 28.5 t -80.75 -47.92 13.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.805 0.336 . . . . 0.0 110.467 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.0 mt -94.05 0.8 56.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.142 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.64 -145.57 32.12 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.513 ' HA ' ' SD ' ' A' ' 51' ' ' MET . 23.4 Cg_endo -66.18 -14.63 45.19 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.203 1.936 . . . . 0.0 111.95 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 1.9 mtm180 -71.16 -16.72 62.55 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' ASN . . . -69.35 -25.73 64.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.881 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.69 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 11.7 t80 -36.5 -26.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.818 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.687 ' O ' ' N ' ' A' ' 143' ' ' ARG . 80.4 mt-30 -70.39 -46.75 63.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.809 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.623 HD22 ' H ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -74.12 -38.51 63.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.554 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.647 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 5.1 m0 -73.24 -17.7 61.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.082 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.18 6.93 6.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.172 0.51 . . . . 0.0 110.92 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.687 ' N ' ' O ' ' A' ' 139' ' ' GLN . 26.2 mtp180 . . . . . 0 C--N 1.317 -0.829 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.554 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 3.0 pt-20 -103.28 10.06 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.626 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -61.65 -103.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.598 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -125.28 -52.22 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.605 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.502 ' O ' ' CG ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -33.68 125.73 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.625 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . 117.19 -7.07 16.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.8 HG21 ' HG2' ' A' ' 96' ' ' PRO . 20.0 pt -102.12 175.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 120.86 0.362 . . . . 0.0 110.664 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.57 169.53 12.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.382 179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.929 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -155.38 156.58 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.298 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' PRO . 72.4 t -114.32 137.66 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.111 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -98.44 146.16 26.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.192 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.567 ' C ' ' H ' ' A' ' 14' ' ' ARG . 1.9 ptpt -41.84 -35.35 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.631 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER -71.72 21.43 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.955 179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 12' ' ' LYS . 3.1 mtm105 57.33 28.35 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.182 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.765 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 3.9 t -98.43 171.29 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.858 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.765 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 44.2 mt-10 -123.12 138.72 54.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.576 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -151.56 172.0 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.765 -179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.37 114.7 27.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.602 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -45.12 -24.55 0.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.76 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 6' ' ' GLY . 0.8 OUTLIER -52.1 -57.6 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 -25.87 17.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.343 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.645 ' O ' ' CD1' ' A' ' 88' ' ' LEU . . . -67.69 -23.68 65.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.46 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 24' ' ' LYS . 63.7 mt -82.97 25.66 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.627 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.677 ' O ' ' NZ ' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -16.16 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.684 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 60.41 -65.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.555 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.69 ' H ' ' HZ2' ' A' ' 117' ' ' LYS . 19.4 tttp 42.9 11.74 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 25' ' ' ASP . 4.2 t0 -144.19 -71.43 0.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.856 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -139.01 155.27 26.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 1.1 mp -130.42 159.31 42.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.537 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -131.92 149.25 19.32 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 57.5 m-85 -131.54 117.48 18.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.332 . . . . 0.0 110.765 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -104.26 119.24 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.505 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 31' ' ' PHE . 21.9 m-85 -116.45 112.47 21.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.523 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.617 ' H ' ' CB ' ' A' ' 68' ' ' SER . 3.9 t 164.55 90.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.732 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -68.03 23.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.295 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.6 m80 -59.72 23.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.367 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.789 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.3 p-90 -78.69 -39.1 37.62 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.629 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.789 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -69.21 -52.94 14.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.439 179.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 71.8 Cg_endo -83.01 164.53 15.36 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.991 2.461 . . . . 0.0 112.273 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 41' ' ' CYS . 50.1 Cg_endo -72.74 172.62 14.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.78 2.32 . . . . 0.0 112.188 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.667 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 0.5 OUTLIER 149.3 -4.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 41' ' ' CYS . 0.7 OUTLIER -37.05 149.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.957 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.19 -36.6 3.02 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.697 ' CE2' ' NE2' ' A' ' 131' ' ' GLN . 31.3 t80 -86.84 -54.68 4.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.043 0.449 . . . . 0.0 110.399 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.565 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.9 OUTLIER -55.26 -45.04 99.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.657 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 45' ' ' THR . 36.2 Cg_exo -50.91 -16.04 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.281 1.988 . . . . 0.0 111.661 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -40.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.118 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.066 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -65.3 -33.05 75.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.107 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -66.71 -29.29 69.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.383 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -78.83 -30.53 45.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.5 ' HG2' ' N ' ' A' ' 135' ' ' PRO . 5.9 tmm? -74.95 -53.06 9.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.422 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.869 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.54 -24.23 65.52 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.777 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.3 t -68.09 -46.14 71.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -65.69 -55.35 17.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.762 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.4 mt -56.02 -37.79 69.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.098 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 52' ' ' TYR . 15.9 t -61.54 -48.63 87.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -51.85 -32.23 31.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.64 21.39 5.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.195 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.605 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER 70.72 23.99 4.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.279 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.762 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 6.82 92.92 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.385 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.625 ' HD2' HD22 ' A' ' 55' ' ' LEU . 27.5 Cg_exo -60.23 39.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.091 2.528 . . . . 0.0 112.497 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.689 ' O ' ' CZ2' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -172.53 154.51 3.14 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.534 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.484 ' HA ' ' CE2' ' A' ' 87' ' ' TRP . 0.3 OUTLIER -113.34 148.68 35.24 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.288 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -103.74 136.17 37.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.336 179.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.1 mm -100.02 137.46 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.495 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 1.4 t80 -106.94 108.49 20.02 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.805 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -128.99 -152.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.062 179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.842 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER 73.95 149.58 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.353 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.609 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 1.3 t -43.34 68.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.254 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.928 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.3 m-20 -104.11 10.46 35.91 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -32.41 -9.85 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.435 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.928 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -80.39 111.89 17.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.711 179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.8 mt-10 -64.6 -25.84 68.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 0.0 110.463 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -79.44 -51.54 9.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.962 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.706 ' OD2' ' CG ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -60.51 -24.14 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.14 -64.74 0.85 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.858 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -65.72 -18.94 65.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.764 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -76.83 -56.31 4.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 110.253 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 2.3 m-85 -60.45 -28.76 68.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.3 mtp -81.3 -52.49 7.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.315 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 77' ' ' PHE . 56.6 mmm -59.09 -23.81 62.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 83' ' ' SER . 1.4 tm-20 -67.43 -54.28 21.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.677 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.851 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.7 p 158.63 4.66 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.113 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 8.2 m80 -89.42 106.84 18.71 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.107 -0.371 . . . . 0.0 110.732 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.99 126.98 0.63 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.634 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.2 OUTLIER -114.97 63.21 0.68 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.995 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.689 ' CZ2' ' O ' ' A' ' 62' ' ' PHE . 24.5 m-90 -160.6 -109.56 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.425 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.786 ' CB ' HD23 ' A' ' 9' ' ' LEU . 1.5 mp -129.59 176.33 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.801 0.81 . . . . 0.0 112.554 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 66' ' ' PHE . . . -139.38 123.3 17.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.729 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.641 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -69.44 113.65 18.47 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.515 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.777 ' O ' ' N ' ' A' ' 93' ' ' ARG . 50.1 Cg_exo -48.91 109.45 0.26 Allowed 'Trans proline' 0 C--N 1.301 -1.948 0 C-N-CA 121.794 1.663 . . . . 0.0 111.265 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 3.2 p90 -29.96 -26.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.411 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.777 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.0 mmt180 -84.15 22.04 1.28 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.218 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.721 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -106.79 63.24 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.84 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -9.47 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.8 ' HG2' HG21 ' A' ' 7' ' ' ILE . 81.0 Cg_exo -38.05 -22.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.796 2.331 . . . . 0.0 112.559 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -78.79 -45.9 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.103 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' N ' ' A' ' 99' ' ' ASN . 0.1 OUTLIER -68.39 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 35.2 t30 -45.0 -31.92 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.571 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.3 t -62.28 -51.17 75.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.768 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.451 ' N ' HG12 ' A' ' 100' ' ' VAL . 4.2 m -65.31 -47.43 76.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.553 0.692 . . . . 0.0 110.285 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.69 -21.62 62.56 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.61 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 0.9 OUTLIER -79.33 -35.47 40.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -76.36 -18.88 58.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.31 35.57 37.21 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.808 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.04 -100.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.68 0.276 . . . . 0.0 110.689 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.808 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 70.54 4.05 4.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.681 179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -98.92 15.75 60.31 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.06 139.11 79.34 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.399 -0.222 . . . . 0.0 110.399 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 56.0 Cg_endo -73.07 139.12 59.56 Favored 'Cis proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.499 -1.459 . . . . 0.0 112.157 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.78 154.04 21.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.744 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.716 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.1 tt -114.93 120.59 40.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.283 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.795 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -104.02 124.03 58.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.594 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.716 HD11 ' CD2' ' A' ' 112' ' ' LEU . 47.1 mm -114.75 129.74 70.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -136.44 152.46 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.596 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.495 ' CD ' ' HB ' ' A' ' 120' ' ' THR . 8.5 mtpt -76.41 174.2 10.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.69 ' HZ2' ' H ' ' A' ' 26' ' ' LYS . 8.1 tptt -62.59 -49.89 73.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.647 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.635 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -71.25 1.46 6.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.549 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.94 64.21 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' CD ' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -51.5 120.48 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.557 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.021 HD13 ' N ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -71.26 143.77 50.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.998 0.427 . . . . 0.0 110.191 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.021 ' N ' HD13 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -137.61 -64.72 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.697 -179.265 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.947 ' H ' HG23 ' A' ' 122' ' ' ILE . 1.2 m -134.68 134.71 41.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.453 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.795 ' CE ' HG13 ' A' ' 113' ' ' VAL . 1.3 mmt -112.72 -29.85 7.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.567 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.666 ' ND2' ' O ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -129.11 35.06 4.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.603 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 129' ' ' GLU . . . -77.37 14.0 9.73 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.645 ' CG ' ' ND2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -43.75 -85.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.797 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 132' ' ' SER . . . -43.7 -33.83 2.54 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 56.9 mt-10 -57.41 -49.42 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.07 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 131' ' ' GLN . 0.3 OUTLIER -67.06 -51.72 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.77 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.697 ' NE2' ' CE2' ' A' ' 44' ' ' PHE . 14.0 mt-30 -63.49 -18.57 63.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.422 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 128' ' ' GLY . 29.0 t -84.9 -52.52 5.95 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.923 0.392 . . . . 0.0 110.037 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 133' ' ' LEU . 10.4 mt -91.35 -4.01 56.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.9 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 55.69 -146.22 31.15 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' N ' ' HG2' ' A' ' 51' ' ' MET . 38.5 Cg_exo -56.11 -21.66 36.09 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.613 2.208 . . . . 0.0 112.143 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.7 mtt85 -71.12 -18.75 62.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.096 0.474 . . . . 0.0 109.819 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.37 -23.94 65.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.117 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.651 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 51.4 t80 -37.53 -19.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.107 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.723 ' O ' ' N ' ' A' ' 143' ' ' ARG . 14.6 pt20 -73.96 -49.36 24.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.101 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.61 ' N ' ' CG ' ' A' ' 139' ' ' GLN . 66.5 m-80 -73.46 -31.7 63.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.564 ' CZ2' ' HB ' ' A' ' 130' ' ' VAL . 6.5 m0 -78.2 -18.67 55.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.898 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -127.15 7.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.84 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 139' ' ' GLN . 3.1 mtp180 . . . . . 0 C--N 1.319 -0.749 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.517 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' OE2' ' A' ' 2' ' ' GLU . 9.8 tmm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.636 ' C ' ' CG ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -163.2 11.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.58 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.636 ' CG ' ' C ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 69.55 165.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.626 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -66.54 -55.56 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.578 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 4' ' ' ILE . 33.7 mt-30 -33.75 132.46 0.22 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.65 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.837 ' H ' HD22 ' A' ' 20' ' ' ASN . . . 112.1 -7.04 27.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.678 HG21 ' HG2' ' A' ' 96' ' ' PRO . 18.9 pt -102.37 176.56 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.907 0.384 . . . . 0.0 110.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.748 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.04 169.84 12.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.812 HD13 ' HB2' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -156.27 158.28 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.286 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' HG3' ' A' ' 91' ' ' PRO . 79.3 t -118.52 111.94 36.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.213 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 15' ' ' CYS . 16.2 mtpt -65.81 138.56 57.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.566 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -42.64 -34.47 0.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.69 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.422 HD22 ' HA ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -68.85 18.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.403 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 66.59 20.09 10.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.436 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' N ' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -99.31 171.34 8.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.641 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.799 ' O ' HG13 ' A' ' 17' ' ' VAL . 9.0 pt-20 -117.85 151.76 36.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.526 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 16' ' ' GLU . 5.6 m -165.83 171.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.417 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.627 ' O ' ' N ' ' A' ' 20' ' ' ASN . 20.1 m120 -99.23 114.44 27.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.49 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.812 ' HB2' HD13 ' A' ' 9' ' ' LEU . . . -35.87 -24.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.742 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.837 HD22 ' H ' ' A' ' 6' ' ' GLY . 0.5 OUTLIER -56.39 -59.11 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.792 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -95.24 -25.88 16.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 88' ' ' LEU . . . -63.31 -33.98 76.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.621 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.69 ' O ' ' N ' ' A' ' 25' ' ' ASP . 33.3 mt -73.28 23.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.628 ' C ' ' O ' ' A' ' 23' ' ' LEU . 26.3 tttm -9.52 -56.41 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 23' ' ' LEU . 34.9 p-10 22.87 96.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.908 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 27' ' ' ASP . 12.9 tttm -37.52 -22.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 25' ' ' ASP . 0.9 OUTLIER 157.82 13.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.301 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -143.3 144.48 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 120.663 0.268 . . . . 0.0 110.306 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' CG2' ' CE1' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -135.03 142.53 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.937 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -127.2 115.97 2.31 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 65' ' ' ILE . 90.7 m-85 -90.45 120.36 31.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.663 0.268 . . . . 0.0 110.455 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.07 126.39 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.709 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 33' ' ' PHE . 1.7 m-85 -119.46 115.61 24.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.249 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.781 ' H ' ' CB ' ' A' ' 68' ' ' SER . 0.0 OUTLIER 169.73 92.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.646 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.705 ' N ' ' OG ' ' A' ' 68' ' ' SER . . . -65.55 35.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.397 . . . . 0.0 110.05 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.64 ' H ' ' C ' ' A' ' 34' ' ' SER . 2.2 m-70 -58.94 14.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.081 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.787 ' CE2' ' SG ' ' A' ' 38' ' ' CYS . 1.4 p-90 -81.6 -42.29 20.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.787 ' SG ' ' CE2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -77.58 -48.24 2.32 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.325 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 38' ' ' CYS . 38.4 Cg_endo -88.12 167.05 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.261 2.641 . . . . 0.0 112.076 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.63 -95.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.774 2.316 . . . . 0.0 112.189 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.3 m 51.52 29.45 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.365 . . . . 0.0 110.481 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 42' ' ' ARG . 5.3 ttm180 -81.35 150.26 28.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.869 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.84 -36.11 3.08 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.691 ' O ' ' CD1' ' A' ' 44' ' ' PHE . 3.0 t80 -86.11 -27.45 24.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 110.105 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.655 HG23 ' CD2' ' A' ' 84' ' ' HIS . 1.3 m -60.64 -59.1 14.92 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.119 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 45' ' ' THR . 7.3 Cg_endo -51.2 -11.77 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.347 2.031 . . . . 0.0 111.833 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.48 -48.92 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.893 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.11 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.29 -31.79 70.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.895 179.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 83' ' ' SER . . . -68.8 -30.44 69.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.046 0.45 . . . . 0.0 110.212 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 54' ' ' GLU . 5.6 t0 -79.0 -29.05 43.47 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.559 ' SD ' HG13 ' A' ' 130' ' ' VAL . 9.8 ttp -75.76 -53.4 8.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.593 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.868 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -66.65 -25.53 66.62 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.75 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 3.3 m -66.01 -46.93 76.16 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 50' ' ' ASP . 2.4 mm-40 -63.76 -58.36 7.1 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.743 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.1 mt -54.28 -37.92 65.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.814 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 52' ' ' TYR . 5.1 t -58.89 -50.8 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.22 -35.55 17.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' O ' ' OG ' ' A' ' 59' ' ' SER . 0.1 OUTLIER -89.83 21.06 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.137 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.614 ' O ' ' C ' ' A' ' 60' ' ' ALA . 12.1 p 70.43 22.49 5.23 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.274 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 9.79 93.77 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.088 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.629 ' HD2' HD22 ' A' ' 55' ' ' LEU . 34.1 Cg_exo -59.05 37.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 123.139 2.559 . . . . 0.0 112.724 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 0.3 OUTLIER -171.67 144.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.366 179.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -104.11 148.18 26.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.971 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.626 ' CD1' ' CE2' ' A' ' 62' ' ' PHE . 1.1 mp -98.95 128.48 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.315 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.537 HG21 ' CE2' ' A' ' 31' ' ' PHE . 2.2 mm -92.36 135.92 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.485 ' CZ ' ' HG2' ' A' ' 80' ' ' MET . 0.2 OUTLIER -98.99 110.27 22.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.977 0.417 . . . . 0.0 111.018 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 68' ' ' SER . 1.5 t -129.57 -154.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.919 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.823 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER 66.84 149.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.67 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.488 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -43.15 70.02 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.903 ' O ' ' N ' ' A' ' 72' ' ' SER . 2.1 m-20 -111.23 10.5 21.76 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.51 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 1.1 ppt_? -34.9 -6.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.58 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.903 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -78.82 110.99 14.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.558 179.336 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.682 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -68.75 -30.08 68.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.064 0.459 . . . . 0.0 110.029 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 7.3 t70 -80.59 -45.2 17.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.263 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' OD2' ' CH2' ' A' ' 37' ' ' TRP . 3.8 m-20 -72.65 -17.73 61.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.598 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.475 ' SD ' ' CE1' ' A' ' 77' ' ' PHE . 30.9 ttm -76.52 -53.95 7.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.954 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.682 ' CD2' ' O ' ' A' ' 73' ' ' GLU . 5.0 m-85 -74.57 -22.87 58.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.535 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.81 -51.45 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.922 0.392 . . . . 0.0 110.249 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 37' ' ' TRP . 1.1 m-85 -62.32 -40.34 96.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.866 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.485 ' HG2' ' CZ ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.39 -41.83 94.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.359 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.681 ' O ' ' SD ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -70.89 -23.98 62.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.551 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.733 ' O ' ' CB ' ' A' ' 83' ' ' SER . 6.5 mt-10 -65.02 -16.3 63.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.805 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 68.0 m 123.11 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.824 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.891 ' NE2' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -90.48 106.99 18.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.795 0.331 . . . . 0.0 110.716 -179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.57 ' O ' ' O ' ' A' ' 84' ' ' HIS . . . 54.84 132.71 0.0 OUTLIER Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 86' ' ' ASP . 9.8 p-10 -129.18 65.24 1.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 56' ' ' VAL . 19.7 m-90 -149.03 -103.88 0.08 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.689 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.955 ' H ' HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -123.2 176.19 6.23 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.678 0.751 . . . . 0.0 112.39 -179.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' HB2' ' HE2' ' A' ' 80' ' ' MET . . . -148.61 127.75 12.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.295 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.665 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -73.31 113.67 24.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.362 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 93' ' ' ARG . 46.7 Cg_exo -49.77 110.13 0.34 Allowed 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 121.7 1.6 . . . . 0.0 111.289 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.593 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -30.23 -26.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.887 0.375 . . . . 0.0 110.462 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 91' ' ' PRO . 12.5 mtp180 -85.28 22.04 1.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.275 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.745 ' N ' ' O ' ' A' ' 91' ' ' PRO . 1.3 t -103.06 63.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.782 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -8.94 -63.36 0.01 OUTLIER Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.781 ' O ' HG23 ' A' ' 100' ' ' VAL . 81.4 Cg_exo -38.31 -25.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.752 2.301 . . . . 0.0 112.403 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -74.84 -38.07 62.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.123 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 95' ' ' GLY . 1.7 t -70.84 -63.86 1.02 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 5.7 m-20 -45.0 -33.59 2.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 96' ' ' PRO . 2.2 t -60.18 -55.26 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.806 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.421 HG22 ' HB ' ' A' ' 106' ' ' ILE . 2.3 m -61.46 -46.6 89.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.697 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.35 -21.13 61.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.351 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.618 ' CB ' ' O ' ' A' ' 99' ' ' ASN . 11.9 tttp -81.58 -39.2 24.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.16 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -76.66 -9.75 58.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.36 30.53 64.6 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.769 ' C ' HG23 ' A' ' 107' ' ' THR . 1.2 mm -69.24 -112.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.666 0.269 . . . . 0.0 110.39 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.769 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER 68.08 -3.65 1.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.929 0.395 . . . . 0.0 110.692 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 106' ' ' ILE . . . -86.44 15.81 48.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.924 HD13 ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -45.62 142.79 3.3 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.521 0.2 . . . . 0.0 110.694 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.69 ' HA ' HG22 ' A' ' 109' ' ' ILE . 57.4 Cg_endo -74.6 139.97 64.68 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 123.335 -1.527 . . . . 0.0 112.157 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -163.59 156.1 17.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.723 ' CD2' HD11 ' A' ' 114' ' ' ILE . 3.4 tt -123.14 127.53 48.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.254 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG22 ' HE2' ' A' ' 124' ' ' MET . 0.9 OUTLIER -111.2 135.91 48.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.0 110.925 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.723 HD11 ' CD2' ' A' ' 112' ' ' LEU . 30.6 mm -119.63 123.9 71.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.176 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.62 154.85 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.101 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.441 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 5.8 mttm -80.8 149.79 29.45 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.538 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.8 tttm -47.64 -49.74 26.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.725 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.521 ' O ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -60.92 -5.91 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.491 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.2 3.71 58.76 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -69.85 121.42 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.733 0.301 . . . . 0.0 110.633 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.2 OUTLIER -72.63 141.0 48.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.986 0.422 . . . . 0.0 110.238 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.981 HG23 ' H ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -130.19 -64.9 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.481 -179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.981 ' H ' HG23 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -141.06 135.32 30.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.261 179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.782 ' HE3' HD11 ' A' ' 121' ' ' LEU . 2.4 mmt -97.65 -114.58 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 125' ' ' ASN . 0.3 OUTLIER -61.43 49.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -76.41 20.6 2.62 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 125' ' ' ASN . 1.4 ttt180 -42.5 -84.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.379 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.5 -26.93 0.73 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -60.85 -56.12 24.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 134' ' ' GLY . 0.6 OUTLIER -62.67 -51.15 75.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.677 ' OE1' ' CE1' ' A' ' 44' ' ' PHE . 3.3 mt-30 -58.03 -29.48 65.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.512 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 30.7 t -73.98 -52.14 13.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 136' ' ' ARG . 11.1 mt -87.7 -12.03 46.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 62.43 -147.03 49.68 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.26 -12.83 17.54 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.723 2.282 . . . . 0.0 112.242 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' CD ' HD22 ' A' ' 133' ' ' LEU . 8.1 ttt180 -84.79 -7.0 59.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.177 0.513 . . . . 0.0 109.729 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.82 -26.59 66.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.235 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.679 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 5.2 t80 -36.33 -24.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.715 ' O ' ' N ' ' A' ' 143' ' ' ARG . 62.5 mt-30 -72.68 -46.64 52.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.022 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.8 m-80 -72.26 -42.45 65.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.671 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.623 ' O ' HD13 ' A' ' 122' ' ' ILE . 10.9 m0 -69.12 -21.76 64.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.109 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -122.58 6.78 9.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.235 0.541 . . . . 0.0 110.871 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.715 ' N ' ' O ' ' A' ' 139' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.531 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -107.41 -91.35 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -112.35 154.21 26.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.642 HG22 ' HB2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -53.61 -55.22 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.487 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.477 ' C ' ' O ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -33.7 117.08 0.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.573 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' HA2' HD22 ' A' ' 20' ' ' ASN . . . 126.11 -1.95 7.8 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 4' ' ' ILE . 7.0 pt -109.35 -177.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.81 0.338 . . . . 0.0 110.518 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.638 ' C ' HD23 ' A' ' 9' ' ' LEU . 1.3 mptt -119.78 138.21 53.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.772 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.673 ' CG ' ' HB2' ' A' ' 19' ' ' ALA . 4.2 mt -115.66 -177.19 3.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.813 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' CYS . 4.0 t -122.54 116.86 50.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.98 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 88' ' ' LEU . 1.1 mtpt -74.23 141.59 45.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.241 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 14' ' ' ARG . 0.6 OUTLIER -42.32 -31.79 0.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.563 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.22 19.58 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.192 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.576 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.3 mtm180 62.1 21.47 12.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.346 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.738 ' SG ' ' N ' ' A' ' 16' ' ' GLU . 12.2 t -101.94 171.54 7.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.634 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.738 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 11.6 pt-20 -128.17 135.03 49.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -138.6 171.35 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.865 0.364 . . . . 0.0 110.907 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -88.64 100.96 13.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.67 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.673 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -38.02 -24.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.128 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ASN . 2.0 t-20 -53.57 -61.65 2.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.009 0.433 . . . . 0.0 110.123 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -97.0 -25.69 15.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.699 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.82 ' HB1' ' CD1' ' A' ' 88' ' ' LEU . . . -59.46 -39.26 83.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.319 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' O ' ' OD2' ' A' ' 25' ' ' ASP . 4.8 tp -69.97 1.47 4.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.992 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 26' ' ' LYS . 15.2 tptt 22.03 -96.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.55 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.679 ' O ' ' N ' ' A' ' 27' ' ' ASP . 21.2 m-20 59.8 -67.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 24' ' ' LYS . 4.1 mttp 43.64 11.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.679 ' N ' ' O ' ' A' ' 25' ' ' ASP . 36.7 t70 -146.42 -75.45 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.603 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 0.7 OUTLIER -137.86 155.94 30.95 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 121.061 0.458 . . . . 0.0 111.65 -178.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 0.5 OUTLIER -128.65 153.77 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.996 179.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.566 ' O ' ' CG1' ' A' ' 65' ' ' ILE . . . -125.01 144.76 15.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 33' ' ' PHE . 58.5 m-85 -127.7 115.76 19.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.871 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -104.36 120.23 40.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.475 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.641 ' O ' ' OG ' ' A' ' 34' ' ' SER . 21.0 m-85 -117.8 110.84 18.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.255 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.646 ' H ' ' CB ' ' A' ' 68' ' ' SER . 6.1 m 168.74 90.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.684 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.761 ' C ' ' H ' ' A' ' 37' ' ' TRP . . . -66.54 19.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 110.254 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.625 ' H ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -58.13 20.91 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.521 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.795 ' CZ2' ' SG ' ' A' ' 38' ' ' CYS . 3.7 p-90 -76.31 -38.49 55.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.477 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.795 ' SG ' ' CZ2' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -67.46 -54.35 18.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.911 0.386 . . . . 0.0 110.438 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 38' ' ' CYS . 73.7 Cg_endo -80.2 164.69 21.84 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.953 2.435 . . . . 0.0 112.17 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.665 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 55.5 Cg_endo -74.02 164.86 33.45 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.827 2.351 . . . . 0.0 112.27 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.665 ' SG ' ' O ' ' A' ' 40' ' ' PRO . 1.3 m 154.82 42.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -81.34 149.74 28.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.977 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.25 -36.62 3.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.719 ' CE1' ' NE2' ' A' ' 131' ' ' GLN . 42.3 t80 -86.83 -54.63 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.088 0.471 . . . . 0.0 110.242 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.618 ' CG2' ' CD2' ' A' ' 84' ' ' HIS . 1.0 OUTLIER -54.29 -45.51 99.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.833 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.0 Cg_exo -47.97 -17.54 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.231 1.954 . . . . 0.0 111.633 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mt -82.03 -37.58 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.107 ' O ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -68.78 -30.13 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 83' ' ' SER . . . -68.38 -31.28 70.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.078 0.466 . . . . 0.0 110.243 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.54 -28.54 46.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.867 ' SD ' HG22 ' A' ' 130' ' ' VAL . 15.6 ttp -75.16 -52.66 10.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.621 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.913 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -68.36 -24.42 64.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.023 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.782 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 4.1 t -72.83 -40.52 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.071 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' CD ' ' C ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -69.21 -50.97 42.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.6 mt -58.51 -41.17 84.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.1 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 52' ' ' TYR . 46.3 t -60.13 -39.37 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -62.45 -29.11 70.28 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.02 21.1 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.231 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' O ' ' C ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER 72.7 22.37 3.23 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 55' ' ' LEU . . . 7.1 92.77 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.628 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 55' ' ' LEU . 22.7 Cg_exo -62.58 36.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.046 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -172.02 154.84 3.57 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.857 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 1.5 tm-20 -115.24 148.98 38.46 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.069 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -99.81 133.27 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.347 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.566 ' CG1' ' O ' ' A' ' 30' ' ' GLY . 1.2 mm -99.74 136.84 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.867 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.29 107.69 18.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.858 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.583 ' O ' ' OD2' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -128.77 -151.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.154 179.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.891 ' O ' ' N ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER 71.41 149.65 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.189 -179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.625 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.3 OUTLIER -40.7 66.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.255 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.911 ' O ' ' N ' ' A' ' 72' ' ' SER . 3.6 m-20 -106.52 10.53 31.26 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HA ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -33.35 -8.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.519 -179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.911 ' N ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -80.36 111.86 17.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.626 179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' A' ' 77' ' ' PHE . 2.3 mt-10 -66.17 -24.29 66.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.615 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.6 -50.18 11.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.293 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CB ' ' CE3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -62.04 -23.56 66.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' PHE . 8.5 ttm -71.83 -64.01 1.02 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.845 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -65.97 -22.12 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.745 -179.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -75.15 -56.29 4.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.961 0.41 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -62.78 -22.58 66.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.11 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -51.37 8.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -28.52 69.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.667 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' O ' ' CB ' ' A' ' 83' ' ' SER . 4.6 mt-10 -59.03 -55.66 32.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.685 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.813 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 2.0 p 157.4 4.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.09 -0.504 . . . . 0.0 112.132 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.632 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 5.5 m80 -94.27 106.86 18.84 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 122.08 -0.387 . . . . 0.0 110.675 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.32 120.07 0.7 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' CG ' ' A' ' 87' ' ' TRP . 0.4 OUTLIER -116.45 60.56 0.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.34 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.739 ' O ' HD23 ' A' ' 88' ' ' LEU . 20.6 m-90 -159.07 -108.15 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.761 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.82 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 4.7 mt -127.57 176.19 7.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.674 0.749 . . . . 0.0 112.568 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -143.93 125.72 15.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.969 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.631 HG22 ' CB ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -72.22 113.36 19.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.469 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.767 ' O ' ' N ' ' A' ' 93' ' ' ARG . 49.5 Cg_exo -49.2 109.62 0.28 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 121.808 1.672 . . . . 0.0 111.457 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 2.6 p90 -29.84 -26.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.398 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.767 ' N ' ' O ' ' A' ' 91' ' ' PRO . 9.5 mtp-105 -84.53 21.92 1.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.279 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.728 ' N ' ' O ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -105.25 62.83 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.776 -179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.624 ' C ' ' O ' ' A' ' 94' ' ' SER . . . -7.86 -63.1 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.745 ' O ' HG23 ' A' ' 100' ' ' VAL . 5.4 Cg_exo -38.06 -24.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 123.081 2.521 . . . . 0.0 112.363 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 95' ' ' GLY . . . -77.87 -42.5 33.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.905 0.384 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -69.38 -64.01 0.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.902 ' HB3' ' HZ2' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -45.07 -33.21 2.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 96' ' ' PRO . 1.7 t -60.74 -52.59 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.787 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.42 ' N ' HG12 ' A' ' 100' ' ' VAL . 3.7 m -63.25 -46.37 87.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 0.0 110.465 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.04 -21.55 63.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.733 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.902 ' HZ2' ' HB3' ' A' ' 99' ' ' ASN . 33.6 mttt -79.23 -35.42 41.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.159 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -77.42 -15.12 59.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.546 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.06 36.23 60.69 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.797 ' C ' HG23 ' A' ' 107' ' ' THR . 1.5 mm -59.29 -105.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.688 0.28 . . . . 0.0 110.718 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.797 HG23 ' C ' ' A' ' 106' ' ' ILE . 0.8 OUTLIER 71.36 5.2 5.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.443 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.518 ' H ' HG22 ' A' ' 106' ' ' ILE . . . -99.74 15.5 59.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.895 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -55.48 139.78 66.59 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 56.1 Cg_endo -72.31 140.88 68.79 Favored 'Cis proline' 0 N--CA 1.495 1.612 0 C-N-CA 123.557 -1.435 . . . . 0.0 112.105 0.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.473 ' HA ' HD21 ' A' ' 125' ' ' ASN . . . -164.39 153.92 13.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.889 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 114' ' ' ILE . 2.3 tt -116.06 124.1 49.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.208 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.726 HG13 ' CE ' ' A' ' 124' ' ' MET . 2.3 t -107.12 125.28 63.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.656 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.764 HD11 ' CD2' ' A' ' 112' ' ' LEU . 44.6 mm -115.61 127.94 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.17 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.1 m -138.28 150.2 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.535 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 120' ' ' THR . 14.5 mttm -71.4 153.8 42.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.701 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 26' ' ' LYS . 0.4 OUTLIER -47.82 -49.78 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.62 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -13.17 20.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.447 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 116' ' ' LYS . . . 99.67 27.66 7.87 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 116' ' ' LYS . 0.2 OUTLIER -91.1 126.46 36.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.772 0.32 . . . . 0.0 110.758 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.949 HD13 ' H ' ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.81 144.77 54.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.335 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 1.023 HG23 ' H ' ' A' ' 123' ' ' SER . 0.8 OUTLIER -136.93 -65.01 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.62 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 1.023 ' H ' HG23 ' A' ' 122' ' ' ILE . 2.0 t -145.85 123.59 11.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.277 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.726 ' CE ' HG13 ' A' ' 113' ' ' VAL . 2.7 mmt -86.34 -108.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.875 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.473 HD21 ' HA ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -58.56 42.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.889 -179.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 124' ' ' MET . . . -77.4 16.91 5.62 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.516 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -42.61 -84.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.769 -179.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 132' ' ' SER . . . -43.49 -29.94 1.28 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 1.0 OUTLIER -58.91 -53.52 57.49 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.867 HG22 ' SD ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -67.7 -49.58 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.719 ' NE2' ' CE1' ' A' ' 44' ' ' PHE . 0.6 OUTLIER -62.73 -20.67 65.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.214 179.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 19.4 m -80.6 -54.48 5.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.074 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 7.1 mt -87.97 5.45 40.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' VAL . . . 56.01 -145.76 33.18 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -67.04 -14.59 44.11 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.271 1.981 . . . . 0.0 112.115 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' LEU . 3.4 mtt-85 -72.36 -10.42 59.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.28 0.562 . . . . 0.0 109.583 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 139' ' ' GLN . . . -67.95 -25.84 65.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 65.0 t80 -36.8 -21.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.761 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 143' ' ' ARG . 26.3 mt-30 -73.81 -51.2 17.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.885 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' ALA . 2.4 m-20 -71.97 -38.97 69.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.632 ' O ' HD13 ' A' ' 122' ' ' ILE . 5.0 m0 -70.64 -20.7 62.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.963 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 138' ' ' PHE . . . -123.78 7.21 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.295 0.569 . . . . 0.0 110.69 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.718 ' N ' ' O ' ' A' ' 139' ' ' GLN . 13.6 mmm180 . . . . . 0 C--N 1.317 -0.847 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 stop_ save_